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Chapter 1 
General Introduction and Scope 
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Over the past two decades global surgery has emerged as a new surgical discipline. Unlike its 
“international surgery” predecessor, global surgery is specifically defined as “an area for study, 
research, practice, and advocacy that places priority on improving health outcomes and achieving 
health equity for all people worldwide who are affected by surgical conditions or have a need for 
surgical care.”(1) The focus on equity of resources and advocacy establishes it therefore not only 
as a professional and academic discipline, but also extends it into social activism and health care 
policy.  
In order to achieve its above-stated goals, global surgery requires reliable metrics of burden of 
disease (BoD) in any given geographical or specialty area and the costs to “repair” the disease,  
both in the short- and long-run. Since the mid-1990s, primarily through the work of the Global 
Burden of Disease (GBD) Study Group (ref), the preferred  metric has progressively become the 
disability-adjusted life-year (DALY). The DALY is a “health gap” measure, a summary measure of 
health incorporating both mortality and morbidity. It is an example of a health-adjusted life years 
(HALY) measurement, similar but not identical with the quality-adjusted life year (QALY)(2). 
 
Figure 1: DALY infographic (3)  
The DALY basic formula is: 
DALY = YLL + YLD = N * LE + I * LE * DW,  
where YLL = years of life lost, YLD = years lived with disability, N= number of deaths in population, 
LE = life expectancy at onset of disease, I = number of incident cases in the population over period 
of time, and DW = disability weight. This “incidence perspective” was originally adopted in 1999 
for the entire formula because of YLL reflecting incident deaths in a population, but was replaced 
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from the GBD 2010 study onward to a prevalence-based YLD, with the revised formula YLD = P * 
DW, where P = number of prevalent cases of a health condition (4). 
Hence the mortality burden is simply expressed as the combined number of years of life lost 
through disease-related fatalities, while the morbidity burden modulates the combined number 
of years spent in disability by the disability weight factor, which is both anchored and constrained 
between 0 (perfect health) and 1(equivalent of death).  
There are several uncertainties and controversies surrounding the factors in this formula, which 
result in a spectrum of estimated DALYs rather than unique values. The life expectancy (LE) value 
used is generally based on a global “standard”, originally and commonly still the LE for Japan (5) 
– although some researchers have opted for country-specific LE values (6). The number of years 
lost or lived with disability is also prone to debate, as it can be a straight arithmetic value, or be 
adjusted to include future discounting and / or age weighting (5,7).  
The most debatable factor however in the DALY formula is the disability weight (DW), which was 
first introduced by Chris Murray in 1994 in the form of 6 operationally-defined classes of disability 
limitations (4). DW values have generally been estimated using various psychometric and 
econometric methods, including rating / visual analogue scales (VAS), paired comparisons (PC), 
standard gambles (SG), person trade-off (PTO), and time trade-off (TTO)(5,8,9). 
The GBD 2006 study has estimated DW values for 131 conditions health states (corresponding to 
291 diseases) across all medical and surgical specialties, using primarily the PTO technique, in 
which respondents are asked to choose between curing a certain number of individuals with one 
disease condition versus another number with a different condition (10). In the recently released 
GBD 2010 study, the number of health state DW values was expanded to 220 (corresponding to 
291 diseases), and the primary estimation method was PC (7). The values thus obtained were 
then used in the standard DALY formula to derive an extensive set of burden of disease data, 
categorized by global regions, countries, disease categories and specific conditions (7,10).  
While the GBD study has successfully provided a full global, regional and national picture of BoD, 
it has not been easily applied to any given clinical discipline. Thus, for instance, among its 220 
published DW values, only 5 actually apply to congenital surgical conditions (cleft lip, cleft palate, 
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anorectal malformation, neural tube defects, and cardiac defects)(4,10) – despite the broad 
spectrum of existing conditions. Thus any potential estimation of BoD within this specialty will 
require the generation of further DW values for the common pediatric surgical conditions.  
Besides the above limitations, the original BoD framework as popularized by the GBD study group 
was not meant to address surgical disease, and especially the impact of surgical intervention. For 
this reason surgical researchers have developed a unique framework for surgical BoD. This 
includes the separation of BoD into what was termed met burden (burden of surgical disease 
already addressed through surgical interventions,  measured in averted DALYs), unmet burden 
(burden of surgical disease remaining to be addressed at any given point in time, measured in 
avertable DALYs), and unmeetable burden (surgical disease deemed inoperable even in ideal 
settings at a given time, measured in unavertable DALYs) (11). While unaverted DALYs are simply 
“generic” DALYs as estimated by their study, averted DALYs take into account not only the direct 
impact of surgical intervention in DALY reduction, but also estimates of post-operative mortality 
and morbidity and probability of residual disease. Therefore this framework is not only able to 
identify the surgical work completed and that remaining to be done, but can evaluate all surgical 
procedures by the relative BoD that they can each address.  
The various stated limitations in the calculation of DALYs have resulted in an ongoing quest for 
alternative measures of burden of surgical disease. These have included the concepts of effective 
coverage (EC), surgical backlog, and cost-effectiveness measures. Effective coverage assesses the 
percentage of surgical interventions in any given area, relative to a standard number of 
interventions corresponding to ideal care (12,13). Surgical backlog attempts to estimate the 
number of unoperated patients with a given condition in an area, using either household surveys 
or age-based cohort calculations (14,15).  
Finally, economic valuations typically attempt to quantify the cost effectiveness of surgical 
interventions by calculating the cost of surgically averting one DALY or QALY (16–21). Such 
studies have shown that surgical interventions, including in pediatric and neonatal surgery, are 
quite cost-effective, at par with many medical interventions and often even more effective than 
them (22,23). The actual financial impact of surgical interventions can also be estimated using 
econometric methods including the value of a statistical life (VSL) (24). Such studies have been 
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incorporated in the recent Lancet Commission on Global Surgery (LCoGS) Surgery 2030, which 
has shown that surgery could restore up to 2.5% of the GNP of many LMICs (25). Unfortunately 
such cost-effectiveness analyses (CEA) are scarce in pediatric surgery, and no full economic 
impact studies have been published to date  on children’s surgery. 
Pediatric surgery is defined as “the diagnostic, operative, and postoperative surgical care of 
patients from prenatal diagnosis through adolescence with congenital and acquired anomalies 
and diseases, be they developmental, inflammatory, neoplastic, or traumatic. The scope of this 
discipline is broadly the same as general surgery, focused especially in infancy and childhood but 
to include the fetus, adolescent, and young adult with special health care needs arising from 
childhood surgical conditions”(26). Moreover, its spectrum varies significantly with the 
geographic and particularly the socioeconomic context (27,28). These features thus make BoD 
considerations in this relatively young subspecialty a useful model for other surgical specialties. 
Theme  
The recognition of surgical care as an essential component of health care has required evidence 
of its potential impact in health care systems and cost-effectiveness by comparison with other 
standard interventions. Such evidence, essential for advocacy for resource allocation in LMICs, is 
very limited in children. Not only are there few outcomes and cost-effectiveness studies in the 
specialty, but the required disability weights for most common pediatric surgical conditions are 
missing, and multidisciplinary long-term follow-up is virtually non-existing, even in high-resource 
countries (29,30).  
The focus of this thesis is therefore two-fold. In part I the theoretical framework for surgical 
burden of disease measurement is reviewed and critiqued, with several alternative metrics 
usable in pediatric surgery being offered.  
Part II includes several empirical studies exploring the implications and applications of the 
theoretical framework. This includes generating disability weights within pediatric surgery, then 
establishing the evidence for the burden of surgical disease in children and the cost-effectiveness 
of its treatment. 
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The following research questions are identified 
1. What are the limitations of the traditional DALY approach in measuring impact of surgical 
treatment, and how can current metrics be adjusted and adapted for meaningful use in a surgical 
specialty? (Chapters 2 and 3) 
2. Can valid disability weights be generated for a wider set of pediatric surgical conditions? 
(Chapter 4) 
3. What is the total burden of surgical disease in children in LMICs, and the magnitude of the 
backlog in surgical care? (Chapters 5 and 6) 
4. What is the burden of disease averted through surgical care of children in LMICs, compared to 
HIC settings? (Chapter 7) 
5. What is the burden of disease lost through delayed access to surgical care in LMICs? (Chapters 
6, 8, and 9) 
6. What is the cost effectiveness and economic impact of surgical care of children in LMICs? 
(chapters 6, 9 and 10)  
In chapter 11 the data are discussed and summarized.  
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Abstract 
Introduction  
In recent years, surgical providers and advocates have engaged in a growing effort to establish 
metrics to estimate capacity for surgical services as well the burden of surgical diseases in 
resource-limited settings. The burden of disease (BoD) studies have established the disability-
adjusted life year (DALY) as the primary metric to measure both disability and premature 
mortality. Nonetheless, DALY-based approaches present methodological challenges, some of 
which are unique to surgical conditions, not fully addressed through the multiple iterations of 
the BoD studies, including the most recent study. 
Methods and Results  
This paper examines these challenges in detail, including issues around age-weighting and 
discounting, and estimates of disability-weights for specific conditions. Surgical burden 
measurements of specific conditions, or through the assessment of hospital wards as platforms 
for service delivery, still have unresolved methodological hurdles. The 2010 BoD study 
addresses some of these issues, but many questions still remain. Other methods estimating 
surgical prevalence, backlogs in treatment, and disability incurred by delays in care may provide 
more practical approaches to disease burden that can be useful tools for clinicians and health 
advocates.  
Conclusions  
These approaches warrant further exploration in LMICs and these debates require active 
engagement by surgical providers and advocates globally.  
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Introduction  
Surgical providers working in low and middle-income countries (LMICs) bear witness to a 
significant  volume of preventable death and disability in some of the world’s most vulnerable 
populations. A  primary goal of surgical initiatives in these settings is to reduce this “burden of 
surgical disease.” To  clinical surgeons, the burden manifests in many forms: the injured patient 
or expectant mother needing  emergency care (and possibly surgery) who succumb or remain 
disabled, the patient with an acute  abdominal emergency who may die from irreversible sepsis 
with or without surgical intervention, or the  correctable deformity or enlarging tumor that 
inexorably progress, causing increasing levels of disability  and/or compromising quality of life 
to the patient, the family, and the community.  
While humanitarian surgeons have attempted to address this burden for decades, its accurate 
measurement has gained attention in recent years. Of course, many other categories of diseases 
also go  untreated or undertreated, and for this reason, the burden of disease (BoD) approach 
was developed to  lend a uniform approach to the measurement of death and disability. This 
paper reviews the  methodology associated with the BoD approach and highlights the 
challenges associated with this  methodology, even in the most recent iterations of the BoD 
study. Some of these challenges are  inherent to the methodology, while others are more 
specific to surgical conditions.  
This discussion is necessary to improve advocacy for surgical conditions, to measure of burden 
on  patients, families, and health care systems, and ultimately, to define impact on public health. 
These  debates may also improve the BoD metrics for non-surgical diseases as well. This paper 
first describes  the BoD model, then details some of the challenges in applying this model to 
surgical conditions, and  the adaptations required in the process. Finally, other conceptual 
approaches that have been used or  may be explored are suggested.  
Current model of burden of disease  
The burden of disease (BoD) framework was developed to measure, at the population level, the 
degree  of ill health due to fatal and non-fatal conditions, as well as the risk factors.[1] The DALY 
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metric was  developed as a composite metric of both mortality and disability. More formally, 
the DALY combines  years of life lost (YLLs) for fatal conditions with years of life lived with 
disability (YLDs): DALY = YLL + YLD.  The YLL is computed as the life expectancy minus the average 
age of death. The calculation of YLDs  requires estimates of disability weights (DWs) for disease 
severity (explained further in this paper). The  DWs have traditionally been estimated through 
complex panel/expert opinion, as discussed below. They  can also be estimated using a table of 
increasing disability markers as proposed by Murray (1994), who  categorized severity of non-
fatal outcomes into six classes, based on the impact on function in various  spheres of life 
activity.[2] While the former set of DWs is limited to the diseases covered by successive  BoD 
studies, the latter can be applied to any known condition and are thus particularly useful for  
specialties (such as surgery) not sufficiently addressed by published BoD studies.  
The impact of health intervention can be measured by the BoD averted in DALYs , using the 
following  formula, for fatal conditions:  
Averted DALYs from one intervention = LEAge at operation * RD * PST  
(LEAge at operation = years of life lost through early death, PST= probability of successful treatment, 
RD = risk of death without the procedure).  
Thus, for instance, the DALYs averted through an appendectomy for acute appendicitis in a 20-
year old patient would be calculated thus: 
60 (life expectancy in a population at age 20) * 0.1 (mortality of acute appendicitis 
between 5-24%) * 1 (over 95% chance of permanent cure for appendectomy) = 6 DALYs. 
For non-fatal conditions, impact can similarly be measured as  
Averted DALYs from one intervention = LEAge at operation  * DW * RPD * PST  
(RPD = risk of  permanent disability). 
The DW value used here is that for unoperated cases (before treatment), and the residual 
disability is accounted for by the PST. Thus, for instance, the DALYs averted through a cleft lip 
repair procedure in a 10-year old girl would be calculated as 
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70 (life expectancy in a population at age 10) * 0.05 (DW for cleft lip) * 1.0 (cleft is a permanent 
disability) * 1.0 (over 95% chance of cure for cleft lip repair) = 3.5 DALYs. 
Both RPD and PST range from 0 to 1, thus more DALYs are averted through interventions for 
conditions  with higher risk of long-term disability and high possibility of successful treatment. 
Multiple  investigators have used this approach, with modifications, to estimate the burden of 
disease averted by  a range of surgical interventions in hospitals in LMICs.[3, 4]  
 Proponents of the BOD methodology cite the uniformity in calculation that allows for 
comparability  between diseases and sequelae without the bias that may be introduced by 
advocates for particular  conditions, or by instruments that can only be used for certain 
categories of conditions.  
Problems with current concept  
Almost from its inception, the Global Burden of Disease (GBD) framework and its metric, the 
DALY, were  met with strong criticism. The view of Alkire et al resonates with many researchers: 
the DALY is a useful  tool to compare health outcomes, but presented as a concept in isolation, 
it has little meaning to most  audiences.[5] Yet the DALY is, and will remain, the GBD metric for 
the foreseeable future. A brief review  of its drawbacks will help frame our contention that it 
might not be the best-suited metric to address  the burden of surgical conditions.  
One of the main purposes of the BoD study was to inform resource allocation. By nature, it was 
more  driven by incidence than by prevalence. Because of the relatively poor quality of data 
from LMICs, it had  to rely on many assumptions concerning effectiveness, quality and 
coverage.[6] By nature also, the use  of the DALY metric implied some value choices: 
hypothetical life expectancy, age weighting, discounting  and the use of disability weights. These 
choices are intrinsically subjective, and thus vulnerable to  critique on ethical, moral, and/or 
philosophical grounds.   
Based on the equity principle, it was decided that an ideal life expectancy (the longest one at 
the time,  found in Japan) should be the universal norm. Although laudable in concept, it soon 
became apparent  that for countries or regions with low life expectancy, the overall burden -
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and therefore also the  avoidable burden, particularly for lethal conditions -could be 
overestimated. Using relevant cohort life  expectancies that are country-or region-specific, as 
suggested by Fox-Rushby, invariably reduces  projected life expectancies in LMICs, so the “true” 
burden is always less than that measured using an  “ideal” life expectancy.[7] Thus the use of 
universal life expectancy, in the context of priority setting and  resource allocation, may put 
unrealistic demands and expectations on policy makers and implementers,  and actually 
decrease the effectiveness of the process.[8] Despite these concerns, until now the BoD  
framework still uses the hypothetical ideal universal life expectancy.   
Age weighting reflects the concept that life is valued differently at different ages. The standard 
DALY, by  using an age-weighting modulation parameter, incorporates the value that life is 
worth less at its  extremes than in the middle productive years. Thus the BoD for children and 
the elderly is  underestimated compared to young adults. Discounting is based on the premise 
that future years have  less value than present years. A standard 3% per year discount, common 
in banking practices, was  applied to DALYs. This approach has been largely criticized on the 
ground that it reflects the values of  the GBD framers, but is not universally acceptable. There 
are thus multiple DALYs: the standard DALY  (0.03,1), with discounting and age weighting, 
DALY(0.03,0) with discounting but no age weighting, and DALY (0,0) without either. The latter 
has recently become the one most often used in BoD studies,  making comparisons with studies 
using the former, “standard” DALY (0.03, 1) both confusing and  difficult.   
Disability weighting is probably the area of greatest controversy. A panel of experts arbitrarily 
assigned  universal DWs between 0 (perfect health) and 1 (death) for a comprehensive (but far 
from exhaustive)  set of non-lethal diseases/conditions, using the person trade-off (PTO) 
approach. DWs are however not  stable – they can change in the short vs. long term, and 
whether the condition is treated or not. It was  also soon noted that the impact of disability is 
highly contextual globally.[9] In addition, many feel that  some diseases or groups of diseases 
associated with poverty (and potentially less familiar to the expert  panel) are under-valued.[10] 
Moreover, a single summary figure is of questionable usefulness for  heterogeneous categories, 
such as intra-cranial injuries, which have a wide array of potential  outcomes.[11] Some DWs 
were actually inconsistent: the DW for thumb amputation was higher than  that for arm 
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amputation, for instance! Most conditions (86% of communicable and 51% of 
noncommunicable  diseases) had the same DW whether they were treated or not, and a few 
DWs actually  increased with treatment (acute glomerulonephritis, for example). The 2004 GBD 
study includes several  flaws: for instance in the Injury group, all of the 12 fractures/dislocations 
have the same DW with or  without treatment, and hip dislocation actually has a DW lower that 
the one for foot fractures. [12]   
Based on all these issues, the appropriateness and usefulness of the initial DWs was questioned.  
Arnesen and Nord (1999) concluded that there was an underlying implicit inference: that it is 
more  important to save a healthy life than a disabled one.[9] Some, but not all, of the above 
concerns have  been addressed by subsequent GBD updates.  
The recently published GBD 2010 has tried to address these criticisms with fundamental 
revisions of its  methodology.[13] YLDs are now calculated in their simplest form: prevalence of 
condition A * DW,  without age weighting or discounting (DALY 0,0). The DWs have themselves 
been revised: a multi- country community-based survey and an open-access web-based survey 
have recruited over 30,000  respondents using paired comparison questions in which they had 
to choose the healthiest of 2  hypothetical health states. DWs thus obtained are now much 
more “democratic”, no longer just in the  realm of expert panels. Of interest also is that, for the 
first time, YLD estimates are adjusted for comorbidities.  Interesting findings include the top 5 
causes of disability in men: low back pain, depression,  falls, use of drugs and road traffic injuries 
(RTIs). In fact, falls and RTIs together account for 70% of all  injury-related YLDs.   
Unfortunately, from a functional standpoint, many of the DWs still do not make much sense: 
back pain  without leg pain has a DW of 0.269 and neck pain 0.221, both many times higher than 
amputation with  treatment of both arms (0.044) or both legs (0.051)! Hip dislocation, with or 
without treatment, has a  DW of 0.017 (more or less the same as hand fracture, 0.016) compare 
poorly to knee dislocation, with or  without treatment, at 0.129. As for spinal cord injury below 
the neck, it has a DW of 0.440 untreated  (still better than recto-vaginal fistula, 0.492), but it 
dips to 0.047 if treated; severe osteoarthritis is worse   (0.171) than severe mental retardation 
(0.157) -these are just a few examples. It appears clearly that  respondents have given more 
weight to pain and social stigma than to loss of function, maybe in  keeping with the fact that 
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these are “disability”, rather than “impairment”, weights. The newest GBD  study will 
undoubtedly open itself up to a new, different set of criticisms. In addition, the Vision Loss  
Expert Group was quick to point out that the new disability weights for vision loss and blindness 
were  much lower than in previous iterations, and did not pass the “common-sense test” 
(blindness given a  barely higher DW at 0.195 that moderate skin disfigurement at 0.187, and 
much lower than mild  alcoholism at 0.259. In response, the authors suggested that maybe it 
was the old weights that were  wrong. They also noted that many other expert groups had made 
similar comments. [14]  One obvious consequence is that comparing studies using the new 
versus old methodology will be very  difficult. For example, low back pain, one of the leading 
causes of YLDs in the current study, is not even  mentioned as a separate entity in previous GBD 
studies.   
It remains to be seen if and how this latest iteration of the GBD study will re-define a more 
effective  DALY. It is likely that a single summary measure will never be completely satisfactory. 
The main  advantage of the DALY, ensuring comparability across a wide spectrum of conditions, 
may also be one of  its greatest drawbacks: oversimplification of complex, multi-layered issues. 
This oversimplification is  prone to mislead policy makers into the false comfort of relying on 
only one number. Using the GBD  framework as the main -and often only – health metric to 
inform priority-setting and resource  allocation, has been decried, even opposed, by many. [8, 
9, 11, 15]   
For surgeons to be able to characterize, measure, and address the growing burden of surgical 
disease  (BoSD), a different paradigm may be necessary. Vos (2009) has recommended 
evaluation of surgical  services rather than surgical conditions.[6] Indeed surgeons, along with 
other clinicians and  policymakers, are concerned not only with how much of a problem there 
is, but also how much of it can  be addressed, and with what measurable impact. If the GBD 
framework is to be used, as proposed by  some (Duda 2008), the recommendations of Fox-
Rushby and Hansen (2001) should be considered: use  of relevant cohort life expectancies, 
presentation of DALYs both with (0.03,1) and without (0,0)  discounting and age weighting, and 
always performing a systematic sensitivity analysis.[16, 17] As it  stands, the GBD framework 
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focuses more on disease than on intervention, and this is less than ideal for  understanding all 
determinants of the BoSD.   
This distinction was further illustrated by a recent first estimate of the disease burden avertable 
through  surgery.[18] Although, by the authors’ own admission, the estimates were based on 
insufficient data,  the attempt to quantify surgical burden across all disease categories 
highlighted methodological  challenges different from those in more vertical clusters. For all the 
reasons above, estimating avoidable  burden from a cross-cutting intervention such as surgery 
proved difficult within the BoD framework, and  the DALY somewhat unyielding for this purpose.   
Alternative approaches  
In addition to DALY estimates of surgical conditions on surgical wards in LMICs, recent estimates 
of  surgical burden have been through community surveys of operative prevalence and unmet 
surgical  need.[19, 20] Other work has focused on specific conditions such as cleft lip and palate, 
and vesicovaginal  fistula using organization-specific databases and multi-country studies. [21, 
22] Economic  estimates have also broadened to value/statistical life over costs per DALY 
averted, widening the  spectrum of tools available to estimate the cost-effectiveness of surgical 
interventions. [23] For nonfatal  conditions, estimates of operative backlog may be useful for 
advocacy and for estimation of  resources required to adequately treat patients. Surgical 
conditions, often curable through a single  intervention, are better amenable to this type of 
assessment, as opposed to chronic diseases requiring  ongoing therapy. Another area in further 
need of scrutiny is the measurement of disability incurred  through delays in care. As diseases 
go untreated, the associated disability increases – yet very few  attempts have been made to 
date to capture this “hidden” disability.   
Such non-DALY based BoD metrics may provide the basis for better assessment of surgical 
systems, and  of the public health impact of surgical care. These approaches are likely to require 
greater academic  debate, validation, and refinement in the foreseeable future. Nonetheless, 
such discussions are critical  to advance the science of surgical metrics within global public 
health and to provide better ways of  analyzing the need and the impact for improved surgical 
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care in resource-limited settings. Only through  these efforts can the gaps in care capacity and 
complications witnessed by surgical providers be  translated into practical data.   
Conclusions  
DALY-based approaches to the burden of disease provide a set of methodological challenges, 
some of  which are unique to surgical conditions, not fully addressed through the multiple 
iterations of the BoD  studies. Even with attempts to quantify burden through specific 
conditions, or through the assessment  of hospital wards as platforms for service delivery, there 
are methodological hurdles that are difficult to  overcome. The 2010 BoD study addresses some 
of these issues, but many questions still remain.  Perhaps more importantly, other methods 
estimating surgical prevalence, backlog in treatment, and  disability incurred by delays in care 
may provide more practical approaches to disease burden that can  be useful tools for clinicians 
and health advocates. These warrant further exploration in LMICs and these  debates require 
active engagement by surgical providers and advocates.   
 
  
23
References  
1. Murray, C.J., A.D. Lopez, and D.T. Jamison, The global burden of disease in 1990: summary  
results, sensitivity analysis and future directions. Bull World Health Organ, 1994. 72(3): p. 
495509.  
2. Murray, C.J., Quantifying the burden of disease: the technical basis for disability-adjusted life 
years. Bull World Health Organ, 1994. 72(3): p. 429-45.  
3.  McCord, C. and Q. Chowdhury, A cost effective small hospital in Bangladesh: what it can 
mean  for emergency obstetric care. Int J Gynaecol Obstet, 2003. 81(1): p. 83-92.  
4.  Gosselin, R.A., A. Thind, and A. Bellardinelli, Cost/DALY averted in a small hospital in Sierra  
Leone: what is the relative contribution of different services? World J Surg, 2006. 30(4): p. 
50511.  
5.  Alkire, B., et al., Potential economic benefit of cleft lip and palate repair in sub-Saharan Africa.  
World J Surg, 2011. 35(6): p. 1194-201.  
6.  Vos, T., Improving the quantitative basis of the surgical burden in low-income countries. PLoS  
Med, 2009. 6(9): p. e1000149.  
7.  Walker, D. and J. Fox-Rushby, Allowing for uncertainty in economic evaluations: qualitative  
sensitivity analysis. Health Policy Plan, 2001. 16(4): p. 435-43.  
8.  Mooney, G. and V. Wiseman, Burden of disease and priority setting. Health Econ, 2000. 9(5): 
p.  369-72.  
9.  Arnesen, T. and E. Nord, The value of DALY life: problems with ethics and validity of disability  
adjusted life years. Bmj, 1999. 319(7222): p. 1423-5.  
10.  King, C.H. and A.M. Bertino, Asymmetries of poverty: why global burden of disease 
valuations  underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis, 2008. 
2(3): p. e209.  
11.  Haagsma, J.A., et al., Improved and standardized method for assessing years lived with 
disability  after injury. Bull World Health Organ, 2012. 90(7): p. 513-21.  
24
12.  Salomon, J.A., et al., Common values in assessing health outcomes from disease and injury:  
disability weights measurement study for the Global Burden of Disease Study 2010. Lancet, 
2012.  380(9859): p. 2129-43.  
13.  Murray, C.J., et al., GBD 2010: design, definitions, and metrics. Lancet, 2012. 380(9859): p. 
20636.   
14.  Taylor, H.R., et al., Disability weights for vision disorders in Global Burden of Disease study.  
Lancet, 2013. 381(9860): p. 23.  
15.  Kapiriri, L., T. Arnesen, and O.F. Norheim, Is cost-effectiveness analysis preferred to severity 
of  disease as the main guiding principle in priority setting in resource poor settings? The case 
of  Uganda. Cost Eff Resour Alloc, 2004. 2(1): p. 1.  
16.  Duda, R.B. and A.G. Hill, Surgery in developing countries: should surgery have a role in  
population-based health care? Bull Am Coll Surg, 2007. 92(5): p. 12-8, 35.  
17.  Fox-Rushby, J.A. and K. Hanson, Calculating and presenting disability adjusted life years 
(DALYs)  in cost-effectiveness analysis. Health Policy Plan, 2001. 16(3): p. 326-31.  
18.  Debas, H., et al., Surgery, in Disease Control Priorities in Developing Countries, D. Jamison, 
Editor  2006, Oxford University Press: New York and Oxford.  
19.  Petroze, R.T., et al., Estimating operative disease prevalence in a low-income country: 
Results of  a nationwide population survey in Rwanda. Surgery, 2012.  
20.  Groen, R.S., et al., Untreated surgical conditions in Sierra Leone: a cluster randomised, cross- 
sectional, countrywide survey. Lancet, 2012. 380(9847): p. 1082-7.  
21.  Capes, T., et al., Obstetric fistula in low and middle income countries. Mt Sinai J Med, 2011.  
78(3): p. 352-61.  
 22.  Poenaru, D., Getting the Job Done: Analysis of the Impact and Effectiveness of the 
SmileTrain  Program in Alleviating the Global Burden of Cleft Disease. World J Surg, 2012.  23.  
Corlew, D.S., Estimation of impact of surgical disease through economic modeling of cleft lip 
and  palate care. World J Surg, 2010. 34(3): p. 391-6.  
25
Chapter 3 
Burden, need, or backlog: A call for improved metrics 
for the global burden of surgical disease 
Poenaru D, Ozgediz D, Gosselin RA 
International Journal of Surgery (2014) 12(5):483-486 
  
26
Abstract 
The global burden of disease (GBD) has been measured primarily through the use of the DALY 
metric. Using this approach, preliminary estimates were that 11% of the GBD is surgical. 
However, prior work has questioned specific aspects of the GBD methodology as well as its 
practicality. This paper refines other conceptual approaches based on met and unmet population 
need for services by considering incident and prevalent need as well as backlogs for treatment 
that can inform effective coverage of services. Some of these methods are tested using the 
example of surgical repair of cleft lip and palate. Measurement of disability incurred by delays in 
care may also be estimated through these approaches and has not previously been estimated 
through a validated model. These concepts may provide more practical information for 
individuals and organizations to advocate for scaling up surgical programs. While many surgical 
conditions are unique, as a single intervention can lead to cure, these concepts may also prove 
useful for non-surgical diseases. Further exploration of these approaches is merited in resource-
limited settings. 
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Introduction: Problems with the current burden of 
disease model 
The burden of disease (BoD) framework was developed as a population measure of ill-health. (1) 
The disability-adjusted life-year (DALY) was a unique innovation because it added disability to 
mortality in a single metric, and since its inception, has been the primary BoD metric. One of its 
greatest benefits has been its facilitation of comparisons across disease categories and risk 
factors, and disparities across regions, enabled by the use a single uniform metric.  
Nonetheless, in isolation, the DALY has little meaning to most audiences, and philosophical and 
methodological criticisms, such as the approach to disability-weighting, have been raised. (2)The 
most recent BoD study has attempted to address some of these concerns. Other models of 
disability advocate a social approach over a medical disease-based approach, highlighting social 
causes and interventions to improve well-being for persons with disabilities. (3) The Katz 
activities of daily life index and the Washington disability index, for example, provide practical 
measurement tools of disability burden, while many authors have also called for a novel 
internationally comparable disability measure. 
Surgical conditions cut across all major disease categories (infectious, non-communicable, 
injuries). This, among other reasons, has made it difficult to estimate surgical burden using the 
DALY approach compared to more “vertical” disease clusters. Surgical conditions are also unique 
because unlike many “medical” interventions, the treatment is often curative with a single 
intervention.  Surgical planners are interested in measuring not only the surgical burden, but also 
the population impact of scaling up surgical interventions. Several studies have attempted to 
estimate burden averted by surgical wards in rural hospitals, but there remains a need for 
improved metrics. (4) 
Suggestions for change 
Several proposals would address the needs highlighted above.  
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Use “need” rather than “burden” 
Although the terms “burden of surgical disease” and “surgical need” have been used 
interchangeably, they are not identical. While BoD refers to “what is there”, need implies “what 
is missing”. BoD was primarily intended to aggregate health state data and was not designed for 
subdivision beyond the level of diseases and associated risk factors. Need, on the other side, has 
already been adapted for global surgery by dividing it into met, unmet, and unmeetable need.(5) 
We therefore propose the term “need” to quantify surgical disease and the impact of surgical 
care. This parallel pathway could allow further development of metrics appropriate to global 
surgery, without applying concepts of BoD in ways that they were not intended.  
Disaggregate BoD into met / unmet, incident and prevalent  
The concept of dividing surgical need into met, unmet, and unmeetable need suggested by 
Bickler et al. has proven extremely useful for global surgery. For any given country, region, or 
surgical condition, one can theoretically estimate a total need (in DALYs) for surgical care, a need 
met at any given point in time (in “averted DALYs”) through current surgical activity, and an 
unmet need (in “avertable DALYs”). This is the essence of the “conventional model” depicted in 
Figure 1A. 
Figure 1: The conventional (A) and proposed (B) models for components of burden of disease 
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Furthermore, access to surgical in LMICs is frequently delayed. For fatal conditions this results in 
increased mortality, but for non-fatal conditions, the significant BoD caused by this delay has not 
been measured to date. Thus when surgical care is provided to a population, the met need will 
be partly “timely met” (or “incident met”, for new cases that are successfully treated on time), 
and “delayed met” (or “prevalent met”, for cases that are being treated in a delayed time frame). 
Delayed provision of care results in an actual averted burden (calculated in future DALYs averted), 
but also finalizes a “lost” unmeetable need (calculated in DALYs lost before the intervention). 
Similarly, in any given population the unmet surgical need will include not only the new cases 
emerging during a period of time (the “new / incident unmet need”), but also those who have 
missed being performed earlier due to ineffective coverage (the “delayed / prevalent unmet 
need”) (Fig. 1B). Appendix 1 provides a real-life example, using cleft lip and palate, and comparing 
metrics generated through the DALY approach with those generated through alternative metrics 
proposed here.. 
It is noteworthy that traditional summary DALY estimates include neither the backlog factor nor 
the lost unmeetable need. Figure 2 depicts a hypothetical typical disaggregation of surgical need 
in ideal settings, in high-income countries (HICs), and in our LMIC calculation above. Besides truly 
unmeetable needs, only in the ideal setting is 100% of the need met promptly, at the “incident” 
stage. In the “real world” there will always be some delayed access resulting in needs met at the 
“prevalent” stage, as well as some unmet and unmeetable needs.   
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Figure 2: Model disaggregation of surgical need in an ideal setting, in a high-income countries (HIC) 
scenario, and in the current calculation for low-and-middle-income countries (LMIC) 
 
Furthermore, the disability associated with untreated surgical disease can increase over time, 
and render delayed surgical intervention less effective. This reality continuously inflates the 
unmet need at the expense of the met need. As a result, care can be delayed to the point of 
becoming so difficult to provide that it becomes ineffective, futile, or even undesirable (hence 
“realistically unmeetable”).  Examples of such futility of intervention include unrepaired cleft 
palate beyond childhood, late-presenting tumors, and delayed presentation of gross 
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Table 1: Estimated Global Surgical Backlog for Selected Non-Fatal Conditions, compared to HIV 
Care 
Cataracts 50 million eyes 
Trichiasis 8.2 million people 
Obstetric fistula 2 million women 
Cleft lip/palate 1.1 million people 
HIV care 9 million people  
 
Tabin et al (2008), Habtamu et. al (2012),  Capes et. al (2008), Poenaru (2012), UNAIDS (2012) 
In the absence of national or regional wait lists, the only option for backlog estimates would be 
extensive (and expensive) community surveys. For example, a recent survey in Sierra Leone 
showed that 25% of household members reported a surgical condition needing attention, while 
in Rwanda, a 41% lifetime prevalence of an operative condition was estimated using the same 
instrument.(11, 12) Piloting the use of such metrics may require prioritized measurement of a 
few surgical conditions for validation, as proposed recently.(13) 
There is however another surrogate measure of backlog: the mean age delay between time of 
onset of a surgical condition and the time of corrective surgery. At a population level, each year 
of delayed intervention results in a new cohort of untreated patients, equal (assuming again no 
condition-related mortality) to the number of new cases with that condition appearing in the 
population. Thus a mean delay of 5 years in an intervention would generate 5 cohorts of 
untreated patients, as exemplified in the calculation above. In the case of congenital conditions, 
the cohorts equal the incidence of the condition in any given population, and the delay is the 
difference between the age at intervention and the ideal age of treatment.  Any condition-related 
mortality would naturally decrease the size of successive cohorts. Figure 3 adds change in backlog 
to a plot of the sample cleft palate calculation over a 10-year period. 
As expected from the above assertions, provision of care in a population in excess of the yearly 
incidence of new cases would gradually result in a decrease in the mean age at treatment, 
reflecting a decrease in backlog.(9, 14, 15) Once the backlog for a specific condition is cleared in 
any given region, the unmet need becomes equal to the yearly incidence in the population, and 
all patients are treated at their ideal age.  
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Combine backlog with effective coverage (EC) of populations 
EC is defined as the fraction of potential health gained that is actually realized for a health 
intervention. At the national level, the best example of the use of EC was in Mexico, where 
effective coverage was estimated for essential health interventions in each region.(16) 
EC was explored as a surgical metric in trauma and obstetrics.(17) In obstetrics, studies of unmet 
need have used emergency obstetric care indicators, thus limiting their applicability to other 
conditions. (18) Mock et al. recently estimated that approximately 2 million deaths could be 
averted globally in severely injured adults with improved trauma systems, though that study did 
not estimate actual EC.(19) 
In its basic form, EC = met need / (met + unmet need). Therefore, in an ideal scenario with no 
unmet need, this ratio would be one; in contrast, with minimal needs met, the ratio would be 
closer to zero. Moreover, EC integrates need, use, and quality of care for an intervention - and 
the aforementioned Mexican study measures of each of these dimensions with validated tools. 
(16) 
Backlog calculations, as discussed in the previous section, may provide a practical method to 
calculate EC for priority non-fatal surgical conditions.  Backlog corresponds to unmet need, while 
met need can be calculated from health facilities providing surgical services. Countries and 
regions with large surgical backlogs would thus have low rates of EC. Regionally, such estimates 
could allow for improved planning and measurement of disparities both within regions and 
countries. The concepts of incident and prevalent met and unmet need as discussed previously 
could be incorporated into EC, but to our knowledge this has not been done. 
Using the hypothetical model calculation above, the EC would be 80% in the absence of a backlog. 
A more realistic estimate is derived however by taking into account the backlog: 
EC = met need / total need = (total need – backlog)/total need = 1 – backlog/total need. 
This EC, actually decreasing over time in our sample calculation, is plotted in Figure 3. 
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Figure 3: Relationship between effective coverage, timely and delayed intervention, and backlog 
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constant across populations, compared to acquired surgical conditions that may exhibit greater 
geographic variation. 
Conclusions  
Current measurements of the BoD are still primarily based on the DALY, which ensured 
comparability through a single metric combining morbidity and mortality, but has also has some 
disadvantages as a sole burden metric. Disability incurred during delays in care, for example, is 
not captured through this model. Alternative, potentially more practical approaches to surgical 
burden include estimates of backlogs for prevalent non-fatal conditions requiring surgical 
treatment. This may also facilitate estimates of incident and prevalent met and unmet need at 
the population level, as well as effective coverage for surgical conditions. Further work is needed 
to explore the usefulness of these approaches for surgical care in LMICs. Initial approaches could 
be made through estimates for surgical congenital anomalies, where incidence across 
populations may be more constant. The metrics proposed here may also prove useful for non-
surgical areas of health service delivery.   
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Abstract 
Background 
Burden of disease (BoD) as measured by Disability-Adjusted Life Years (DALYs) is one of 
the criteria for priority-setting in health care resource allocation. DALYs incorporate 
disability weights (DWs), which are currently expert-derived estimates or non-existent 
for most pediatric surgical conditions. The objective of this study is to establish DWs for 
a subset of key pediatric congenital anomalies using a range of health valuation metrics 
with caregivers in both high and low-resource settings. 
Methods 
We described 15 health states to health professionals (physicians, nurses, social 
workers, and therapists) and community caregivers in Kenya and Canada. The health 
states summaries were expert- and community-derived, consisting of a narrated 
description of the disease and a functional profile described in EQ-5D-5L style. DWs for 
each health state were elicited using four health valuation exercises (preference 
ranking, visual analogue scale (VAS), paired comparison (PC), and time trade-off (TTO)). 
The PC data were anchored internally to the TTO and externally to existing data to yield 
DWs for each health state on a scale from 0 (health) to 1 (dead). Any differences in DWs 
between the two countries were analyzed. 
Findings 
In total, 154 participants, matched by profession, were recruited from Kijabe, Kenya 
(n=78) and Hamilton, Canada (n=76). Overall calculated DWs for 15 health states ranged 
from 0·13 to 0·77, with little difference between countries (intra-class coefficient 0.97). 
However, DWs generated in Kenya for severe hypospadias and undescended testes 
were higher than Canadian-derived DWs (p=0.04 and p<0.003, respectively).  
Interpretation 
We have derived country-specific DWs for pediatric congenital anomalies using several 
low-cost methods and  inter-professional and community caregivers. The TTO-anchored 
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PC method appears best suited for future use. The majority of DWs do not appear to 
differ significantly between the two cultural contexts and could be used to inform 
further work on estimating the  burden of global pediatric surgical disease. Care should 
be taken in comparing the DWs obtained in the current study to the existent list of DWs 
because methodological differences may impact on their compatibility. 
Background 
The global health data provided through the Global Burden of Disease (GBD) study1 
using the Disability-Adjusted Life Year (DALY) metric has been a key component in the 
development of health policy, especially in low- and middle-income countries (LMICs). In 
such settings, in the absence of available primary data, GBD data have been proposed 
and used for broad health care initiatives, such as the Lancet Commission on Global 
Surgery2. Within specialty areas, this necessitates a level of granularity that has not been 
originally intended or provided. Such is the case of pediatric surgery, where concerted 
efforts to improve access to care and quality of care lack data support.   
In 2006, Debas conservatively estimated that 11% of the GBD was being attributed to 
“surgical disease”3, i.e. health conditions primarily treated through surgical intervention. 
More recently, Shrime et al placed this percentage to as high as 30%4, though the 
methodology used to derive this figure is not clear. Disproportionately carrying this 
surgical burden are children in LMICs, who have garnered increased attention in the 
global surgery community5. Congenital anomalies, one of the largest subsets of pediatric 
surgical conditions, are believed to account for 1.9% of the GBD6, although this is likely 
to be an underestimate due to the limited number of conditions studied and the 
difficulty associated with capturing BoD data7. The primary objective of this study was 
thus to enable the estimation of DALYs for a subset of key pediatric congenital 
anomalies. 
The DALY is a widely used metric in LMICs  developed to quantify BoD and inform global 
priority-setting and resource allocation8,9. It encompasses both mortality and morbidity 
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by combining the number of years lost due to premature mortality (Years of Life Lost, 
YLLs) and the Years Lived with Disability (YLDs). Calculating the latter requires a disease-
specific disability weight (DW), which is an empirically determined factor reflecting the 
health decline associated with each health state, ranging between 0 (perfect health) and 
1 (death)7,10. Estimation methodologies for DWs are wide-ranging and potentially 
contentious11. All valuation methods are by definition judgmental tasks solved by 
participants at the moment of the exercise and results about their compatibility are 
mixed as best8. There is no reason to expect the same results across all methods, yet 
comparability with other DWs remains a key requirement in the GBD context to prevent 
methodological differences impacting the outcomes of burden of disease comparisons 
across countries and diseases areas. A preferred option therefore is to construct new 
DWs using similar estimation methods and assumptions as used in the GBD context, 
although this has been somewhat of a moving target.   
Many different methods for DW estimation have developed over time. DWs may for 
instance be elicited through various psychometric exercises 12  or by trade-off 
methods 13 . The former include ranking exercises, magnitude estimation, visual 
analogue scaling (VAS), and pairwise comparison (PC) or rank ordering tasks. The latter 
comprise the standard gamble, time trade-off (TTO), and person trade-off (PTO)8 
methods. The earliest DALY version appeared in a 1993 World Development Report, 
assigning conditions to various degrees of perceived disability14. In the second DALY 
version by Murray and Lopez , published in 1996 as part of the 1990 GBD study15, 
medical expert decisions-makers valued a subset of 22 indicator disease-oriented 
scenarios using the PTO method, then used the rating scale generated for the entire set 
of 131 conditions. The Dutch Disability Weights Project16  expanded the available 
weights by eliciting PTO values for another set of conditions described using the EQ-5D 
and an additional cognition dimension17. Subsequent modeling of those Dutch data by 
the Australian BoD team further expanded the set of available DWs18. In the most recent 
GBD update19, the methodology was significantly changed to a world-wide survey of 
over 30,000 household- and web-based PCs covering 220 unique health states. The 
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results of the PCs were then anchored on a subset of 30 health states for which 
population health equivalence choices were elicited through one of the four used web-
based surveys. Other parallel efforts in North America include the US National Institutes 
of Health DALY study8, and the Public Health Agency of Canada’s  Classification and 
Measurement System of Functional Health (the CLAMES system)20. Haagsma et al offers 
a comprehensive review of DW methods and studies published through 201221. 
The methods have clearly advanced with the scope of DW investigation. The methods 
used in the most recent GBD update are flexible and generate a high level of granularity 
by adopting the PC method while minimizing complexity of respondents’ task through a 
limited number of complex population health equivalence choices19. Despite the above 
efforts, DW values for many surgical conditions, particularly within subspecialties, are 
missing22, thus rendering the quantification of surgical BoD challenging. Moreover, the 
original and subsequent GBD studies have summarized health states and their sequelae 
by age groups, regions and countries, rather than analyzing them by (sub)specialty. As a 
result, the burden of surgical conditions affecting children, especially in LMICs, has not 
been formally estimated, and their DWs are conspicuously missing3. In fact the 2006 
extensive volume on the GBD Study only included DW values for 7 congenital surgical 
conditions in four disciplines, themselves pulled from the original GBD 1990 study 7, and 
there were none in GBD 2010. In their absence, surgical specialty literature has used DW 
proxies, estimated by expert opinion using ballpark disability descriptions23,24,25,26.   
This study intends to address the above gaps by investigating DWs for 15 congenital 
pediatric surgical conditions. Given the controversy surrounding the influence of cultural 
factors on the DW process26, this study’s DWs were derived in both Canada and Kenya. 
In developing our strategy we acknowledged the GBD Study viewpoint that achieving 
comparability of DWs across countries, time periods and – in our case- disease areas is 
of utmost importance. While the possibilities to perfectly achieve this are inherently 
limited because data will necessarily be collected at a different  moment in time and in 
different resource contexts, we attempted to broaden our methodology while 
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maintaining as high a comparability of assumptions and methods with the original data 
estimates as possible.  
Methods 
Study Design and Participants 
Data was collected for this study in Kijabe, Kenya and Hamilton, Canada between March 
and August 2012. Research ethics approval was obtained at both institutions (AIC Kijabe 
Hospital and Hamilton Integrated Research Ethics Board [11-328]) and written consent 
obtained from all participants. Total sample size was based on feasibility of recruitment 
at both centers.  
Focus groups at both sites were conducted primarily in English, with Kenyan community 
groups in Swahili and then translated. Participants were selected based on experience 
with pediatric congenital anomalies (balancing experienced and non-experienced) and 
were recruited to match roles (i.e., physician, nurse, social worker, therapist, community 
participant) between the two sites. Data were collected in Kenya over 2 weeks at AIC 
Kijabe Hospital and in a community setting in Nairobi, and in Canada over 3 months at 
McMaster Children’s Hospital. Each participant completed all study instruments in a 
single three-hour session. Focus groups were facilitated by a local research assistant and 
the research coordinator, and comprised 5-15 participants based on individual 
availability. 
Health State Descriptions 
We developed a set of lay descriptive handouts as suggested by Rehm and Frick8 for 
each of 15 health states (mild / severe hypospadias, undescended testis, cleft lip, cleft 
palate, mild / severe imperforate anus, Hirschsprung’s Disease before / after colostomy, 
mild / severe spina bifida, mild / severe abdominal wall defect, hydrocephalus, and 
intestinal atresia). An example of a handout is shown in Figure 1. These health states 
were chosen based on a ranking of the most prevalent congenital pediatric surgical 
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conditions encountered at both sites. The handouts were circulated amongst an expert 
panel for face validity of the lay descriptions of functional health status and symptoms 
of each state; diagrams were included to improve understanding. Each handout 
comprised a disability profile description on 8 domains, including the five EQ-5D 
dimensions (mobility, self-care, usual activities, pain, mood)14,  and three additional 
domains: “cognitive functioning”, “evacuation problems”, and “social stigma”. The three 
additional domains were informed by the CLAMES study17, the Dutch Disability Weights 
project13, and from our qualitative community-based focus groups with Kenyan 
caregivers of children with neural tube defects exploring culturally-based social stigma27 
as suggested by Kapiriri et al28. 
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Figure 1: health state information example  
Hirschsprung’s Disease 1 
Background: 
Hirschsprung’s disease is a condition of the intestine in which the muscle cells of the bowel can’t push the 
stool through, leading to blockage. The intestine becomes very large and may also get infected. 
Children with this condition may stop having bowel movements, vomit, be very constipated, not gain 
weight properly, or even have severe diarrhea. These problems can happen right after birth or anytime in 
childhood. 
The condition requires surgery, where the part of the intestine which doesn’t function well is cut out. 
Often children also require a colostomy (an opening in their skin on their side where their stool comes 
out, instead of from their anus). A bag is attached (stuck) to their side around this opening to collect their 
stool. This bag needs to be cleaned, changed and washed regularly. Colostomies can sometimes smell 
bad. 
 
Hirschsprung’s disease is divided in the following stages: 
1) Before colostomy 
2) After colostomy  
 
We now ask you to value the following health state: 
Children with Hirschsprung’s disease who have not yet had a colostomy  
Description: 
  No problems with moving about 
  No problems with washing and dressing self 
  Some problems with performing usual activities 
  Some / severe pain and discomfort 
  Moderately anxious or depressed 
  No / some social stigma  
  No thinking problems 
  Severe bowel problems (e.g. constipation, blockage, soiling, leakage) 
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Based on severity and surgical management, some conditions were divided into two 
distinct health states (e.g., Hirschsprung’s before and after colostomy). All valuations 
applied only to the health states before definitive treatment (untreated) – thus a state 
such as “Hirschsprung’s after colostomy” referred to a temporary procedure still 
requiring a definitive surgery. Five health states also had DWs derived by the GBD 1990 
study13  and were used as the gold standard and were compared against our newly 
derived DWs. 
Valuation Tasks 
Standard protocols were developed for research staff training and participant 
explanations. Prior to data collection at each site, a pilot focus group with a 
representative sample was conducted to assess understanding and language for each 
exercise and for the lay description handouts using a series of Likert scales.  
All participants completed four health valuation exercises for each health state, 
including Preference Ranking (PR), Visual Analogue Scales (VAS), Paired Comparisons 
(PC) and Time Trade-Off exercises (TTO)29. Participants were asked to complete the 
exercises in the following order: PR, VAS, PC, TTO. The PR task was introduced to 
familiarize participants with the various health sates and obtain an understanding of 
their relative severity. The VAS task was then introduced to introduce the concept of 
health valuation and to ensure their understanding of the health state descriptions and 
the purpose of the exercises. After these simpler tasks, the participants then completed 
the more complicated PC and TTO exercises which were used as the primary data for 
this study. The PC method was specifically chosen for consistency with GBD 
methodology. PC data, however, are generated on a latent scale, and these values need 
anchoring to the full health-dead scale in any of several ways. In our case, we were able 
to harmonize the results with the GBD scale by using the values for overlapping 
conditions as anchor points for the PC results. Alternatively, the TTO values might be 
used to identify how the PC-derived latent values relate to the full health-dead scale as 
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shown by Rowen et al30. The use of TTO additionally enables comparison of our DW 
values with those published in the wider health-related quality of life (HRQoL) literature 
where TTO is a preferred valuation method. Having these two options was considered 
relevant as the feasibility and validity of the option of anchoring the new DWs to 
existing GBD data depends on the level of congruence across the new and existing DWs. 
To complete the PR, each participant was given a set of 15 health state index cards in 
random order, and asked to rank each from least to most severe. Next, participants 
completed a VAS using a 100-point line anchored by death and perfect health with 5-
point increments demarcated on the line. Participants were instructed to mark an exact 
point on the line for each health state in terms of severity. Additional instructions 
included placing similar health states closer together and vice-versa. Participants then 
completed a series of PCs that directly compared each health state to every other one, 
choosing which state was more severe. This resulted in 105 pairwise comparisons (15 
*14 / 2) for each participant. 
In the TTO exercise participants were instructed to trade off years of healthy life for 
years of life lived in the specific health state, as if they were the parent of a child with 
the condition, and as if they were trading years of their child’s life. The TTO adopted a 
time frame (T) of 60 years (derived from WHO standard life expectancy rates), and a 
smallest tradeable unit of 10 years. For example a participant could choose between 
living for 60 years in a particular health state or living 10, 20, 30, etc. years in perfect 
health. The TTO exercise was aimed at determining the number of years t in perfect 
health that would make the two options equally attractive (i.e. the indifference point), 
so that the value of a life year could be computed as t/T. 
Statistical Analysis 
All participants’ individual responses from each valuation measure were included. DWs 
were calculated for each health state, by each exercise, for each country. We 
summarized the data from the PR task by averaging the rank order for each health 
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state and transforming the data to a continuous number between 0 and 1. Of note, 
these scores reflect how good or bad all health states are relative to the value of the 
best and the worst state in the set, but not relative to health states that were not included 
in the choice tasks - e.g. dead and full health. Therefore these scores cannot be used as 
DWs. For the VAS, direct measurements from the VAS scale were obtained and 
averaged amongst participants. In the PC exercise the proportion of the number of 
times each health state was chosen over its comparator was calculated for each 
condition, and using the normal curve, the proportions were transformed into Z-scores. 
The scores associated with each health state were then summed and averaged to yield 
an overall Z-score corresponding with the probability of a health state being chosen 
over all others31. The resulting score is a DW that is estimated on a latent scale (the 
resulting values are not yet anchored on the full health-dead scale).  Addition of the 
magnitude of the most negative score and subsequent division by the highest score was 
applied to all values to yield a set of weights spanning a range of 0 to 1. Finally, DWs 
were calculated from the TTO exercise with the formula “utility = time in full health / 
time in disease state”. 
The final analytical step involved anchoring of the PC-derived values onto the full health-
dead scale. There are several ways to achieve this. Relying solely on data collected in 
this study, the PC scores obtained on latent scales were anchored to mean TTO values 
(PC-TTO) through linear regression, as suggested by Stouthard et al15 and Rowen et al31. 
Alternatively, the PC-derived values may be anchored on the full health-dead scale by 
using previously reported DWs, i.e. those from GBD 1990, for the 5 health states 
included in both data sets. The Intraclass Correlation Coefficient (ICC) assuming a one-
way random model for average measures was used to analyze the agreement between 
the PC-derived values obtained in our study and the TTO and GBD values. 
Formal quantitative data comparisons between sites were analyzed using SPSS v20.0 
with a 5% significance level and Z scores computed in an Excel® spreadsheet. Results 
were presented using summative descriptive statistics with means, standard deviations, 
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and 95% confidence intervals where appropriate. Differences between groups were 
assessed using either the Fisher Exact Test or the Mann Whitney U test, depending on 
normalcy of the data. All DW data was first explored graphically for trends at each site, 
as well as descriptively between sites. 
Results 
In total 154 participants were recruited, 78 from Kenya and 76 from Canada (Table 1). 
DWs obtained from each of the four exercises (using internally derived PC-TTO values) is 
depicted in Figures 2a and 2b for Kenya and Canada, respectively.  
Table 1: Study Participant Characteristics (n=154) 
Participants Kenya Canada 
Healthcare Professionals 60 64 
Physicians 20 25 
Nurses 35 32 
Allied health professionals 5 7 
Community Members 18 12 
Total 78 76 
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Figure 2a. Kenyan Disability Weights per Exercise 
 DW = disability weight; VAS = visual analog scale; TTO = time trade-off method; PC-TTO = TTO-anchored 
paired comparisons method. 
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
D
W
VAS
TTO
Ranking
PC-TTO
50
  
Figure 2b. Canadian Disability Weights per Exercise 
  
DW = disability weight; VAS = visual analog scale; TTO = time trade-off method; PC-TTO = TTO-anchored 
paired comparisons method. 
Tables 2a and 2b detail the DW values obtained at each site by all methods, including 
both internal (TTO) and external (GBD) anchoring of PC values.  
Comparison of results across the 2 sites is shown using both TTO-anchored and GBD-
anchored PC values in Table 3, and overall values obtained by the 2 anchoring methods 
are depicted in Figure 3.  
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Table 2a: Kenyan Disability Weights per Tool (n=78) 
Health State Ran
king 
VAS TTO PC-TTO PC-GBD 
Mild Hypospadias 0.2 0.2 0.126 0.212 0 
Undescended Testes 0.07 0.22 0.419 0.317 0.115 
Cleft Lip with no cleft palate 0.13 0.21 0.226 0.293 0.076 
Mild Imperforate Anus 0.27 0.33 0.293 0.356 0.179 
Hirschsprung's Disease AFTER 
Colostomy 
0.4 0.32 0.419 0.351 0.170 
Severe Hypospadias 0.6 0.45 0.496 0.415 0.275 
Cleft Palate with/without cleft 
lip 
0.33 0.4 0.419 0.408 0.264 
Mild Spina Bifida 0.53 0.45 0.419 0.452 0.336 
Mild Abdominal Wall Defect 0.47 0.56 0.479 0.505 0.421 
Hirschsprung's Disease BEFORE 
Colostomy 
0.8 0.66 0.581 0.569 0.526 
Hydrocephalus 0.73 0.61 0.671 0.607 0.587 
Severe Imperforate Anus 0.67 0.73 0.683 0.710 0.756 
Severe Spina Bifida 0.93 0.71 0.659 0.716 0.765 
Severe Abdominal Wall Defect 1 0.85 0.748 0.711 0.758 
Intestinal Atresia 0.87 0.81 0.732 0.758 0.834 
VAS = visual analog scale; TTO = time trade-off method; X-rank = TTO/VAS anchored ranking method; X-PC 
= TTO/VAS anchored paired comparisons method. 
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Table 2b: Canadian Disability Weights per Tool (n=78) 
Health State Ranking VAS TTO PC-TTO PC-GBD 
Mild Hypospadias (distal) 0.133 0.185 0.037 0.055 0 
Undescended Testes 0.067 0.164 0.087 0.069 0 
Cleft Lip with no cleft palate 0.267 0.326 0.213 0.196 0.058 
Mild Imperforate Anus 0.4 0.407 0.296 0.348 0.298 
Hirschsprung's Disease AFTER 
Colostomy 
0.533 0.385 0.217 0.252 0.146 
Severe Hypospadias (proximal) 0.2 0.357 0.257 0.221 0.098 
Cleft Palate with or without 
cleft lip 
0.333 0.448 0.365 0.336 0.280 
Mild Spina Bifida 0.467 0.428 0.272 0.320 0.254 
Mild Abdominal Wall Defect 0.733 0.608 0.398 0.447 0.455 
Hirschsprung's Disease BEFORE 
Colostomy 
0.667 0.618 0.508 0.460 0.475 
Hydrocephalus 0.8 0.613 0.627 0.559 0.632 
Severe Imperforate Anus 0.6 0.641 0.589 0.627 0.740 
Severe Spina Bifida 0.867 0.694 0.587 0.620 0.729 
Severe Abdominal Wall Defect 0.933 0.834 0.729 0.672 0.812 
Intestinal Atresia 1 0.885 0.773 0.797 1 
 
VAS = visual analog scale; TTO = time trade-off method; X-rank = TTO/VAS anchored 
ranking method; X-PC = TTO/VAS anchored paired comparisons method. 
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Table 3: Multi-National Disability Weight Comparison 
Health State KE PC-TTO CAN PC-TTO KE PC-GBD CAN PC-GBD 
Mild Hypospadias (distal) 0.212 0.055 0 0 
Undescended Testes 0.317 0.069 0.115 0 
Cleft Lip with no cleft palate 0.292 0.196 0.076 0.123 
Mild Imperforate Anus  0.356 0.348 0.179 0.249 
Hirschsprung's Disease AFTER 
Colostomy 
0.351 0.252 0.170 0.189 
Severe Hypospadias (proximal) 0.415 0.221 0.275 0.209 
Cleft Palate with or without 
cleft lip 
0.408 0.336 0.264 0.273 
Mild Spina Bifida  0.452 0.320 0.336 0.289 
Mild Abdominal Wall Defect 0.505 0.447 0.421 0.394 
Hirschsprung's Disease BEFORE 
Colostomy 
0.569 0.459 0.526 0.439 
Hydrocephalus 0.607 0.559 0.5870 0.520 
Severe Imperforate Anus  0.710 0.627 0.7555 0.621 
Severe Spina Bifida  0.716 0.619 0.765 0.620 
Severe Abdominal Wall Defect 0.711 0.672 0.758 0.648 
Intestinal Atresia 0.758 0.797 0.834 1 
KE = Kenya; CAN = Canada; VAS = visual analog scale; TTO = time trade-off method; X-rank = TTO/VAS 
anchored ranking method; X-PC = TTO/VAS anchored paired comparisons method. 
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Figure 3. Disability Weights by internal and external anchoring methods 
  
DW = disability weight; PC-TTO = TTO-anchored paired comparisons method;  PC-GBD = GBD-anchored 
paired comparisons method. 
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In general, discrepancies entailed higher estimated DW values in Kenya, and for severe 
hypospadias and undescended testes these values were statistically significantly higher 
than Canadian-derived DWs (p=0.04 and p<0.003, respectively).  
Disability weights for the common health states included both in our study and the GBD 
1990 study are compared in Figure 4. While values were generally similar for several 
health states, discrepancies were noted particularly for cleft lip and palate, and these 
discrepancies were reduced when our PC values were anchored externally to the GBD 
study.  
The ICC showed high levels of reliability between the DW data calculated for both Kenya 
and Canada (ICC 0.97,  95%CI: 0.93-0.99), as well as between the GBD values, TTO-
anchored and GBD-anchored DW values for the 5 health conditions common to both 
studies (ICC=0.97; 95%CI 0.83-1.0).  
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Figure 4. Global Disability Weights for common conditions in GBD 1990 and current study 
  
 
DW = disability weight; GBD = GBD 1990 study; DAPS = current study; PC-TTO = TTO-anchored paired 
comparisons method;  PC-GBD = GBD-anchored paired comparisons method.
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Discussion 
The GBD effort over the past two decades has been instrumental in quantifying health 
burden, needs and factors both geographically and by broad sets of conditions, thus 
providing an invaluable body of information to policy-makers and healthcare 
professionals. The GBD project and its wide adoption by the World Health Organization, 
World Bank, and several national bodies32,33,34,35 has also been essential in establishing 
DALYs as the preferred metric globally in disease burden measurement. While the GBD 
project has been extremely comprehensive, its stated global and all-inclusive purpose 
has resulted in limited granularity within specific medical and surgical specialty areas. In 
particular in LMICs, in the absence of direct population data, efforts to estimate DALYs 
are constrained by the available DW values, which are frequently very sparse. The 
current study has aimed to generate DW values for a set of congenital pediatric surgical 
conditions as a way to start filling that gap. 
The task was successfully accomplished in both study settings. DW values generated by 
VAS, ranking, PC & TTO for the 15 health states spanned the full health-dead spectrum 
and were generally comparable. Latent scale PC values were alternatively anchored 
both internally to the TTO and externally to the GBD scale, generating again similar 
results. With a few exceptions (discussed below), inter-country results showed 
significant similarity, as documented by the ICC values. Internally generated PC-TTO 
values correlated well with GBD values for common conditions, and anchoring to these 
values naturally improved the correlation. 
DW Values 
In the absence of previous studies within the subspecialty, and faced with a wide choice 
of valuation methods available, each with its own benefits and shortcomings, the 
authors chose to start with four different methods, both psychometric and econometric, 
and  compare the results obtained by these broad inputs for each health state. This 
strategy produced a large number of data points without over-burdening the 
participants, and allowed inter-method comparisons as well as both a priori and post-
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hoc suggestions for preferred methods. Yet, we also faced the complex question of how 
to deal with potential discrepancies across the methods. Variation in DW estimates 
could result from  participants’ different health states interpretation, their risk aversion 
and time preference, but also to differences in valuations between exercises for the 
same health state, and overall distributional concerns such as VAS distortion36.  
An anticipated strength of the chosen set of methods was its ability to generate 
different types of data: PC values being derived on a latent scale they can complement 
other methods while avoiding potential conflicts of scale when other methods are 
paired (e.g. VAS and TTO). This strategy is increasingly popular31,36,37. The adoption of PC 
in the recent version of the GBD Study also strongly mitigates in favor of its use on the 
latent scale. Pooling of values obtained across the other methods has to the best of our 
knowledge not been done – instead a choice for either one is made based on pros and 
cons of each. Similarly, while rank data could be used to provide values on a latent scale 
like PC, the latter is favored for its greater reliability, with rank data often used just as a 
“warm-up” exercise38. Nevertheless presence of values derived from multiple methods 
remains beneficial, allows at least to assess convergence across methods and 
demonstrate validity. Against that background we were pleased with the high level of 
agreement, as shown in the high ICC values, that was achieved across the methods.  
 The DW values generated for the 15 health states across the two sites were generally 
similar based on high ICC values, leading support to the assertion that DWs are stable 
cross-nationally and cross-culturally39,16. Two notable exceptions to this purported DW 
stability were encountered in the current study. Severe (i.e. proximal) hypospadias and 
undescended testes were assigned higher DW values in Kenya. This discrepancy may be 
explained culturally: both health states include the possibility of infertility in their 
descriptions, a state associated with significant stigma in many non-Western 
cultures40,41.  
Limited possibilities exist for external validation of the DW estimates generated in this 
study. The GBD 1990 study, already used in our study for external anchoring, included 
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DWs for 7 congenital surgical conditions (cleft lip, cleft palate, abdominal wall defects, 
imperforate anus, cardiac defects, esophageal atresia, and spina bifida)7, and later DW 
studies globally did not expand this list. Moreover, only the cleft lip and palate states 
include both untreated and treated values, a significant limitation to the use of other 
published DW values in surgical arenas. Within the limitation of slightly different 
methodologies used, the current study had the dual opportunity of using the DW values 
of the common health states for both external validation (of PC-TTO values) and 
external anchoring (as in PC-GBD values). We consider the PC-TTO as our primary “take-
home” results as they are internally derived and not dependent on overlapping health 
states with other studies. Moreover, the 2 methods generally generated similar DW 
values, well within the same order of magnitude. Of note however, cleft lip and palate 
received however significantly lower values in the GBD study. This may be due to 
disability from cleft lip/palate being artificially limited to the first 5 years of life in the 
GBD study, a constraint not reflecting the reality of older children living with this 
untreated condition in LMICs42.  
Comparison to GBD 2010 Study and Advantages 
With the recent publication of the GBD 2010 study, any parallel attempt at deriving DWs 
must be justifiable, valid, and comparable. The primary justification for the current 
study is simply the necessity to obtain a wider set of DW values within a given specialty, 
for the purpose of generating relevant specialty-specific BoD data that can inform policy 
decision making in this area. Yet in order to offer valid inter-specialty comparisons, the 
methodology of such parallel studies must be sufficiently similar to that of the GBD gold 
standard. Without the benefit of the latest iteration of the GBD study at the time of 
study design, and using a much smaller study sample, the authors chose a panel of 
valuation methods which allowed the comparison of commonly used methods in the 
literature. In light of the current results, the use of paired comparisons appears justified 
and probably sufficient, in conjunction with a method of anchoring the results to the 
health-dead scale. This process resembles the GBD Study in its use of PCs, though 
differing from it in the anchoring method. Other strengths of the current study include 
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standardized and explicit health state descriptions, and input from both health care 
workers and families familiar with the conditions investigated. But caveats remain, such 
as the different approach to describing the health states, and uncertainty whether the 
same health state DW values will be obtained in PCs if more or less health states are 
included in the experiment. The checklist for any such future efforts must include clear, 
consistent health state descriptions and a single psychometric valuation such as PC, 
anchored firmly to the disability scale. Moreover, studying health states spanning a wide 
range of severity would facilitate robust data generation.  
The main limitation of the study pertains to the underlying concept of the DALY and of 
the disability weighting which it requires. In the first place, it is extremely difficult to 
harmonize universal DW values with the widely divergent sociocultural and economic 
contexts where they are derived43. Furthermore, there are multiple controversial value 
decisions in the computations of DALYs which can significantly impact the ultimate BoD 
conclusions drawn from them44,45, as well as limitations inherent within the specific 
health valuation exercises themselves. Finally, DALYs seem to underestimate several 
specialty areas, such as neglected tropical diseases46 and surgical conditions18.  
Conclusions and Applications 
The current study has successfully generated a set of DW values for pediatric congenital 
anomalies, making these values available for all necessary future studies47. The process 
involved in generating such a limited DW set was relatively straightforward and 
inexpensive, and, within the confines of the above limitations, the results were robust 
and comparable to those generated by large global studies. The DWs do not appear to 
differ significantly across divergent socio-cultural contexts and can be used to calculate 
both the met and the unmet burden of global pediatric surgical disease48. 
While the extensive global and national BoD studies will remain the basis for global 
policy decisions, the study suggests that DW sets may be expanded and refined within a 
surgical specialty. While waiting for future studies to show whether other specialties 
may be equally successful in the process, a cautious, well-guided advance is 
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recommended in this novel field in order to ultimately generate practical knowledge in 
global health.  
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Abstract  
Background 
Efforts to estimate the burden of pediatric surgical disease in Africa are limited by the absence 
of population-based data.  
Methods 
Community volunteers randomly surveyed households at sites across Kenya. Caretakers were 
asked to identify on a photographic portfolio several visible congenital malformations present 
among the children in their household. Disability-adjusted life years (DALYs) were calculated 
based on life expectancy tables and published and estimated disability weights for the 
conditions encountered. 
Results 
Caregivers of 5,559 children (54% female) were surveyed in 1,909 households. Overall 
prevalence of congenital malformations was 6.3 / 1000, amounting to 54 - 120 DALYs per 1000 
depending on the life tables used. The most prevalent condition in the survey was club foot, 
while spina bifida had the highest burden of disease. 
Discussion 
This study is the first to document the prevalence of selected surgical congenital malformations 
among children in Kenya and the burden of disease associated with them.  
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Introduction 
Congenital malformations are a significant cause of morbidity and mortality, especially in low- 
and middle-income countries (LMICs). Debas et al [1] estimate that congenital malformations 
account for 9% of the surgical burden of disease (BoD), contributing to the disability 
experienced by 150 million children around the world, with disabilities being more common 
among children in LMICs [2]. These disabilities represent a burden placed on child development 
and family responsibilities, and are both the cause and the result of poor socioeconomic status 
[2,3].  
The burden of childhood surgical disease from congenital malformations is significant in sub-
Saharan African settings. In Gambia, such conditions represented the second highest 
proportion of children presenting for surgical care, preceded only by injuries [4,5]. Surgical 
procedures to address congenital malformations comprised 40% of all operations performed at 
a major teaching hospital in northern Nigeria [6], and nearly 1 in 4 children presenting at a 
major sub-Saharan hospital suffered from congenital malformations [4,5]. In studies that 
focused on specific malformations and/or geographic regions, the incidence of congenital 
malformations in LMICs was calculated to be between 3.9 and 11.8 per 1,000 live births [7,8]. 
However, in such studies congenital malformations are likely to be underreported due to 
stigmatization or fear associated with being rejected by the community [9,10].  
Based on the premise that about half of all congenital malformations are surgical [1], an 
obvious method of decreasing the burden of childhood disease is the prevention and early 
treatment of neonatal surgical conditions, many of which result in disability or death when left 
untreated [11]. Surgical care can have a significant impact on the health burden of congenital 
malformations, which account for 3% of pediatric deaths and 24 million disability-adjusted life 
years (DALYs) worldwide [12]. DALYs are a widely accepted metric of disease burden, as they 
take into account both the years of life lost and the reduced quality of life resulting from 
disability.  
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There is limited data on the extent and impact of pediatric disabilities in LMICs. In response to 
the increased recognition of disabilities as a major global health concern, a comprehensive 
review of three large databases was undertaken to identify publications focused on pediatric 
intellectual, hearing, speech, vision, motor, and neurological disabilities in LMICs [9]. The 
reviewers noted a paucity of information on most pediatric disabilities with the exception of 
intellectual and hearing impairments, and few LMICs have epidemiological information on 
pediatric disabilities in their region. The Kenya National Survey for Persons with Disabilities 
recently estimated a 2.4% overall prevalence of disability among Kenyan children aged 0 to 14 
years [13]. There is a need however for more detailed data on specific disabilities in order to 
identify the most effective health care interventions for alleviating the morbidity and mortality 
of pediatric congenital disease. Moreover, quantification of the disease burden of congenital 
malformations potentially avertable by surgery allows for comparisons with other health 
interventions competing for limited resources. We are not aware of any population-based study 
quantifying the burden of surgically treatable congenital malformations in an African country. 
The objective of this study therefore was to estimate the prevalence and burden of selected 
surgical congenital malformations among children in Kenya. 
Methods 
Design 
The study is a population-based prevalence survey. It entailed field workers surveying 
households and looking for family members 16 years of age or younger who have any of a set of 
8 visible congenital malformations. The field  workers were recruited by liaising with the local 
community health office at each designated site. The workers were already volunteering at, or 
employed by, the health office and were known in the community and familiar with visible 
disabilities. They were trained on site by one of 3 study coordinators, who would then follow 
them on their initial home visits to ensure adequate performance.  The study sample consisted 
of caretakers – parents and other guardians – from a sample of 10 urban and rural locations in 
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Kenya. These locations were selected to match the population distribution in Kenya by 
province.  
Within each location, interviews were conducted by the field worker in a random selection of 
households, using a method of the World Health Organization Expanded Programme on 
Immunization as described by Durkin et al [14]. According to this method, in each study 
community the field worker began in a central location (such as the community’s local 
government health center or chief’s office), and walked in one of four possible directions 
(north, south, east, west). The field worker, through a random process, then selected a 
household to interview which was  
1) along the left or right side of the road (by throwing a dice, with 1 to 3 = left, 4 to 6 = 
right); and  
2) between 1 and 6 houses away from his/her starting location (e.g. for a 4, go to the 4th 
house on the side of the road that was decided in step 1). 
A household was defined as a family, including its caretakers/servants, who shared a single 
front door within a residential property that borders the side of the road. The field worker 
continued in the direction of travel using the above process of sampling until the community 
boundary was reached. This process was then repeated in the 3 other remaining directions. In 
the event that the direction of travel was no longer possible (such as at a T-junction), the field 
worker used a random process to decide a new direction to travel (left or right) until the 
earliest opportunity to resume the original direction. In the event of no children living in the 
selected household, or if nobody was at home , the next closest household was approached.  
A standard portfolio of photographs of congenital malformations was provided to each 
community worker as a screening tool to help caretakers identify the conditions of interest 
(cleft lip, club foot, spina bifida / encephalocele, hydrocephalus, hypospadias, bladder 
exstrophy, and imperforated anus). These conditions were chosen because they are easily 
identifiable, visible deformities for which surgical treatment is available in the country. 
Caretakers from each interviewed household were presented with the screening tool and 
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shown additional pictures if there was confusion in the identification of the condition. 
Caretakers were also asked to provide additional information, including education level, 
household income and their child(ren)’s place of birth 1 . Similar door-to-door interview 
techniques, along with the use of photographic albums, have been previously used to 
determine the community-based prevalence rate of pediatric disabilities [7,15].  
Sample size 
 The overall prevalence of pediatric disabilities in community-based studies in LMICs 
varies between 0.4% - 12.7% [3,15,16,17,18,19,20], and the prevalence of neurological and 
motor disabilities among children in LMICs varies between 0.2% - 6.1% and 0.2% - 2.8%, 
respectively [17,17,18,18,21,21,22]. Using a point estimate of 4% as the prevalence of all the 
disabilities that we seek to identify in our study, and applying standard statistical formulae for 
calculating 95% confidence intervals from the binomial distribution, we estimated that a survey 
of 5,000 children would provide 95% confidence intervals of 3.5 - 4.6%. We therefore intended 
to survey an average of 500 children within each of the 10 communities sampled. Assuming an 
average household size of 5.3 [23], we anticipated on average interviewing the caretakers of 3 
children per household, 167 households per community, and 1,670 households in total. The 
sample size calculation was performed using a standard online statistical calculator [24]. 
DALY Calculation 
 Burden of disease (BoD) estimates were calculated using previously established 
methods [25] and universal and country-specific life tables provided by the GBD Study [26] and 
the World Health Organization [27]. DALYs are calculated as the sum of  
                                                     
1  The survey and the photographic portfolio are available for download from 
http://dl.dropbox.com/u/9254603/KIDS%20study/KIDS%20survey.docx 
and http://dl.dropbox.com/u/9254603/KIDS%20study/KIDS%20photo%20portfolio.pdf , respectively. 
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life years lost due to premature mortality (YLL) and years lived with disability (YLD), where YLD 
is   the product of the life expectancy at disease onsetand the disability weight (DW). In light of 
the fact that the current study only attempted to identify prevalent conditions among living 
children and that the study assumed that these conditions do not affect mortality rates in these 
children, the DALY calculation included only the YLD. As the GBD Study provides DWs for only a 
few selected pediatric surgical conditions, DWs for the remainder was estimated using the scale 
endorsed by the World Health Organization [28] and shown in Table 1.  
Table 1: Disability weights used in disability-adjusted life year (DALY) calculations [28] 
Description Weight 
Limited ability to perform at least one activity in one of the following areas: 
recreation, education, procreation or occupation 0.1 
Limited ability to perform most activities in one of the following areas: recreation, 
education, procreation or occupation 0.2 
Limited ability to perform activities in two or more of the following areas: 
recreation, education, procreation or occupation 0.4 
Limited ability to perform most activities in all of the following areas: recreation, 
education, procreation, or occupation 0.6 
Needs assistance with instrumental activities of daily living such as meal 
preparation, shopping or housework 0.8 
Needs assistance with activities of daily living such as eating, personal hygiene or 
toilet use 0.9 
 
Age weighting and discounting [28,29,30] are common practices in GBD studies, but they 
remain somewhat controversial, especially when applied to children [29,30,31]. The authors 
therefore chose to do a sensitivity analysis on life expectancy tables, using 3 different tables: 
Kenya standard uniform, undiscounted tables (so-called YLL(0,0)), Kenya standard age-
weighted, 3% future discounted  tables (YLL(3,1)), and universal standard undiscounted tables 
[28]. 
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Statistical analysis 
Descriptive statistics were applied to the demographic variables and DALYs, using Microsoft 
Excel® software. 
Ethics 
This study was approved by the Research Ethics Committee of AIC Kijabe Hospital in Kijabe, 
Kenya. Before entering each locale, the community chiefs were first approached for written 
consent to undertake this study in their jurisdiction. Verbal consent was also obtained from the 
household caretakers before proceeding with the interviews. 
Results 
Between July 2009 and March 2010 the caregivers of a total of 5,559 children were surveyed in 
1,909 households. All 8 provinces were sampled at or above their intended target levels. There 
were no non-responders in the study: of all caretakers that were invited to participate in the 
study, none refused to participate. The distribution of respondents by location is shown in 
Table 2. Figure 1 depicts the location of the homesteads surveyed - most children resided in the 
population-rich Rift Valley and Eastern provinces. Fifty-five percent of the households were in 
rural areas, and there were 2.9 eligible children on average per interviewed household.  
Table 2: Distribution of households and children interviewed, by province Percentage is in 
parenthesis. 
 Rift 
Valley 
Eastern Nyanza Western Central Coast Nairobi North 
Eastern 
Total 
Homesteads 540  
(28.3) 
319  
(16.7) 
254  
(13.3) 
196  
(10.3) 
250  
(13.1) 
140  
(7.3) 
145  
(7.6) 
65  
(3.4) 
1909 
(100.0) 
Children 2114 
(38.0) 
787  
(14.2) 
747  
(13.4) 
451  
(8.1) 
620  
(11.2) 
336  
(6.0) 
253  
(4.6) 
251  
(4.5) 
5559 
(100.0) 
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Figure 1: Location of surveyed homesteads by province 
 
Additional demographic characteristics of the caretakers are presented in Table 3. The highest 
education level among the majority of caretakers was primary school or no formal education at 
all, with fathers more likely to attain higher education. Almost half of the households (45%) 
included children who were born in the home rather than at a clinic or hospital. The median 
household income was 5,000 KSh / month (range, 0 to 600,000) or approximately US$65 / 
month. These demographics are fairly consonant with published socio-economic studies for 
Kenya [32].  
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Table 3: Demographic characteristics of caretakers interviewed 
 Number Percent 
Household location   
Urban 232 12.2 
Suburban 634 33.2 
Rural 1043 54.6 
 
Child(ren)'s place of birth   
Home 454 23.8 
Local clinic 963 50.4 
Both 411 21.5 
No children / Declined to answer 81 4.2 
 
Income distribution Average monthly income per 
household (KES) 
Percent share of 
wealth 
Poorest 20% 1,101 2.9 
Second 20% 3,036 8.0 
Middle 20% 4,770 12.5 
Fourth 20% 7,449 19.5 
Highest 20% 21,775 57.1 
Declined to answer: 562 households  
 
Education level Mother (%) Father (%) 
Did not attend school 233 (12.2) 183 (9.6) 
Primary 869 (45.5) 631 (33.1) 
Secondary 546 (28.6) 608 (31.8) 
College 166 (8.7) 201 (10.5) 
University 39 (2.0) 69 (3.6) 
Not applicable / Declined to answer 56 (2.9) 217 (11.4) 
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There were 35 malformations encountered in the 8 selected conditions sought by the current 
study, 19 males and 16 females (Table 4). Forty-nine percent of the children identified were 
under 5 years of age, 31% were between 5 and 10 years, and 20% were over 10 years old. 
The population prevalence of these malformations and associated disability weights is shown in 
Table 4. The overall rate of congenital malformations was 6.3 per 1,000 children. Club foot was 
the most prevalent malformation encountered (2.9 per 1,000 children) both in males and 
females .  
Table 4: Disability weight, number and prevalence of congenital malformations 
Condition Disability 
Weight 
Number Prevalence (per 1,000) 
Total 95% CI 
Bladder exstrophy  
0.6 
1 0.2 0.0-1.0 
Cleft lip 0.05 2 0.4 0.0-1.3 
Club foot 0.1 16 2.9 1.6-4.7 
Encephalocele 0.6 2 0.4 0.0-3.7 
Hydrocephalus 0.4 5 0.9 0.3-2.1 
Hypospadias 0.1 5 0.9 0.3-2.1 
Imperforate anus 0.85 1 0.2 0.0-1.0 
Spina bifida 0.6 3 0.5 0.1-1.6 
TOTAL  35 6.3 4.4-8.7 
 
Figure 2 depicts the spread of estimated DALYs from each malformation by 3 different 
calculation methods. Spina bifida carried the highest BoD by all methods (106-234 DALYs in the 
sample), while cleft lip the lowest (3.5-7.7 DALYs). The lowest estimate of total burden of 
surgical disease in the sample was 303 DALYs (54 DALYs / 1,000 children) when age-weighted, 
discounted Kenya YLL values were used, and 669 DALYs  (120 DALYs / 1,000 children) when 
using universal, unweighted and undiscounted YLL values. The standard deviation of the DALYs 
per 1,000 estimated by all methods was 29. 
79
  
Figure 2: Sensitivity analysis for burden of disease (in DALYs) from selected congenital 
malformations 
 
DALY (0,0): DALYs using standard undiscounted Kenya life expectancy table 
DALY (3,1): DALYs using age-weighted and 3% discounted Kenya life expectancy table 
DALY (US): DALYs using universal standard undiscounted life expectancy table 
Figure 3 compares the prevalence of the selected malformations with the mean BoD (as 
calculated by the 3 methods above), by gender, associated with them – both per 1,000 children. 
While the prevalence is plotted in increasing order, the corresponding BoD varies widely in 
order. 
Spina bifida resulted in the greatest BoD, with rates of 19 - 42 DALYs per 1,000 children. When 
stratified for gender, hydrocephalus represented the greatest BoD among males (10 - 20.7 
DALYs per 1,000 children) and spina bifida for females (15.1 - 32.2 DALYs per 1,000 children). 
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Figure 3: Prevalence and mean burden of disease from selected congenital malformations, by 
gender 
 
Discussion 
To our knowledge, this is the first population-based study to estimate the prevalence and 
burden of congenital surgical malformations in Kenya. Population-based estimates of 
congenital malformations and pediatric disabilities in LMICs are scarce. 
One reason for the scarcity of data is the challenge of reliably selecting a random, non-biased 
sample in LMIC populations. Many similar surveys are based on hospital-based birth data [33], 
which naturally miss the significant percentage of births in LMICs which occur outside health 
care facilities. Moreover, surveys are often done in urban areas, because of the challenges of 
rural surveying. Address registries, village maps, and telephone directories were not available 
for any of the communities targeted, which led us to the sampling method described above. 
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This simple method allowed us to quickly and inexpensively train community workers to 
administer the survey. Moreover, the use of photographic portfolios in interviews has been 
shown to be an effective way of helping respondents identify various congenital malformations 
[7,15] - especially important in resource-poor settings where illiteracy may be an issue.  
The significance of the study lies in its ability to derive population-based data for common 
visible congenital anomalies. BoD metrics hold advantages over traditional ones such as 
prevalence, as demonstrated by Figure 2. Depending on the DW of each condition and the age 
of each child, some conditions (e.g., imperforate anus, spina bifida and hydrocephalus) carry a 
disproportionately higher BoD than implied by their prevalence - while the opposite is true for 
less disabling conditions such as club foot, cleft lip and hypospadias. 
The nature of the survey questions resulted in prevalence rates for these conditions, which may 
differ from their  corresponding incidence rates. While incidence rates are more generally 
accepted as the metric in epidemiological studies of congenital conditions, prevalence 
estimates are needed for BoD calculations [14,15,16,16]. Prevalence directly allows the 
estimation of surgical backlog in any area, as well as unmet need or avertable DALYs [25].  
Although comparisons with other studies should be made with caution, the prevalence rates 
obtained in this study  seem to be lower than in other published reports [7,8,34]. This may be in 
part due to the survey method, as detailed below. Moreover, the study generated prevalence, 
rather than incidence, rates. In situations when the congenital malformation carries a low 
mortality (e.g. club foot, hypospadias or cleft lip), the prevalence rate should be similar to the 
yearly incidence rate. For instance club foot was estimated in our study at 2.9 per 1,000, twice 
the rate recently found recently in the Uganda Sustainable Clubfoot Care Project [33]. Given 
however that most malformations still carry with them some risk of death, our results would 
therefore tend to underestimate the true incidence of the congenital malformations of interest. 
This approach offers therefore minimum  prevalence and BoD estimates for the population in 
question. 
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The DALY calculations were significantly dependent on the life expectancy tables used - 
although all values were reassuringly well within the same order of magnitude. The age-
weighted life tables slightly increased the DALY values, while future discounting decreased the 
values by roughly 50%. As discussed earlier, the choice of age weighting and discounting is 
debatable, carrying a fair amount of social value judgment and therefore uncertainty [35]. In 
the absence of a clear consensus, sensitivity analysis at least presents a spectrum of plausible 
results [35,36]. The use of universal rather than country-specific life tables is also not 
standardized. While the majority of surgical studies simply followed the universal tables 
introduced in the original GBD Study [28], the availability of country-specific tables allows us 
and others to be more specific in the calculations [37]. 
The BoD associated with congenital malformations is very significant by comparison to adult 
surgical or medical conditions. This is due to a unique mix of features of congenital 
malformations: young age, typically infant (thus maximum number of years potentially to be 
lived with a disability); often severe nature (thus associated with either premature death or 
high DW); stable, chronic condition (unlike trauma or other surgical emergencies, in the 
absence of treatment the disability simply persists for decades); and frequently some measure 
of residual life-long disability even after successful treatment (for instance impaired mobility in 
spina bifida, speech problems in cleft palate, or incontinence in imperforate anus). The accurate 
measurement of the BoD associated with congenital malformations can therefore play a 
significant role in the efforts to document the importance of surgical intervention for congenital 
malformations. In as much as the GBD study set out “to disentangle epidemiology from 
advocacy in order to produce objective, independent and demographically plausible 
assessments of the burdens of particular conditions and diseases” [35], such objective 
assessments as can be generated must be put to use for the sake of improved health care for 
those in need [38]. 
Ultimately, an area-wide survey of congenital malformations achieves much more than help 
derive some prevalence and BoD values. As Pirani et al found out in their country-wide 
Ugandan study, their survey raised awareness of congenital malformations within the 
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population, and provided a unique opportunity for mass education on congenital disabilities 
and their treatment [33].  
Limitations 
There are several limitations to this study. In the first place, we based our sample size 
calculation on a point estimate that is greater than the true prevalence calculated at the end of 
the study. Upon data analysis, this produced confidence intervals that were skewed around 
their point estimates. Such values should be interpreted with some caution, as they do not 
precisely mirror the binomial distribution that the sample size was based upon.  
Secondly, the results of this study may be underestimates due to the caretakers’ difficulty in 
disclosing their children’s health status. In our setting the sampling requirements and literacy 
considerations resulted in the natural use of community workers for interviewing caretakers. 
The use of interviewer-administered surveys however for potentially sensitive topics may lead 
to less truthful information gathered when compared to other methods such as paper-based 
surveys [39]. In fact, we noticed caretakers commonly responding that they have seen children 
in their community who had conditions mentioned in the portfolio. This may indicate parents’ 
willingness to participate in the survey, but an unwillingness to disclose when the child with the 
malformation in question was theirs [9,10].  
Thirdly, the photographic portfolio was very useful for most, but not all, conditions surveyed. In 
the case of genitourinary and anorectal conditions, cultural sensitivity required that 
photographs be only used if requested by the respondent, which may have led to some 
inaccuracy in the responses.  
Finally, the disability weights used in this study are simple estimates using the rather coarse 
WHO tool. The fact is that the GBD Study has not produced many disability weights within 
surgery, especially pediatric surgery. Currently there are published DW values for only 6 
pediatric surgical conditions (abdominal wall defects, anorectal atresia, cleft lip and palate, 
esophageal atresia, congenital heart anomalies, and spina bifida)[26]. It is obvious that an 
accurate measurement of the burden of pediatric surgical disease will require the formal 
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establishment of disability weights associated with a large variety of pediatric surgical 
conditions.   
Future considerations 
 This study provided an important first step in establishing prevalence rates and disease 
burden for surgically correctible congenital malformations in Kenya, a topic that has received 
little previous attention. The project reinforced the feasibility of low-scale population-based 
BoD studies in resource-limited settings. Future studies may include surveys assessing both the 
incidence and prevalence of congenital malformations, as well as larger sample sizes. Further 
studies also need to cover a broader range of both congenital and acquired malformations — 
this study focused on relatively common, externally visible congenital anomalies — in order to 
provide a more comprehensive scope of the burden of congenital disease and disability that 
can potentially be treated by surgery.  
The recognition of surgery as an effective intervention in LMICs has been hindered by the 
perception that it is a non-cost-effective luxury [40]. In recent years however surgery has 
gained attention as a cost-effective way of addressing the global BoD [11]. Similarly to the 
existing cost effectiveness analysis (CEA) studies in general and trauma surgery [41,42] in 
LMICs, CEA studies in pediatric surgery are essential tools in the global advocacy effort towards 
appropriate resource allocation for the surgical treatment and long-term rehabilitation of 
children with congenital malformations.  
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 Abstract 
Background 
Surgery is increasingly recognized as a means to reduce the morbidity and mortality of disabling 
impairments in resource-limited environments. We sought to estimate the burden of surgically 
correctable disabling impairments and the cost-effectiveness of their treatment among children 
in a large refugee camp.   
Methods 
This is a chart review of all patients aged 0 to 18 years from Dadaab Refugee Camp (Kenya)  
treated at a facility primarily responsible for providing pediatric surgical care in the region. Total 
disability-adjusted life years (DALYs) averted were calculated using life expectancy tables and 
established or estimated disability weights. A sensitivity analysis was performed using various life 
expectancy tables. Delayed averted DALYs caused by delay in care were also estimated. Inpatient 
costs were collected to perform a cost-effectiveness analysis.  
Results 
Between 2005 and 2011 a total of 640 procedures were performed on 341 patients. The median 
age at surgery was 4.6 years, and 33% of children treated were female. Only 13.5% of surgeries 
estimated as required for common congenital surgical conditions were actually performed. The 
total number of DALYs averted was 4,136 – 9,529 (6.4 -14.8 per patient), depending on the 
calculation method used. Cost-effectiveness analysis resulted in values of $40 - $88 per DALY. 
Conclusions 
The burden of pediatric surgical disabling impairments in refugee camps is substantial. Surgical 
intervention to address this burden is both feasible and cost-effective. Such intervention can 
significantly decrease the burden of disability among children affected by armed conflicts. 
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 Introduction 
Childhood disability is a significant cause of morbidity, especially in low- and middle-income 
countries (LMICs). The World Health Organization (WHO) estimates that 150 million children 
suffer from some type of disability globally, the majority of whom reside in LMICs with limited 
access to medical care [1]. Multiple studies have shown that children with functional disabilities 
have substantially decreased quality of life (QOL) when compared to non-disabled children 
[2,3,4]. Some of this decrease in QOL in LMICs results from the marginalization and stigma, both 
in the home and in the community [5,6]. Evidence exists that childhood disability is a major risk 
factor for limitations in daily activities into adulthood [7].  
The Dadaab Refugee Camp 
Shortly after the outbreak of the civil war in Somalia, the Dadaab camp was opened in 1992 in 
North-Eastern Kenya. Originally built for less than 90,000 inhabitants, it is currently home to over 
460,000 predominantly  Somali refugees, with others originating in other unstable neighboring 
countries [8,9]. Health care in the camp is provided by several humanitarian organizations under 
the umbrella of the United Nations High Commission for Refugees (UNHCR). As a result of the 
ongoing conflict in the horn of Africa, the already limited health care resources in the camp are 
continuously stretched by increasing numbers of refugees (typically over 1,000 new arrivals 
daily). Disabilities among the refugees are frequent and significant [10], due to the larger 
proportion of vulnerable persons seeking refuge, as well as the extremely limited health care 
provision for the past 20 years in Somalia. This results in a significant backlog of care, with 
patients of all ages frequently presenting with untreated chronic surgical conditions and 
disabilities, both congenital and acquired. 
Burden of surgical disease 
Surgery plays an important role in reducing the burden of disabilities in LMICs. Congenital 
abnormalities represent an important cause of pediatric disability, and approximately half of such 
abnormalities require surgical intervention [11]. Moreover, in LMICs trauma is frequently the 
commonest cause for children’s surgery [ 12 ], and when injuries are left untreated or are 
improperly treated, chronic disability often ensues [7,13]. Finally, it is estimated that only 3.5% 
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 of all surgical procedures are performed in the poorest third of the world, despite a burden of 
disease (BoD) greater than in the rest of the world [14]. 
Disability adjusted life years (DALYs), a health gap measure combining the morbidity and 
mortality associated with a disease, have become a standard metric to quantify BoD [15]. DALYs 
often highlight diseases with a chronic component: while only 3% of all pediatric deaths are 
attributable to congenital malformations, these account for a staggering 24 million DALYs 
worldwide [15]. Within global surgery, BoD has been divided into met need (surgical care already 
provided, or DALYs averted), unmet need (potentially avoidable/treatable disability and death 
due to surgical conditions, or DALYs avertable), and unmeetable need (disability and premature 
death that is unavoidable, even with the best surgical care) [16,17]. 
DALYs lend themselves to cost-effectiveness analysis (CEA), by estimating the cost required to 
offset one DALY through any given health care intervention. Interestingly, surgical treatment has 
been shown to cost not more – and in fact often less – in $/DALY than proven medical 
interventions such as immunizations and anti-retroviral therapy [18,19,20]. 
While health care services to displaced people have been emphasized by the global health 
community [21,22], surgical services are rarely mentioned. Moreover, the BoD stemming from 
conflict-related population migration has never been estimated to our knowledge, neither 
globally nor locally. The objective of this study is to calculate the burden of surgically averted 
disease among children in the world’s largest refugee camp, and estimate the cost-effectiveness 
of surgical intervention in this group. Such information, especially when extended to populations, 
will be important for resources advocacy in the care of these vulnerable groups.   
Methods 
We reviewed the hospital records of all patients aged 0 to 18 years residing in the Dadaab 
Refugee Camp and treated at BethanyKids at Kijabe Hospital, the primary pediatric surgical 
provider for the camp. BethanyKids is an international faith-based organization dedicated to the 
holistic care of children with surgical conditions. The BethanyKids unit in Kijabe, Kenya has 65 
beds, 2 operating rooms, and a full surgical and rehabilitation staff. Based on a long-lasting 
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 relationship with the UNHCR, BethanyKids surgeons have visited the refugee camp for patient 
screening and follow-up every 2 months since 2004. 
Patient records were abstracted for gender, birth date, diagnosis, and surgical interventions; 
outpatient records were excluded. Mean age of refugee patients undergoing common congenital 
procedures was compared to that of non-refugee patients in the BethanyKids database during 
the same time period (8,642 patients). 
Estimates of the number of children in the camp with several common congenital conditions 
were derived as the sum of the yearly number of new cases expected in the camp for each 
condition (calculated using average global incidence rates per 1,000 and yearly birth estimates in 
the camp) plus the yearly number of refugee children expected to enter the camp with each 
condition. The latter value assumes (based on consistent observations over the study period) that 
no child born with the index conditions received adequate care before reaching the camp. An 
example of such a calculation follows. 
# cleft lip cases expected in 2010 = 300,000 (average camp population in 2010 [23]) * 43/1,000 
(Somalia birth rate) * 1/1,000 (average cleft lip incidence in Africa) + 13,000 (new refugees arrived 
in Dadaab in 2010) * 0.62 (percentage of children in Dadaab [23]) * 1/1,000  (average cleft lip 
prevalence) = 20.96. 
DALY calculation 
BoD estimates were calculated using previously established methods and country-specific life 
tables provided by the Global Burden of Disease Study [24]. DALYs were calculated as the product 
of the years lived with disability (YLD) and the disability weight (DW). Both universal and specific 
life expectancy tables for the sampled population (Somali) were used [25,26]. Years of Life Lost 
(YLL) were estimated for each patient based on their life expectancy at time of treatment. Age 
weighting and future discounting [24,25] are common methods in global burden of disease (GBD) 
studies, but remain somewhat controversial, especially when applied to children [27,28,29]. A 
sensitivity analysis was therefore performed on the life expectancy tables, using both “plain” 
values without any age weighting or discounting (so-called YLL(0,0)) and standard tables 
(YLL(3,1), denoting 3% discounting of future years and applied age weighting) [26]. 
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 Averted DALYs (representing met need) were defined as the number of DALYs potentially gained 
through each surgical procedure by averting death [YLL] and decreasing morbidity from condition 
for the rest of the child’s expected life (YLD) [16]. The YLD estimate includes the DW, the 
potentially less than unitary risk of permanent disability without surgery (RPD), and the less than 
unitary probability of a fully successful surgery (PST). The latter factor aims to account both for 
the possibility of post-operative complications and the need for further procedures. While DWs 
exist for a few pediatric surgical conditions [15], for the remaining conditions they were 
estimated by the authors using the functional scale provided by Murray [25]. Averted DALYs 
through any intervention are thus calculated as previously described [20,30] using the formula: 
 LEAge at operation * DW * RPD * PST,  
where the last 3 terms are constrained between 0 and 1.  
In this study all interventions were elective and thus performed on chronic surgical disability 
states, thus we conservatively assumed that there were no actual deaths (or YLL) prevented 
through our interventions. The final averted DALYs in this study were therefore based on YLD 
only. Following is a graphic representation of the impact of surgical intervention on a patient:  
Birth           Ageoperation                                     LE 
  |______________________________|______________________________________________________________________________| 
  DWuntreated*Ageoperation+       LEAge at operation * DWuntreated * RPD * PST   
 
Averted DALY values can be calculated either per patient, or as a cohort / population total. For 
instance, a 6 year-old boy with hydrocephalus treated by ventriculo-peritoneal shunt insertion 
would have 71.05 (LEAge at operation) * 0.4 (DW) * 1 (RPD>95%) * 0.7 (PST between 50% - 95%) = 
19.9 DALYs averted.  
We also estimated the delayed averted BoD caused by the observed delays in provision of care 
(backlog). This was done by multiplying the DW with the delay in care (age of actual operation 
minus ideal age of operation). In the example above, the delayed averted surgical burden was (6 
– 0.2) * 0.4 (DW) = 2.3 DALYs. Because of inherent challenges in accurate history of acquired 
conditions, this measurement was restricted to congenital malformations. 
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 Cost-effectiveness analysis 
Inpatient costs associated with surgical procedures were extracted from the patient database. 
This included actual patient bills for the operating room, hospital stay, medications and supplies, 
staff salaries, and administrative charges. While staff salaries were included in the hospital bill, 
the surgeons volunteered their time and some surgical supplies were donated. The cost-
effectiveness ratio was derived from the aggregate cost of all surgical admissions divided by the 
total DALYs averted through the procedures performed. 
Ethics 
This study was approved by the Research Ethics Committee of BethanyKids at Kijabe Hospital.  
Results 
Between March 2005 and June 2011, 640 surgical procedures were performed at BethanyKids of 
Kijabe Hospital, Kenya on 341 children (under 18 years) from the Dadaab Refugee Camp. Median 
age of the children was 4.6 years and 66% were male. Forty-three percent of procedures were 
performed for congenital anomalies and 57% for acquired conditions. 
The commonest congenital and acquired procedures performed are listed in Table 1, with the 
median age at operation. Figure 1 compares the age at surgery for the commonest congenital 
procedures on refugee children with a similar sample of non-displaced patients during the same 
time period. Cleft lip repair and burn contracture release were the commonest procedures 
performed for congenital and acquired conditions, respectively. 
  
97
 Table 1. Most common congenital and acquired surgical procedures with their median age 
Procedure Number Median age [yrs] 
Congenital 
Posterior medial release for club foot 34 4.4 
VP shunt insertion 31 1.3 
Cleft lip repair 40 6.2 
Hypospadias repair 26 5.8 
PSARP for imperforate anus 17 1.6 
Colostomy 15 2.0 
Colostomy closure 14 2.2 
Acquired 
Dressing change 111 3.7 
Contracture release 66 5.9 
Debridement 20 2.2 
Cast change 14 8.6 
Biopsy 12 8.1 
1 Club foot was treated surgically rather than with serial casting because of the advanced age of the patients. 
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 Figure 1: Median age of various surgical procedures for refugee vs. non-refugee patients
 
PMR = posterior median release; VPS = ventriculoperitoneal shunt; PSARP = posterior sagittal anorectoplasty  
Figure 2 compares the expected cases of the 5 commonest congenital conditions over the study 
period with the actual number of procedures performed for those conditions. The ratio of 
surgeries performed over those expected was 13% (range, 10 – 30%).  
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 Figure 2: Number of children with 5 most common congenital conditions operated in Dadaab vs. 
estimated cases over study period  
 
ARM = anorectal malformation  
Estimated total and per procedure averted DALYs are presented in Figures 3 and 4, respectively, 
while delayed averted DALYs are shown in Figure 5. Sensitivity analysis resulted in a total of 4,136 
– 9,529 DALYs averted over the study period (corresponding to 6.4 – 14.8 DALYs per patient), 
evenly distributed between congenital (totaling 2,065 – 4,911 DALYs, or 7.4 – 17.6 DALYs per 
patient) and acquired conditions (totaling 2,071 – 4,618 DALYs, or 5.7 – 12.7 DALYs per patient). 
The total delayed averted surgical BoD for congenital malformations in this study cohort was 
estimated at 300 DALYs over the study period, representing 1.1 DALYs per patient.  
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 Figure 3: Sensitivity analysis for total burden of disease (in DALYs) averted by surgical specialty 
 
DALY (0,0): DALYs using standard undiscounted Kenya life expectancy table 
DALY (3,1): DALYs using age-weighted and 3% discounted Kenya life expectancy table 
DALY (US): DALYs using universal standard undiscounted life expectancy table 
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 Figure 4: Sensitivity analysis for burden of disease (in DALYs) averted per surgical procedure by 
surgical specialty  
 
DALY (0,0): DALYs using standard undiscounted Kenya life expectancy table 
DALY (3,1): DALYs using age-weighted and 3% discounted Kenya life expectancy table 
DALY (US): DALYs using universal standard undiscounted life expectancy table 
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 Figure 5: Total and average delayed averted DALYs by surgical specialty  
 
daDALY = delayed averted DALY  
The number of surgical procedures by specialty is compared to the respective averted BoD in 
Figure 6. Plastic and general surgical procedures accounted for the most total attributable DALYs 
averted, while general and neurosurgical procedures resulted in the largest number of averted 
DALYs per patient. General surgery was also associated with the highest proportion of delayed 
averted DALYs (93.8).  
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 Figure 6: Number of surgical procedures and corresponding DALYs in each specialty   
  
Accurate hospital bills were available for 289 surgical admissions (45% of total). The total costs 
incurred from the surgical treatment of these children was $141,675. This figure yielded cost-
effectiveness ratios between $40 - $88 per DALY. Cost-effectiveness ratios for each specialty are 
presented in Figure 7, showing neurosurgical procedures to have the lowest cost per DALY ($26 
- $65).  
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 Figure 7: Sensitivity analysis on cost per averted DALY in each surgical specialty   
  
DALY (0,0): DALYs using standard undiscounted Kenya life expectancy table 
DALY (3,1): DALYs using age-weighted and 3% discounted Kenya life expectancy table 
DALY (US): DALYs using universal standard undiscounted life expectancy table 
Discussion 
Displaced persons are a significant vulnerable group globally, and children are among the most 
vulnerable in most limited-resource settings – yet the surgical needs of children in refugee camp 
settings have been ignored in the literature. This is the first study to quantify the burden of 
surgically correctable disabilities among children in a large refugee camp. While burden of 
surgical disease is generally neglected across Sub-Saharan Africa [31], we have found in Dadaab 
this burden to be very significant. With the increasing backlog of persons seeking refugee 
registration in the camp, there is a compelling case to highlight the magnitude of the surgical 
work already performed, as well as still required, in this setting.  
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 The demographics of the children cared for over the 6-year study period are not representative 
of any other known population group, as they reflect a multitude of forces affecting migrant 
populations in areas of armed conflict. Although there is no evidence that surgical disease is more 
common among refugees,  vulnerable groups such as the young and the ill will be preferentially 
evacuated from conflict areas, thus appearing in refugee camps more frequently than in the 
general population [23]. Limited data from Dadaab however reveals that many disabilities are 
not recognized: in 2009 only 2.6% of the population were registered by the rehabilitation 
agencies [32]. Of these persons with disabilities, only 450 were under 18 years of age and had a 
physical disability. While the total number of surgical procedures performed by BethanyKids over 
5 years compares well with this figure, it is obvious that 450 is a gross underestimate of pediatric 
physical disability in the camp, as many new children with surgical disabilities entered the camp 
over the study period. Figure 2 highlights the inadequacy of pediatric surgical care in Dadaab: on 
average only 13.5% of the estimated children with congenital surgical disabilities received 
treatment. While this figure is fraught with many uncertainties and assumptions, it does provide 
a rough idea of the magnitude of the surgical need in this displaced population.  
The male preponderance of the operated children mirrors the 60% male refugee ratio found in 
several camp surveys [23]. Other explanations may include issues of gender-based access to care 
and a higher prevalence of acquired injury-related surgical disabilities in males.  
The unique variety of surgical conditions, both congenital and acquired, presenting in the refugee 
camp reflects a population virtually devoid of previous access to surgical care. Thus it is expected 
that most, if not all, fatal conditions have died, while non-fatal conditions generally survived, first 
presenting for care at whichever age refugees reached the camp health care system (Table 1, Fig. 
1). This extreme scenario virtually transforms urgent pediatric surgical conditions into chronic 
elective disabilities – as witnessed by teenagers and even adults with unrepaired open bladder 
exstrophy, cleft lip, or recto-vestibular fistula. 
This unique spectrum of disease, quite different from that of “traditional” pediatric surgery, 
requires a corresponding unique skill set for any organization attempting to serve such 
populations. At BethanyKids we have developed over the years such expertise, and are passing it 
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 on to national pediatric surgeons through a disability-focused accredited pediatric surgical 
training program.   
While DALYs may not provide the most accurate reflection of the true perception of a disease 
state by the individual [25], they have rapidly become the most common metric for BoD. The 
total BoD in any population includes the met, unmet and unmeetable components [16]. In the 
context of a refugee camp, the unmet need continuously fluctuates based on the demographics 
and health status of the incoming and outgoing refugees. Due however to the fact that 
BethanyKids was the sole provider of pediatric surgical care in the camps over several years, we 
had the unique opportunity to estimate the magnitude of the met need. This magnitude depends 
on the life tables used and the inherent assumptions regarding age weighting, future discounting, 
and use of country-specific vs. universal tables discussed above. Generally the lowest DALY values 
were generated by the country-specific, discounted tables - while undiscounted, universal tables 
produced the highest values. While each of these options has its inherent pros and cons, it is 
reassuring that all DALY estimates were well within one order of magnitude.  
The ability of DALYs to capture the burden of chronic disability is highlighted by the disparity 
between numbers of surgical procedures in each specialty and their corresponding BoD. General 
surgical and neurosurgical procedures appear to be associated with the greatest BoD, likely 
because of the higher DW frequently characterizing congenital malformations in these specialties 
(such as imperforate anus and spina bifida).  
Besides the met surgical need attributable to surgical interventions, our data allows the 
calculation of the delayed averted burden, caused by the years lived with disability (YLD) 
preceding the surgical treatment. This previously unidentified factor is likely a sub-component of 
the unmet need, although its irrecoverable nature makes it behave more like an unmeetable 
need. Not only is past suffering not recoverable, but, in the case of many pediatric surgical 
conditions, delay in care may be associated with more challenging surgical procedures and a 
higher likelihood of complications. A 20-year old patent with unoperated cleft palate will not only 
have suffered for 20 years from the sequelae of her condition, but her surgery will be more 
challenging than in a 1 year-old, and her speech deficits likely irreversible. The advanced age at 
surgery for congenital malformations in the displaced children compared to non-displaced ones 
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 (Fig. 1) highlights an even greater surgical backlog in the refugee camps than in the surrounding, 
already severely resource-limited, LMICs - and the higher delayed averted burden in this most 
vulnerable population. The tremendous challenge caused by armed conflict and population 
displacement is further increased by the inadequacy of the current pediatric surgical care 
provided (evidenced by less than 25% of children with congenital surgical conditions receiving 
treatment). Ongoing efforts by the UNHCR and its implementing partner agencies to improve 
health care in the camps are hindered by the constant increase in refugee numbers and the 
security concerns of the ongoing armed conflict in the region [8].  
Our study draws upon previously established CEA methods for surgical interventions 
[19,20,2828]. The current cost-effectiveness ratios of $40 - $88 per DALY compare favorably with 
other studies showing surgical intervention to be a cost-effective method of decreasing BoD. 
Debas et al [11] estimated a cost per averted DALY in LMICs between $33 and $94, while Gosselin 
et al arrived at CEA values of $172 / DALY in a Nigerian hospital and $223 per DALY in Haiti [30]. 
Our cost per DALY may have been artificially decreased by the exclusion of “fixed” costs like the 
depreciation of hospital equipment, and the reliance on donated surgeon time and equipment. 
More likely however, even highly specialized surgical procedures on children are likely to be cost-
effective because of the long life expectancy following the procedure, and hence the many years 
of disability averted. This favorable CEA supports the inclusion of pediatric surgical care in the 
package of services offered to displaced populations.  
The most cost-effective procedures proved to be neurosurgical ones (due likely to the impact of 
relatively simple procedures like ventriculo-peritoneal shunts on high-DW conditions), while 
urological operations were the most expensive (the majority being hypospadias repairs, with a 
relatively low DW).  
Limitations 
Our study has several limitations. Despite the apparently comprehensive nature of the surgical 
care provided by the BethanyKids facility, the type of procedures performed reflected in part the 
type of surgical expertise available during that time. Moreover, with waiting times up to one year 
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 for most procedures, our data cannot be used to estimate true BoD in the camp over a given 
period of time – this remains a task for future studies.  
While we have attempted to capture the uncertainty factor intrinsic to the various life tables [33] 
in the sensitivity analysis, the 3 estimated YLL modifiers (DW, RPD, and PST) each carry significant 
additional uncertainty. As most DWs for the conditions included in the study were not available 
in the literature, the study needed to rely on much coarser estimates using published methods. 
As for the RPD and PST, they are both not only crude but very context-dependent: for many 
surgical conditions, delay in treatment can increase both the risk of permanent disability (such 
as speech problems in cleft palate) and lower the probability of successful treatment (such as 
urinary continence in bladder exstrophy closure). Moreover, the PST depends significantly on the 
quality of the surgical facilities, equipment and expertise available, as well as on a multitude of 
other patient-related factors (such as nutritional status, anemia, and other co-morbid conditions) 
which are difficult to quantify. Also as stated in the Methods, we have conservatively assumed 
that no actual deaths were averted by our elective procedure, as the vast majority of deaths in 
our patient population from their conditions would have occurred before they had access to 
surgery.  
Finally, all CEA inherently carries multiple assumptions and a large degree of uncertainty [28]. 
While some limitations were evident in our case (surgeons’ salaries, donated equipment, fixed 
costs), dollar values associated with surgical work remain difficult to assign with any certainty.   
Conclusion 
This first estimate of burden of surgical disease averted in the Dadaab Refugee Camp highlights 
the significant impact that surgical intervention can have in such a setting, and its cost-
effectiveness. Given the magnitude of the number of persons displaced by armed conflicts across 
the globe, such data can inform appropriate resource allocation for the health care needs of 
these vulnerable populations.   
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Abstract 
Background 
Pediatric surgical practice is different in low- and middle-income countries as compared to North 
America.  While resources are limited, the impact of pediatric surgical procedures is significant.  
The objective of this study was to calculate and compare Disability-Adjusted Life Years (DALYs) 
averted in a Kenyan and Canadian surgical unit for a subset of pediatric congenital anomalies.  
Methods 
Medical records of children having undergone surgical procedures for 13 congenital conditions 
in both surgical units were collected over 12 months. DALYs for each condition were calculated 
using previously obtained disability weights derived in each country. Age-adjusted life expectancy 
rates from the WHO were used to determine years of life lost (YLL). Risk of permanent disability 
without surgery (RPD) and probability of successful treatment (PST) values were obtained from 
the literature and included in the DALY calculation. 
Results 
The conditions accounting for the largest total number of averted DALYs in Kenya were 
hydrocephalus (60.8%) and spina bifida (18.1%), whereas in Canada they were hydrocephalus 
(24.2%) and undescended testes (19.2%). A total of 23,169 DALYs were averted through 1,042 
surgical procedures (22.2 DALYs per procedure) during the study period in Kenya, compared to 
5,497 DALYs through 373 procedures (14.7 DALYs per procedure) in Canada.  
Conclusions 
Using recent developments in burden of disease measurement, the results point to the significant 
impact of pediatric surgical centers in addressing the global burden of congenital surgical disease. 
The study carries significant implications for resource allocation and training. 
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Introduction 
An estimated 93 million children live with some form of moderate or severe disability worldwide 
[1]. Among the top ten leading causes of pediatric morbidity and mortality worldwide are 
congenital conditions, which affect 7% of all births around the world [2]. The burden of congenital 
anomalies on children, families, and health systems is particularly acute in low- and middle-
income countries (LMICs), which experience a disproportionate number of these serious birth 
defects (94%) [3,4]. Children affected with these congenital anomalies, who survive infancy, often 
continue to live with disability and experience significant physiological and psychological effects, 
including community stigma and discrimination [5].  
Timely surgical intervention prevents both death and disability associated with many congenital 
anomalies. Lack of access to surgically trained healthcare providers, operating room facilities, 
and surgical supplies are some of the factors that impair the delivery of adequate surgical care in 
LMICs for these conditions [6]. This lack of access continues to exist despite recent economic 
analyses that demonstrate that surgery is a more cost-effective means of reducing disease 
burden than many other medical interventions [7-9], and the recognition that access to surgical 
care is one of the top 8 interventions integral to the progression of welfare among the world’s 
poorest populations [10].  
Traditional research methods of quantifying and evaluating the effect of surgical interventions 
have underestimated the larger impact of surgery in preventing a lifetime of disability in a child. 
The Global Burden of Disease (BoD) Study uses the Disability-Adjusted Life Year (DALY), a health 
metric combining morbidity and mortality, which has become the tool of choice for policy-makers 
involved in priority-setting and resource allocation [11]. The DALY measure combines Years of 
Life Lost (YLL) with Years Lost due to Disability (YLD), recognizing the disease burden associated 
with non-fatal yet disabling conditions [12, 13]. Using the DALY methodology, previous studies 
have determined that surgical conditions account for 11% of the global BoD, and in Africa the 
surgical BoD is nearly double that estimated in North America [14]. Furthermore the Disease 
Control Priorities (DCP) study has established that congenital anomalies contribute 9% of the 
surgical BoD [15]. 
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In terms of the need for surgical care, the surgical BoD can be subdivided into three categories: 
met need (averted DALYs), unmet need (avertable DALYs) and unmeetable need (unavoidable 
morbidity and mortality even with intervention) [16]. Estimates of averted DALYs can be used to 
compare the cost-effectiveness of surgical interventions with other medical treatments, as 
mentioned above, while estimates of avertable DALYs primarily inform priority-setting and the 
allocation of limited health resources.  
Although some researchers have compared the incidence of neonatal surgical conditions in LMICs 
with high-income countries (HICs) [17], no studies have compared the impact of pediatric surgery 
in HICs with LMICs using the DALY metric.  The objective of this study was to use the DALY 
methodology to compare the averted burden of surgical disease from 13 congenital health states 
addressed by pediatric surgeons working in a high-income country (Canada) with a low-income 
country (Kenya). 
Materials and Methods 
Settings 
BethanyKids at Kijabe Hospital (BKKH) is an international faith-based children’s surgical unit 
located in a rural general hospital 65 kilometers northwest of Nairobi, Kenya. The institution 
relies on external funding through various agencies and donors to provide affordable surgical 
care and rehabilitation.  
McMaster Children’s Hospital (MCH) is located in Hamilton, a major metropolitan city in southern 
Ontario, Canada; it is a regional pediatric academic tertiary care center. Comparative data on the 
two sites are presented in Table 1 [18-20].  
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Table 1 Comparison of the Two Study Settings 
 BethanyKids at Kijabe 
Hospital (Kenya) 
McMaster Children’s 
Hospital (Canada) 
Number of pediatric beds 67 159 
Number of operating rooms 2 4 
Number of pediatric surgeons 
covering chosen subspecialties 
2 11 
Number of pediatric surgical 
procedures per year 
2,200 4,935 
Referral population  
 
Fertility rate (births/1000 
women) [18] 
43 million (not exclusive 
provider) 
4.5 
2.3 million (exclusive 
provider) 
1.6 
Country rank in UN Human 
Development Index (out of 187) 
[19] 
145 11 
Country physician: population 
ratio (per 1,000) [20] 
0.2 2.1 
 
Data Collection 
We chose to compare 13 congenital health states addressed through pediatric surgical 
procedures in both centers.  We used the procedures as proxies for the health states and included 
pediatric surgical subspecialties available at both sites: pediatric general surgery, urology, plastic 
surgery, and neurosurgery.  The 13 health states chosen included mild and severe forms of major 
congenital anomalies which could be easily compared.  For example, “mild imperforate anus” 
(perineal fistula or low vestibular fistula) did not require a colostomy, while “severe imperforate 
anus” (rectourethral fistula or cloaca)  meant that a colostomy was required. Similarly, “severe 
spina bifida” was defined as paraplegia, and “severe hypospadias” was defined as having a penile 
shaft or more proximal opening requiring a complex repair.  All cases of gastroschisis or 
omphalocele were considered “severe abdominal wall defects”. In the case of  health states 
requiring staged repairs, all necessary procedures were included. 
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After research ethics approval at both sites (Hamilton Health Sciences Integrated Research Board 
(#11-328) and Kijabe Hospital Research Ethics Board), medical records were reviewed for all 
patients under the age of 18 who had one of these surgical procedures at BKKH or MCH between 
November 2011 and October 2012. Data on birth date, sex, diagnosis, surgical intervention, and 
age at time of procedure were abstracted from patient records.  
BoD Analysis  
The disability prevented through surgery at each site was estimated using published DALY-based 
methods [8]. We examined only the met need for surgical care, expressed in averted DALYs, using 
the formula:  
Averted DALYs = YLL × DW × RPD × PST, 
where Years of Life Lost (YLL) is the sum of years lost through premature mortality and the 
Disability Weight (DW) is a factor reflecting the severity of a disease on a scale from 0 (perfect 
health) to 1 (equivalent to death). Risk of Permanent Disability (RPD) and Probability of Successful 
Treatment (PST) are variables constrained between 0 and 1 that account for the long-term impact 
of an intervention [8].  
YLL values were determined by subtracting the age of the patient undergoing surgery from his or 
her life expectancy at the time of treatment, using country- and gender-specific discounted and 
age-adjusted life expectancy tables from the World Health Organization (WHO) [21]. Country-
specific DW values for each health state were derived from our previous study [22]. RPD and PST 
values were determined using an established scoring system from the literature [8,23] and were 
agreed upon by an expert panel of surgeons. Given the nature of congenital anomalies, it was 
assumed that all health states would result in permanent disability or death if left untreated 
(RPD=1). The value chosen for PST was 0.7 for all conditions except for severe spina bifida (0.3), 
undescended testis (0.1) and mild hypospadias (0.1). In the case of health states requiring 
multiple (staged) procedures, the incremental BoD averted through each procedure was 
calculated separately, commensurate to its relative impact on the health state.  
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Once averted DALYs per patient were estimated, the total averted DALYs at each site over a 
period of one year were calculated and compared. All descriptive statistics, including counts, 
percentages, means and standard deviations, were performed using SPSS v20.0 (Chicago, Illinois).  
Results 
The mean age of the patients included was 2.2 years (SD=3.8) at BKKH and 3.0 years (SD=3.8) at 
MCH; 38% were female at BKKH and 16% at MCH.  The distribution of surgical procedures by 
specialty in each site is presented in Figure 1. Over 2/3 of procedures at BKKH where 
neurosurgical, while at MCH where urological. Table 2 lists the disability weights and numbers of 
procedures performed at each site for each health state, from which total and mean averted 
DALYs were estimated; the procedures performed for each health states are included, as well as 
a sample calculation of averted DALYs for clarification. The mean age at operation for each health 
state is provided in Figure 2, comparing values for each at BKKH with MCH. The delays in surgery 
at the Kenyan site are evident, particularly for children with cleft, gastrointestinal and 
genitourinary conditions. Figure 3 compares mean DALYs averted through surgery per patient for 
each health state. Surgery for severe abdominal wall defects and intestinal atresia led to the 
highest mean averted DALYs per patient in both Kenya (38.06 and 36.29 DALYs respectively) and 
in Canada (50.16 and 53.93 DALYs respectively).  
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Figure 1 Proportion of Procedures at each Site by Pediatric Surgical Subspecialty  
 
 
 
 
 
 
 
Distribution of the surgeries (Sx) performed per subspecialty at BethanyKids at Kijabe Hospital (BKKH) and 
McMaster Children’s Hospital (MCH) between November 2011 and October 2012 
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Table 2 Health States and Averted DALYs Distribution at each Site  
1 An example of calculation of averted DALYs for one patient with hydrocephalus follows: 
        Averted DALYs = YLL × DW × RPD × PST = 62.1 × 0.74 ×1 × 0.7 = 32.17 
 
Health State 
 
Surgical 
Procedure 
Disability 
Weights 
(DW)2 
Number of 
Cases (%) 
Mean Averted DALYs 
per patient 
Total Averted 
DALYs (%) 
Site  BKKH MC
H 
BKK
H 
MCH BKKH MCH BKKH MCH 
Plastic Surgery          
Cleft Lip cleft lip repair 0.18 0.2
2 
46 
(4.8) 
19 
(5.1) 
7.63 12.39 351 
(1.5) 
235 
(4.3) 
Cleft Palate  cleft palate 
repair 
0.38 0.3
5 
11 
(1.1) 
21 
(5.6) 
15.93 12.39 175 
(0.8) 
417 
(7.6) 
General Surgery          
Hirschsprung’s 
Disease 
colostomy, pull-
through, 
colostomy 
closure 
0.72 0.6
9 
5 
(0.5) 
5 
(1.3) 
30.08 39.28 150 
(0.6) 
196 
(3.6) 
Mild 
Imperforate 
Anus 
anoplasty 0.28 0.3
2 
31 
(3.2) 
4 
(1.1) 
11.62 18.66 360 
(1.6) 
75 
(1.4) 
Severe 
Imperforate 
Anus  
colostomy, 
PSARP3, 
colostomy 
closure 
0.81 0.7
3 
37 
(3.8) 
2 
(0.5) 
33.82 40.32 1251 
(5.4) 
81 
(1.5) 
Severe 
Abdominal Wall 
Defect  
abdominal wall 
closure 
0.92 0.8
8 
3 
(0.3) 
10 
(2.7) 
38.06 50.16 114 
(0.5) 
502 
(9.1) 
Intestinal 
Atresia  
atresia repair 0.90 0.9
5 
1 
(0.1) 
10 
(2.7) 
36.29 53.93 36 (0.2) 539 
(9.8) 
Neurosurgery          
Hydrocephalus  ventriculoperito
neal shunting or 
ETV4 
0.74 0.7
5 
456 
(47.4
) 
33 
(8.8) 
30.89 40.39 14085 
(60.8) 
1333 
(24.2) 
Mild Spina 
Bifida  
closure spina 
bifida 
0.46 0.3
3 
20 
(2.1) 
4 
(1.1) 
19.35 17.94 387 
(1.7) 
72 
(1.3) 
Severe Spina 
Bifida  
closure spina 
bifida 
0.87 0.8
1 
268 
(27.8
) 
4 
(1.1) 
15.64 24.66 4193 
(18.1) 
99 
(1.8) 
Urology          
Undescended 
Testes  
orchidopexy 0.22 0.0
8 
87 
(9.0) 
164 
(44.0) 
12.59 6.45 1095 
(4.7) 
1058(
19.2) 
Mild 
Hypospadias  
hypospadias 
repair 
0.12 0.1
0 
40 
(4.2) 
65 
(17.4) 
6.98 7.83 279 
(1.2) 
509 
(9.3) 
Severe 
Hypospadias  
hypospadias 
repair 
0.50 0.2
2 
25 
(2.6) 
32 
(8.6) 
20.54 11.93 513 
(2.2) 
381 
(6.9) 
Total    1,04
2 
373   23,169 5,497 
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2 DWs derivation detailed in concurrent publication [22]; 3 posterior sagittal anorectoplasty; 4 endoscopic third 
ventriculostomy 
 
Figure 2 Mean Age at Operation at each Site by Health State 
 
Distribution of ages of patients undergoing pediatric surgical procedures at BethanyKids at Kijabe Hospital (BKKH) 
and McMaster Children’s Hospital (MCH) between November 2011 and October 2012 
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Figure 3 Mean DALYs Averted per Patient by Health State 
 
Distribution of the DALYs Averted per health state based on the patient population at BethanyKids at Kijabe 
Hospital (BKKH) and McMaster Children’s Hospital (MCH) between November 2011 and October 2012 
The individual health states accounting for the largest total number of averted DALYs in Kenya 
were hydrocephalus (60.8%) and spina bifida (18.1%), whereas in Canada they were 
hydrocephalus (24.2%) and undescended testes (19.2%). A total of 23,169 DALYs were averted 
through 1,042 surgical procedures (22.2 DALYs per procedure) during the study period in Kenya, 
compared to 5,497 DALYs through 373 procedures (14.7 DALYs per procedure) in Canada.  
Discussion 
The current study compares the outputs of two pediatric surgical units in two very different 
populations, with very dissimilar resources. The countries were chosen non-randomly as sites of 
clinical activity of the authors, but are almost literally at the opposite ends of the spectrum of the 
Human Development Index [19]. What can we learn from such a comparison? Drilling down into 
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the detailed impact each unit has on the burden of surgical disease can help to better understand 
the training and resource needs in a lower-income country. The goal of improving pediatric 
surgical care in LMICs will not be met by copying the practices of a children’s hospital in a 
developed country. Western surgeons who want to work with partners in developing countries 
must know what the needs there are, and whether they have the skills and experience to 
meaningfully contribute.  
Settings and Practice patterns 
The two settings compared in this study are both semi-autonomous, dedicated, academic 
pediatric surgical units, bringing together specialized physicians and other personnel, and 
involved in training multiple levels of health care providers. The similarities however stop there, 
as the infrastructure, resources, and practice of the units are very different. In general the 
Canadian site is much larger institution with more facilities and more dedicated surgeons (Table 
1).  As an example, the Canadian site includes a 60-bed fully-serviced neonatal Intensive Care 
Unit (ICU), while the Kenyan site only has access to a 20-bed nursery with no neonatal ventilators 
and no total parenteral nutrition.  
In comparing the mortality and morbidity prevented through surgical procedures at the two sites, 
the first observation is that the two hospitals have very different patient populations. As ours is 
not a population-based study, the differences reflect to a large extent practice and referral 
patterns, rather than prevalence of disease. There are multiple factors likely involved in these 
patterns, including finances, transport, education, center reputation, and existing referral 
networks. BKKH is also a rather unique institution within a LMIC setting, providing high-quality 
specialty care at affordable prices through a significant reliance on expatriate physicians and 
donated equipment. While this model is different from that of the prevailing governmental 
institutions, it must be noted that there are in fact multiple non-governmental health care 
provision models in LMICs (private hospitals, church / mission hospitals, “niche” hospitals 
addressing selected specialized conditions, and temporary platforms) [24], and their combined 
impact towards the health care provision in many African countries is significant. 
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BKKH is also a national (and even African regional) referral centre for pediatric neurosurgery [25]: 
70% of operative procedures at BKKH were for hydrocephalus or severe spina bifida. This might 
reflect the high prevalence of congenital neural tube defects in East Africa, largely preventable 
through better prenatal nutrition [26]. The prenatal incidence appears lower in North America, 
with the majority of such severe conditions identified prenatally leading to termination of 
pregnancy [26]. As an externally funded charity organization with North American-trained 
pediatric neurosurgeons and rehabilitation experts, BethanyKids fills a niche in treating these 
children who would otherwise often die untreated. 
Conversely, the sum of annual pediatric surgical cases for 11 of the 13 selected conditions 
(excluding neurosurgery) is quite similar between MCH and BKKH (345 and 302, respectively). 
There are however several other differences in practice which stand out. For instance, BKKH 
recorded only one surgical procedure for intestinal atresia, whereas MCH had 10. This likely 
reflects delays in neonatal diagnosis of bowel obstruction in LMICs, as well as limited access to 
tertiary neonatal care required for such conditions, including ventilators and intravenous 
nutrition found in ICUs. The other difference observed is the large number of anorectal anomalies 
operated on at BKKH, which again likely reflects a referral bias, since BethanyKids is known to 
have this expertise, even when the initial life-saving colostomy surgery may have been done at 
other centers.  
In the absence of the significant neurosurgical and general pediatric chronic surgical disabilities 
found in Kenya, the most common procedures captured at the Canadian site, accounting for 62% 
of the cases, were for mild hypospadias and undescended testis. These are generally less severe 
surgical conditions, accounting for only 29% of the total DALYs. This underscores the usefulness 
of the DALY metric, which offers a more complete picture of the impact of interventions on the 
BoD than is provided by the simple number of procedures.  
Age at surgery 
The comparison of age at time of surgery between the two sites reveals the overall older age of 
children operated on in Kenya. This is consistent with earlier work by the authors [9, 23], and 
thus believed to be a true reflection of delays in access to surgical care in LMICs. Only for three 
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health states were children operated in Canada at an older age: hydrocephalus, mild spina bifida, 
and abdominal wall defects. These three states include patients being operated on at an 
advanced age in Canada for mild defects, as reflected in the bimodal distributions of ages, with 
mode values of 0 for all. 
Burden of disease 
The next comparison involved calculating the DALYs averted per child for each health state. As 
shown in Figure 3, the mean averted DALYs per case were generally lower at BKKH, reflecting the 
shorter expected lifespan in Kenya, and therefore lower averted future disability. Only for two 
health states did procedures in Kenya result in a higher value of averted DALYs per case: severe 
hypospadias and undescended testis. This is accounted for by the higher DW assigned to these 
conditions in Kenya, possibly explained by a greater concern for male infertility [27].  
The analysis of total averted DALYs for the 13 health states revealed the annual surgically averted 
BoD of BKKH to be 23,169 DALYs, four times that of MCH. This figure compares favorably with 
similar studies from adult limited–resource surgical settings: for instance Gosselin and Heitto 
estimated that in a district trauma hospital in Cambodia 3,786 DALYs were averted over a 3-
month period through 895 surgical interventions, though many of these interventions were more 
minor [7]. Since the Kenyan site is operating with fewer staff and resources than the Canadian 
one, this comparison is striking and underscores the impact that surgical care can have in LMICs. 
Our study did not include a cost analysis, but it is known that the greater BoD averted through 
surgery in resource-poor settings is also very cost-effective [7-9, 23], thus further strengthening 
the key role of surgery in global health care. The addition of a cost-effectiveness analysis would 
increases the usefulness of the study for health policy and resource allocation, however obtaining 
accurate costing estimates for a hospital setting which receives substantial donations of 
equipment and other resources could be challenging. 
The average impact of each procedure (22.2 DALYs in Kenya vs. 14.7 DALYs in Canada) is an 
indicator of both disease severity and local priorities.  The main contributor to this difference is 
the higher DW attributed to undescended testis in Kenya.  This is an example of how the DALY 
methodology can identify local priorities – male fertility appears to be more highly valued in 
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Kenya, thus resulting in a higher DW for undescended testes than in Canada [22].  Although the 
selected conditions are not a reflection of the entire spectrum of pediatric surgical practice in 
either institution (such common conditions as hernias, appendicitis and trauma were not 
included), the averted burden in Kenya is impressive in light of the resources available.  
The BoD in DALYs averted through any given surgical intervention reflects the DW of the 
underlying health state, the age of the patient, and the effectiveness of the intervention. Thus, 
for instance, neurosurgical procedures are generally associated with higher mean averted DALYs 
than plastic surgical procedures. This however must not be interpreted as favoring one type of 
specialty care over another, as factors like costs of infrastructure, equipment and supplies, and 
expertise also vary widely among surgical specialties, and health care needs in LMICs are 
tremendous in all specialties.  
The focus of this study was on the averted DALYs, or the met need. The avertable DALYs, or unmet 
need, is beyond the scope of this study as its estimation requires population-based data. The 
limited literature on the subject however suggests that this unmet need is very significant in 
LMICs: previous studies have estimated, for instance, that there is a backlog of over 300,000 
uncorrected cleft lip cases in Africa alone [23], and that on average less than 15% of required 
surgical procedures for children are actually performed in a large African refugee camp [9]. 
Another relatively ignored component of the unmet need in surgery is that incurred through 
delay in care. This component, dubbed “delayed avertable DALYs”, has been found to be quite 
significant in LMICs [9, 23].  
The DALY metric is most commonly used in LMIC settings, however DALYs have also been 
calculated in high-income country (HIC) settings. A WHO report used the DALY metric in a HIC as 
well as a LMIC setting to highlight the disparities and create a common comparison [28].  
Research in HICs often uses Quality-Adjusted Life Years (QALYs) as a measure of the impact of 
interventions on surgical conditions.  Robberstad investigated the utility of QALYs, DALYs and life 
years gained (LYs) on priority-setting [29]. The paper concluded that trade-offs in terms of quality 
and quantity are being made in health, especially where resources are scarce, and that both the 
DALY and the QALY, while representing different health states, are useful in priority-setting 
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wherever the resources are not sufficient to meet the needs of a population. This type of setting 
can be seen even within Canada and the United States, and DALYs could be an additional useful 
metric for assessing the impact of poor or delayed access to care in developed nations.  
Training implications  
The practice of sending someone from a LMIC to a HIC institution to train, and then expecting 
them to return home and replicate the HIC practice observed is a faulty training model. In light 
of the observed widely divergent practice patterns in LMICs, surgical training is best done locally, 
within the setting of the local disease patterns, and using local resources. Outside experts can 
provide specific subspecialty training and academic support, and short-term courses or rotations 
in HICs can complement and enrich this training. The local pediatric surgeon in LMICs requires a 
much broader range of experience and skills than does his or her HIC counterpart, since their 
practice may well include pediatric plastic surgery, urology and even neurosurgery in addition to 
the traditional scope of pediatric general surgery. BethanyKids models this philosophy of training, 
being part of the Pan-African Academy of Christian Surgeons (PAACS), an Africa-wide pediatric 
surgical training program with this stated goal – to train pediatric surgeons in Africa, for Africa 
[30].  
Limitations 
There are several significant limitations to the current study. In the first place, the comparison 
between the two sites is somewhat arbitrary in light of the widely divergent practice and referral 
patterns at each site. Pediatric surgeons in HICs mostly do pediatric general surgery, working 
alongside other pediatric surgical specialists – while in LMICs pediatric surgeons usually include 
urology and plastic surgery in their practice. In the absence of clearly set practice and referral 
guidelines, the nature of the work performed in any institution in LMICs is vastly predicated by 
available skills, informal referral networks, funding, geographical and transport realities, and 
widely uneven distribution of specialist care. While the Canadian site (MCH) may be fairly 
representative of other similar-sized pediatric surgical units in the developed world, the Kenyan 
site (BKKH) is quite unique in its focus and outputs in the developing world, and a pediatric 
surgical unit in a government hospital might provide a more useful comparison. The reality, 
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however, is that there is not one standard institutional type in LMICs, but a conglomerate of 
various approaches and health care venues. Thus caution must be exercised when attempting to 
generalize findings at any one site to the entire country or region. 
The actual choice of the 13 health states was well-informed, but not random - representing the 
pediatric surgical conditions more prevalent at both sites and for which DW estimates existed. 
While most of these health states corresponded to a specific single surgical procedure, this was 
not always the case – as apparent in the use of colostomy in the management of children with 
Hirschsprung’s Disease in Kenya. 
Finally, the calculation of DALYs also introduced a significant level of uncertainty. This is due to 
multiple assumptions and controversies in the disability weight estimates, universal vs. country-
specific life expectancies, and the use of age-weighting and discounting [31]. Moreover, the 
actual impact of each intervention was not known as follow-up was not available or practical to 
include. While the PST component in theory accounts for this and is primarily predicated by the 
surgical condition, the diverse care environments of the two sites may lead to slightly different 
PST values, and this was not accounted for in the study.  
The DALY calculation for health states requiring planned staged procedures is challenging and 
imperfect. While in principle the combined averted BoD through a one-stage protocol must be 
the same as for a 3-stage protocol for the same health state, the individual impact of each stage 
(such as a colostomy) is very hard to estimate, and no DW values are available in the literature 
for this. In our study we have accounted for the full impact of each staged intervention in the 
case of the 2 health states requiring staging (severe imperforate anus and Hirschsprung’s disease) 
– thus the total averted DALYs for these 2 health states may have been overestimated.  
Conclusions 
Despite the above limitations, the current study highlights both the widely divergent scope of 
practice of pediatric surgeons across the global South – North divide, and the significant impact 
of pediatric surgery in averting the global BoD of congenital anomalies in both settings. The harsh 
reality of pediatric surgical practice in resource-poor settings is that children with life-threatening 
neonatal conditions frequently die before reaching appropriate care facilities, while those with 
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non-threatening congenital conditions live with their disease often to an advanced age due to 
significant delays in access to surgical care. Thus the practice of the HIC pediatric surgeon focuses 
on the urgent treatment of neonatal conditions, while the LMIC surgeon often needs to treat 
children with elective disabling, unoperated chronic surgical conditions - in addition to a variable 
volume of neonatal emergencies depending on availability of urgent access to care. Furthermore, 
HIC pediatric surgeons wishing to operate in LMIC settings must understand the local scope of 
pediatric disease.  
This study provides a unique comparative snapshot into global pediatric surgical practice, and 
utilizes the recent developments in BoD measurement to estimate the true impact of this practice 
using the DALY framework. A question that still remains is the appropriateness of the DALY metric 
in health policy setting. Future studies could look at the needs of health planners, decision 
makers, and health administrators to see if another health metric may be more applicable. 
Overall, this study opens multiple future research opportunities in other subspecialties for a 
global understanding of health measurement and impact of this measurement on health care 
practice and resource allocation. 
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Abstract 
Background: Disability-adjusted life years (DALYs) have become the standard metric for 
estimating burden of disease (BoD), but have not yet been applied to delayed access to surgical 
procedures. This study estimates the DALYs accrued from delayed access to surgical care in two 
pediatric surgical units in Kenya and Canada.  
Methods: Records of operations for 13 congenital health states in a Kenyan and a Canadian 
hospital were prospectively collected for 2012. DALYs caused by delayed presentation were 
estimated thus:  
Delayed DALYs = DW * (actual – ideal age at surgery),  
where DW=disability weight for each procedure, and ideal age at surgery derived by expert 
consensus.  
Results: 1,208 first-time procedures in general surgery (338), neurosurgery (621), plastic 
surgery (93), and urology (156) were included (870 in Kenya, 338 in Canada). Delays were 
longest in general surgery (46 months), and longer in Kenya than in Canada in all specialties. 
The longest delays in Kenya were for orchidopexy (72 months) and posterior sagittal 
anorectoplasty (PSARP) (74 months), and in Canada for orchidopexy (40 months). 
Corresponding total delayed BoD was highest in general surgery (273 DALYs) and neurosurgery 
(159 DALYs), and higher again in Kenya than in Canada (484 cf. 84 DALYs). Mean delayed BoD 
was highest for PSARP (1.9 DALYs/procedure) and colostomy (1.7 DALYs/procedure) being the 
highest.  
Conclusions: Estimating the BoD resulting from delayed surgery is feasible, and reflects both 
late presentation and limited access to care. Further exploration of these factors can make 
delayed DALYs a useful measure of health care coverage and waitlist prioritization.   
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Introduction 
Congenital conditions are among the top ten leading causes of pediatric morbidity and 
mortality and are estimated to affect 7% of all births around the world [1]. This estimate 
translates into approximately 93 million children living with some form of moderate or severe 
disability [2]. Timely surgical intervention is known to prevent both the death and disability 
associated with many of these congenital anomalies, however lack of timely access to surgically 
trained healthcare providers, operating room facilities, and surgical supplies are some of the 
factors that impair the delivery of adequate surgical care, especially in resource limited settings 
[3]. This lack of access continues to exist despite recent economic analyses that demonstrate 
that surgery can be a more cost-effective use of scarce resources in reducing disease burden 
when compared to many other medical interventions and should be considered an essential 
part of public healthcare [4-6]. This delay in access to surgical care, especially in children with 
congenital anomalies, remains however an under-studied priority, even within the global 
burden of disease literature. 
The Global Burden of Disease (BoD) Study, the gold standard in the field, employs the Disability-
Adjusted Life Year (DALY) as the health metric of choice. This metric integrates measurement of 
both the morbidity and mortality of a specific health state and is the new standard framework 
for quantifying and evaluating the effect of different interventions based on their ability to 
avert disability [7]. The DALY measure combines Years of Life Lost (YLL) with Years Lost due to 
Disability (YLD), thus recognizing the disease burden associated with non-fatal yet disabling 
conditions [8, 9]. Included in the DALY calculation is a disease-specific assessment called a 
Disability Weight (DW). DWs are an empirically determined metric reflecting the decline of 
health associated with a certain health state, ranging between 0 (perfect health) and 1 (death) 
[10, 11]. Through the successful application of the DALY methodology previous studies have 
determined that surgical conditions account for 11% of the global BoD, and in Africa the 
surgical BoD is nearly double that estimated in North America [12]. Furthermore the Disease 
Control Priorities (DCP) study has established that congenital anomalies contribute 9% of the 
surgical BoD [13]. 
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In terms of need for surgical care, BoD can be subdivided into 3 categories: met need (averted 
DALYs), unmet need (avertable DALYs) and unmeetable need (unavoidable morbidity and 
mortality even with intervention) [14]. Estimates of averted DALYs can be used to compare the 
cost-effectiveness of surgical procedures with other medical treatments, as mentioned above, 
while estimates of avertable DALYs primarily inform priority-setting and the allocation of 
limited health resources.  
While a few recent studies are starting to explore the impact of surgery through averted DALYs 
in various specialties and to compare this impact between high-income countries (HICs) and  
LMICs [15-19], there is to date no information on the magnitude of the BoD caused exclusively 
by delayed access to surgical care. This “delayed burden of disease” component represents the 
burden suffered by patients who live with a given surgical condition for months or years, while 
awaiting treatment.  
The objective of this study was to use a recently developed surgical DALY methodology to 
compare the delayed burden of surgical disease accrued through 13 congenital health states 
addressed by pediatric surgery in a high-income country (Canada) with a low-income country 
(Kenya). 
Methods 
Settings 
BethanyKids at Kijabe Hospital (BKKH) is an international faith-based pediatric surgical unit 
located in a secondary and tertiary general hospital 65 kilometers outside of Nairobi, Kenya. 
The unit relies on external funding through various agencies and donors to provide affordable 
surgical care and rehabilitation.  
McMaster Children’s Hospital (MCH) is a regional pediatric academic tertiary care center 
located in Hamilton, a major metropolitan city in southern Ontario, Canada. Comparative data 
regarding the two sites has been presented in a recent publication [20]. 
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Data Collection 
We chose to compare 13 health states addressable through pediatric surgical procedures in 
both centers. The reasons and procedures used in choosing these health states are detailed in 
our recent publication [20]. Twelve distinct surgical procedures were identified as proxies for 
treating these health states, as two of the health states (hypospadias and abdominal defect) 
each included a mild and a severe form, while one state (severe imperforate anus) required two 
procedures. 
After research ethics approval at both sites (Hamilton Health Sciences Integrated Research 
Board (#11-328) and the Kijabe Hospital Research Ethics Board), medical records were reviewed 
for all patients under the age of 18 who had one of these surgical procedures at BKKH or MCH 
between November 2011 and October 2012. Data on birth date, sex, diagnosis, surgical 
procedure, and age at time of procedure were abstracted from patient records. Patient 
selection in Canada was based on the associated Ministry of Health and Long-term Care 
Schedule of Benefits surgical procedure code rather than primary diagnosis or health state. We 
excluded all secondary/redo procedures, as well as primary procedures deemed to have been 
intentionally delayed because of concurrent patient risk factors and/or co-morbidities. 
Burden of Disease (BoD) Analysis  
The disability prevented through surgery at each site was estimated using published DALY-
based methods [5]. DALYs caused by delayed access to surgery for each procedure were 
estimated using the formula:  
Delayed DALYs = DW * (age at surgery – ideal age at surgery), 
where DW is the Disability Weight recently estimated for each procedure in both countries [20], 
and the ideal age at surgery was derived from the literature using current clinical practice 
guidelines where available (Table 1) or by expert consensus in the absence of published 
guidelines.  
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Table 1. Literature used to Determine Recommended Age at Surgery 
Condition* Recommended 
Age at Surgery 
Publication 
Year 
Source 
Hypospadias 6-18 months 2009 European Association of Urology (EAU) and the 
National Guideline Clearinghouse (NGC) 
http://www.guideline.gov/content.aspx?id=12594  
Cleft Lip with no 
Cleft Palate 
3 months 2012 NHS http://www.nhs.uk/Conditions/Cleft-lip-and-
palate/Pages/Treatment.aspx  
Cleft Palate with 
or without cleft 
lip 
6-12 months 2012 NHS http://www.nhs.uk/Conditions/Cleft-lip-and-
palate/Pages/Treatment.aspx  
Undescended 
Testes 
12-18 months 2009 European Association of Urology (EAU) and the 
National Guideline Clearinghouse (NGC) 
http://www.guideline.gov/content.aspx?id=14430  
Hirschsprung's 
Disease 
at diagnosis  IPEG guideline reviewed with no mention of age 
http://www.ipeg.org/hirschsprungs/  
Hydrocephalus at diagnosis  American Association of Neurological Surgeons 
reviewed with no mention of age 
Imperforate Anus 3-4 weeks of age  APSA 
http://www.pediatricsurgerymd.org/AM/Template.c
fm?Section=List_Of_Conditions1&template=/CM/Co
ntentDisplay.cfm&ContentID=4289  
Spina Bifida 48 hours of life 2005 American Association of Neurological Surgeons 
Intestinal Atresia at birth  Expert consultation 
Abdominal Wall 
Defect 
at birth  Expert consultation 
 * “mild” and “severe” forms of hypospadias, spina bifida and imperforate anus are grouped together in the 
absence of distinct management protocols. 
Once delayed DALYs per patient were calculated, the total number of delayed DALYs accrued at 
each site over a period of one year was calculated and compared. Descriptive and comparative 
statistics, including counts, percentages, means and Student’s t-test were performed using 
Microsoft Excel®. 
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Results 
The study included 1,423 surgical procedures in patients under 18 years of age within the 
identified 13 health states. After removing secondary procedures and those intentionally 
delayed for medical reasons, there were 1,208 surgical procedures left. The distribution of the 
12 procedures across sites, genders and specialties is detailed in Table 2.  
Table 2: Number of Consecutive Procedures by Site, Gender, and Specialty  
 MCH BKKH Total 
 F M Total F M Total  
Abdominal wall closure 4 3 7 1 2 3 10 
Anoplasty 0 2 2 0 1 1 3 
Coloanal pull-through 3 2 5 1 9 10 15 
Colostomy 0 0 0 7 15 22 22 
Intestinal atresia repair 1 4 5 0 1 1 6 
Orchidopexy N/A 163 163 N/A 88 88 251 
PSARP1 7 2 9 8 14 22 31 
General Surgery Total 15 176 191 17 130 147 338 
Spina bifida closure 3 3 6 139 144 283 289 
VPS insertion/ETV2 5 4 9 143 180 323 332 
Neurosurgery Surgery Total 8 7 15 282 324 606 621 
Cleft lip repair 7 11 18 18 30 48 66 
Cleft palate repair 11 8 19 2 6 8 27 
Plastic Surgery Total 18 19 37 20 36 56 93 
Hypospadias repair N/A 95 95 N/A 61 61 156 
Urology Total N/A 95 95 N/A 61 61 156 
Grand Total 41 297 338 319 551 870 1208 
MCH = McMaster Children’s Hospital; BKKH = BethanyKids Kijabe Hospital; 1 PSARP = Posterior sagittal 
anorectoplasty; 2 VPS = Ventriculoperitoneal shunt; ETV = Endoscopic third ventriculostomy  
The delay in surgical intervention was first estimated in months, and is detailed by procedure in 
Table 3 and by specialty in Figure 1. As noted, mean delays in surgery were statistically 
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significantly higher in Kenya for most procedures which included sufficient data points, with the 
exception of hydrocephalus procedures which had similar mean ages across sites.  
Table 3: Mean Delay to Surgery for each Procedure by Site (in months) 
Procedure MCH1 BKKH p value 
Abdominal wall closure 0 0.1 0.05 
Anoplasty 0 5.6 NS 
Cleft lip repair 5.6 39.8 <0.001 
Cleft palate repair 11.4 47.6 NS 
Coloanal pull-through 13.0 30.3 NS 
Colostomy N/A 26.4 NS 
Hypospadias repair 17.2 50.0 <0.0001 
Intestinal atresia repair 0 0.1 NS 
Orchidopexy 40.4 71.7 <0.0001 
PSARP 0 74.4 <0.001 
Spina bifida closure 0 4.5 <0.0001 
VPS insertion/ETV 4.5 3.7 NS 
MCH = McMaster Children’s Hospital; BKKH = BethanyKids Kijabe Hospital; NS = Not significant; PSARP = Posterior 
sagittal anorectoplasty; VPS = Ventriculo-peritoneal shunt; ETV = Endoscopic third ventriculostomy; N/A -= not 
applicable. 1Age data from MCH was converted from years.  
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Figure 1: Mean Delay to Surgical Procedure for each Specialty by Site 
  
MCH = McMaster Children’s Hospital; BKKH = BethanyKids Kijabe Hospital; * p < 0.0001  
The cumulative DALYs resulted from this temporal delay were then estimated and depicted in 
Figure 2 (by procedure) and Figure 3 (by specialty). These cumulative values reflect both the 
predominance of neurosurgical procedures at BKKH, and the major delays at that site in the 
care of children primarily with intestinal and urological conditions.  
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Figure 2: Total Delayed DALYs Accrued by Procedure and Site 
 
 
MCH = McMaster Children’s Hospital; BKKH = BethanyKids Kijabe Hospital; PSARP = posterior sagittal 
anorectoplasty; VPS = ventriculo-peritoneal shunt; ETV = endoscopic third ventriculostomy. 
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Figure 3: Total Delayed DALYs Accrued by Specialty and Site 
 
MCH = McMaster Children’s Hospital; BKKH = BethanyKids Kijabe Hospital. 
Finally, mean delayed DALYs incurred for each surgical procedure were also estimated by 
procedure type (Figure 4) and by specialty (Figure 5). These figures highlight the impact of 
delays in the care of children particularly with intestinal, urological, and plastic surgery 
conditions.  
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Figure 4: Mean Delayed DALYs per Surgery Procedure and Site 
  
MCH = McMaster Children’s Hospital; BKKH = BethanyKids Kijabe Hospital; PSARP = posterior sagittal 
anorectoplasty; VPS = ventriculo-peritoneal shunt; ETV = endoscopic third ventriculostomy.  
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Figure 5: Mean Delayed DALYs per Surgical Specialty by Site 
 
MCH = McMaster Children’s Hospital; BKKH = BethanyKids Kijabe Hospital. 
Discussion 
The current study attempts for the first time to quantify the delayed burden of surgical disease, 
placing an empirical value on the well-known reality of surgical procedures in Low- and Middle-
Income Countries (LMICs) often being significantly delayed [21, 22]. Moreover, the study 
compares this delayed burden between two pediatric surgical units in two very different 
populations, with very different resources. Similarly to our previous report [20], the countries 
were chosen non-randomly as sites of clinical activity of the authors, and are nearly at the 
opposite ends of the spectrum of the Human Development Index [23]. This comparison aims to 
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highlight predictable inequities in access and delivery of surgical care between resource-rich 
and resource-limited settings.  
Settings and Practice patterns 
The two settings compared in this study have been previously described in detail [20], and the 
inherent differences in their patient populations, referral patterns, and clinical strategies have 
been highlighted. Such differences account for the obvious discrepancies between numbers of 
specific procedures noted in Table 1 between the sites. This applies particularly to the notable 
predominance of neurosurgical procedures in BKKH, a reflection of a unique referral pattern 
established over the past decade in Kenya.  
Delay in surgery 
The comparison of mean delays in presentation to surgery between the two sites highlights the 
delayed access to surgery at BKKH. For instance, the average age of children operated for cleft 
lip was over three years, for hypospadias four years, and for orchidopexy and posterior sagittal 
anorectoplasty (PSARP) 6 years. This is consistent with earlier work by the authors [6, 16], and 
thus believed to be a true reflection of delays in access to surgical care in LMICs, in keeping with 
other reports [24, 25]. Only in the case of hydrocephalus were children in Canada operated at 
an older age, probably reflecting many instances of mild disease being diagnosed only in later 
childhood. By contrast, the vast majority of hydrocephalus in the East African setting is either 
spina bifida-related or follows neonatal encephalitis [26], thus the mean age of four months at 
time of surgery still represents a significant delay. 
It is important to note that the delay observed at both sites in our study includes several 
components: delay of presentation to medical care, delay of referral for specialized care, and 
finally delay to actual surgery. Especially in HICs there are currently some major efforts 
underway to quantify and monitor the latter 2 delays (labelled W1 and W2 in the Canadian 
Paediatric Surgical Wait Times (CPSWT) Project) [27] for purposes of resource allocation, but in 
fact in both settings the delay to original presentation to health care facilities remains most 
important and harder to measure.  
148
       
 
 
Delayed Burden of disease 
The estimated delayed BoD expands simple wait time by factoring in the DW of each untreated 
condition. This factor, varying between 0 (full health) and 1 (death), has been estimated for 
several pediatric surgical conditions [28]. The total delayed DALYs shown in Figures 2 and 3 are 
also modulated by institutional surgical volumes, thus reflecting of the actual delayed burden 
encountered in a high- and a low-income setting. The mean delayed DALYs per procedure, as 
shown in Figures 4 and 5, eliminate the institutional volume factor and thus highlight the 
surgical conditions in which children suffered the most while waiting for surgery. This burden 
was highest within general surgery, particularly intestinal conditions (imperforate anus and 
Hirschsprung’s disease), with urological conditions (hypospadias and undescended testes) and 
cleft palate following. 
What is the significance of the delayed burden of disease? The concept appears necessary, as 
the only attempt to bring to light and to measure the years spent by any person suffering from 
a disabling surgical condition before they are treated. It must be noted that this component is, 
however, essentially untreatable – it cannot be eliminated through surgery, though it can be 
prevented through prompt surgical care before it starts accumulating. This may be the reason 
why the concept didn’t even appear in the classic grouping of surgical burden into met, unmet 
and unmeetable need [13, 14]. As these three components must by definition add up to the 
total BoD attributed to any condition as estimated by the Global Burden of Disease (GBD) Study 
[8, 13], where does the delayed burden fit in? Our previous work has placed it in either of the 
three groupings [6, 15], as it can be considered met need addressed once the surgical 
procedure is done, unmet need waiting for a surgical procedure, or as “lost” unmeetable need 
that can no longer be gained back even after the surgery is completed. Another way to 
conceptualize this is to split both met and unmet need into an “incident” or “timely” 
component representing new congenital cases being born, and a “prevalent” or “delayed” 
component which is the backlog of unoperated children with that condition awaiting surgery 
[15]. Within this framework (Figure 6), the delayed burden fits within the prevalent need, as it 
results from children who have not been treated in a timely fashion. 
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Figure 6: The Conventional and Expanded Models for Components of Burden of Surgical Disease 
 
Time-based estimates of delayed BoD quantify the magnitude of the access to care issue, but 
do not necessarily provide insights into the causes of such delays. As addressed by many others 
[25, 29-33], the causes are broad and multi-factorial, including geographical challenges 
(distance to appropriate health care points), educational and cultural challenges (knowledge 
that a condition is treatable and where to seek help), human resource limitations (sufficient 
numbers of well-trained surgeons and other health care workers), infrastructure issues (roads 
for transport, hospitals), financial challenges (cost of care, of transport, and lost income while 
caring for the child), and technological limitations (such as anesthesia and imaging). 
The methodology presented applies itself well to congenital conditions which often, but not 
always, have clearly set guidelines for timely treatment after birth, but it can also be applied to 
acquired conditions in which prompt treatment is recommended from the time of presentation 
(e.g. cancer, acute appendicitis). Moreover, while developed for surgical conditions, the 
delayed BoD concept can in fact be used for medical conditions as well: it can therefore be 
applied to the stroke, myocardial infarction, or pneumonia patient suffering while waiting to 
receive appropriate treatment.  
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Implications for LMIC settings 
The concepts of met and unmet BoD, access to care, effective coverage and backlog have only 
recently being further explored and applied to global surgical conditions [15, 33-35]. Recent 
reports highlight the great discrepancy between the unmet and the met BoD for various 
conditions [32, 36, 37] and the inadequate effective coverage [33, 38]. Early global backlog 
estimates for isolated surgical conditions are sometimes shocking: a recent report estimated 
that there are over 600,000 children with unoperated cleft lip/palate in Africa and South-East 
Asia alone [16].  
The current effort continues this process of exploring health care inequities and needs in LMICs 
by expanding and quantifying the backlog concept. Not only are there hundreds of thousands of 
children awaiting surgery in LMICs, but they have been waiting for many years all the while 
suffering from the BoD or disability of their condition. This type of information adds a human 
rights component to our clinical activity [37, 39], allowing pediatric surgeons and other 
stakeholders to focus their global involvement efforts, and lobby for additional resources 
needed to address the issue.  
Implications for HICs settings 
The delays in access to surgical care, and associated delayed DALYs, are predictably much lower 
in HICs – but they still exist. While many of the resource limitations operational in LMICs may 
not be relevant here, delays typically reflect waiting times for referral to surgical care as well as 
waiting for surgical intervention. Such delays are reflected in the wait list policies introduced in 
many resource-rich settings, and highlight that such waiting times may not only incur risk to 
life, but engender an associated BoD that we implicitly expect our patients and their families to 
bear [40]. The burden of waiting one year for a hypospadias repair or orchidopexy is not the 
same as that of waiting with a colostomy or a cleft lip/palate – and the methodology presented 
in this paper allows us to estimate and compare BoD accrued through waiting times. Therefore 
the efforts underway in HICs to establish, monitor and compare surgical wait lists could benefit 
from BoD data to allow for more equitable comparisons both within and across surgical 
specialties.  
151
       
 
 
Limitations 
The current study has several significant limitations. In the first place, the choice of the two 
institutions was arbitrary, and the ensuing comparison included widely divergent practice and 
referral patterns at each site. Pediatric surgeons in LMICs have a much broader scope of 
practice, including urology, plastic surgery, and even neurosurgery or orthopedics. Moreover, 
the nature of the practice in most institutions in LMICs is vastly predicated by available skills, 
informal referral networks, funding, geographical and transport realities, and widely uneven 
distribution of specialist care. While the Canadian institution (MCH) may be fairly 
representative of other similar-sized pediatric surgical units in the developed world, the Kenyan 
unit (BKKH) is quite unique in its focus and outputs in the developing world. Therefore the 
findings of this study cannot be easily generalized to other sites, particularly within LMICs.  
The study only presents a snapshot of the delayed BoD from a pre-selected set of 12 surgical 
procedures. These procedures address the 13 non-random health states representing the 
pediatric surgical conditions most prevalent at both sites and for which DW estimates existed. 
Naturally, the extent of the delayed BoD will change significantly among surgical conditions, 
institutions, and geographical regions.  
As mentioned above, the delays observed in our study must be approached with caution. They 
all include the time to original presentation to a health care facility, thus are not only a 
reflection of quality of access to care. Moreover, they are imperfect as it is very difficult to 
identify those patients in both settings whose procedures were intentionally delayed for 
legitimate, medical, reasons. Moreover, the age at surgery collected at MCH was only available 
in years, thus needing conversion into months for delay calculations.  
Identifying an ideal time for surgery for any given condition is not straightforward, and clearly 
depends on the context of care. The authors have been as conservative as possible, selecting 
the older ideal age whenever a range existed in current literature. This approach also addressed 
issues of anesthetic safety in LMICs, which often predicate intentional delays in surgery within 
the neonatal and infancy periods. Finally, the calculation of DALYs also introduced a significant 
level of uncertainty. This is due to multiple assumptions and controversies in the DW estimates 
and age-weighting [10].  
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Conclusions 
Despite the above limitations, the current study highlights a hitherto unaddressed issue in 
global burden of surgical disease research. Any child with a congenital disease apparent from 
birth who is seen and operated on by a surgeon well within her/his childhood or even teenage 
years has suffered a real and measurable burden of disease which can no longer be redeemed. 
An awareness of this reality will hopefully motivate surgeons and policy makers alike to 
increase their efforts globally, while quantifying the delayed burden will foster informed 
prioritization of surgical activity in both the global South and North.  
The recent World Health Assembly side meeting [41], other global action groups [42-44], and 
independent reports [14, 25, 37, 39, 45, 46] have all affirmed the importance of surgery as an 
essential primary care intervention. Knowing not only the extent of the global need we face, 
but also the human cost of delaying intervention can guide us as a profession to face the 
challenges ahead in an informed and committed fashion. 
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Abstract  
Background  
The study measured the success of SmileTrain, the largest cleft charity globally, in alleviating the 
global burden of disease (GBD). It was done by estimating averted disability-adjusted life years 
(DALYs) and delayed averted DALYs because of the global backlog in cleft procedures.  
Methods  
Anonymized data for all procedures in the SmileTrain global database were analyzed by age, sex, 
country, region, and surgery type. DALYs averted were calculated using life expectancy tables and 
established and estimated disability weights. The cost-effectiveness analysis used mean 
SmileTrain procedural disbursement figures. Sensitivity analysis was performed using various 
cleft incidence rates, life expectancy tables, and disability weights.  
Results  
During 2003–2010 a total of 536,846 operations were performed on 364,467 patients—86 % in 
Southeast Asia and the western Pacific region. Procedure numbers increased yearly. Mean age 
at primary surgery—6.2 years (9.8 years in Africa)—remained fairly constant over time in each 
region. Globally, 2.1–4.7 million DALYs were averted through the operations at a total estimated 
cost of US$196 M. Mean DALYs per patient were 3.8–9.0, and mean cost per DALY was $72–$134. 
Total delayed GBD due to advanced age at surgery was 191,000–457,000 DALYs.  
Conclusions  
Despite an unparalleled number of surgeries performed and yearly increase by one charity, the 
unmet and delayed averted cleft GBD remains significant in all regions. Large geographic 
disparities reflect varied challenges regarding access to surgery. Cleft surgeries are cost-effective 
interventions to reduce the global burden of disease (GBD). Future challenges include increased 
collaboration among cleft care providers and a focus on remote global areas by building 
infrastructure and local training.  
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Introduction  
Cleft lip and palate is a relatively common congenital anomaly across the world, with a variable 
incidence worldwide of 1 in 300–1 in 500 new births [1]. Although cleft lip is a disfiguring 
condition and cleft palate carries significant morbidity in terms of feeding and speech 
development, their mortality rate is generally low. Surgical correction is relatively 
straightforward but requires surgical specialty expertise and, particularly in the case of cleft 
palate, good postoperative facilities to avoid potentially deadly early complications.  
In low- and middle-income countries (LMICs) large numbers of children with clefts remain 
untreated for many years, even into adulthood [2]. This situation has created a significant, yet 
unquantified surgical backlog in many LMICs.  
SmileTrain is the world’s leading charity (by numbers treated) providing care for patients with 
cleft lip and palate. Its stated mission is ‘‘to provide a child born with a cleft the same 
opportunities in life as a child born without’’ [3]. It pursues this mission by providing free cleft 
surgery across the world (more than 700,000 surgical interventions over 12 years in 84 countries) 
and training medical professionals (more than 1,400 medical conferences). It also offers 
rehabilitative care such as speech therapy and orthodontics. The unique approach of SmileTrain 
is based on building local surgical capacity through training and funding: currently there are more 
than 2,300 national partner surgeons in more than 1,100 partner institutions.  
The metrics of GBD, expressed in disability-adjusted life years (DALYs), have become essential for 
setting priorities, particularly in LMICs [4, 5]. Within global surgery, the burden of disease has 
been divided into met need (surgical care already provided, or DALYs averted), unmet need 
(potentially avoidable/treatable disability and death due to surgical conditions, or DALYs 
avertable), and unmeetable need (disability and premature death that is unavoidable, even with 
the best surgical care) [4, 6]. When combined with GBD measurements, cost-effectiveness 
analysis can generate $/DALY values for specific interventions.  
This study estimates the averted and delayed averted global burden of cleft disease and the cost-
effectiveness of the work of SmileTrain using GBD methods.  
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Materials and methods  
Data collection  
The main data set was extracted and anonymized from the current SmileTrain database of all 
cleft surgical procedures, obtained directly from and with courtesy of Smile- Train. Data accessed 
in Excel format included age, sex, country, region, and type of surgery. Countries were assigned 
to world regions according to the World Health Organization [7]. Only first-time surgical 
procedures were included in age calculations.  
Effective coverage rates for cleft surgery in each country were calculated for the year 2010 using 
available country-specific population and crude birth rates. A sensitivity analysis was performed 
using three incidences for cleft lip/ palate: 1:700 live births (average global value); 1:300 
(maximum average incidence); and 1:1,500 (minimum average incidence) [1]. Naturally, in many 
countries other cleft charities contribute to the work, although generally their impact is small 
relative to that of SmileTrain. Unfortunately, there are no global data on combined cleft 
interventions, so our calculations are limited to the current data set.  
The backlog in cleft surgeries in each country or region was estimated using the following 
formula: 
Backlog = (actual – ideal age at surgery) * population * crude birth rate  
* cleft incidence 
This formula was based on the observation that, on a national or regional level, each year of 
advanced age at surgery (over and above the ideal age) represents a full cohort equal to the 
number of new cases during that year. For instance, an average age of 3 years at surgery 
corresponds to a backlog of 2.5 yearly cohorts. The age cohorts would be reduced by any 
deaths—a factor that is presumed low in high-income countries but remains unknown in LMICs.  
Again, a sensitivity analysis was performed using the three incidences. DALYs  
Burden of disease estimates were calculated using previously established methods and country-
specific life tables [8]. DALYs were calculated as the product of years lived with disability (YLD) 
and disability weight (DW). Although DW values exist for only a few congenital surgical 
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conditions, they are fortunately available for primary cleft lip and palate [8]. DWs for other cleft-
related procedures were estimated in the present study using paired comparisons with the 
available weights.  
Averted DALYs (met need) were calculated using both country-specific [9] and universal [10] life 
expectancy tables. A sensitivity analysis was also performed using global average DWs (0.049 for 
cleft lip and 0.101 for cleft palate [8]) and treated/untreated DW estimates from the original GBD 
tables [5]. DWs were adjusted by the estimated success of surgery and risk of permanent 
disability as suggested by McCord and Chowdhury [11] and modified by Gosselin et al. [12, 13]. 
The types of surgical procedures with their corresponding DALY formula factors are listed in Table 
1.  
Table 1: Factors for calculating DALYs averted for each surgical procedure 
 Disability weight Risk of permanent 
disability without 
treatment [11Error! 
Bookmark not 
defined.] 
Probability of 
successful treatment 
[11] 
Unilateral cleft lip 
repair 
0.05 1 1 
Bilateral cleft lip 
repair 
0.05 1 1 
Cleft palate closure 0.1 1 0.7 
Cleft lip revision 0.05 1 1 
Closure palatine 
fistula 
0.05 1 0.7 
 
Severity of disease / risk of permanent disability without treatment: 1 for >95%, 0.7 for 50-95%, 0.3 for 5-50%, 0 
for <5%. Effectiveness of treatment:  1 for >95%, 0.7 for 50-95%, 0.3 for 5-50%, 0 for <5%.  
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 Age weighting and discounting [8] are common practices in GBD studies, but they remain 
somewhat controversial, especially when applied to children [14–16]. The assumption, for 
instance, that a cleft disability exists only in children<5 years of age is clearly suspect [17]. In 
LMICs there are literally thousands of older patients (even into their 60s) who continue to suffer 
from this disability. The author therefore chose to do a sensitivity analysis on life expectancy 
tables using both plain values without any age weighing or discounting [the so-called YLL(0,0)] 
and standard YLL(3,1) tables, denoting 3 % discounting of future years and applied age weighing] 
[8]. To avoid crowding charts with all the potential values from these three sensitivity analyses 
for each DALY, we chose three permutations that provided a minimum, maximum, and average 
DALY value.  
Delay in surgical care leads to a hitherto unestimated burden of disability. This ‘‘delayed averted 
burden’’ is probably a component of the unmet need, although the actual time lived with 
disability before provision of care is unrecoverable. We have attempted to estimate it using the 
formula:  
Delayed averted burden = (actual – ideal age at surgery) x DW 
The actual age naturally applies only to the first surgery performed for each child. The ideal age 
is based on conservative international surgical standards of practice (6 months of age for cleft lip 
repair, 12 months for cleft palate). Two separate sets of estimates for delayed averted burden 
were derived based on the DW sensitivity analysis.  
Cost-effectiveness analysis  
The cost-effectiveness analysis (CEA) was performed using mean averted DALYs per procedure 
and the average SmileTrain global reimbursement rates for cleft surgery. These reimbursement 
rates varied slightly by country but not by type of procedure. They were set to cover all surgery- 
related expenses with no cost to the patient. Only primary cleft lip and palate repairs were 
included in this calculation. Again, three sets of $/DALY values were derived for each region, 
corresponding to the three sets of averted DALY values previously calculated.  
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Statistical analysis  
Simple descriptive statistics (totals and averages) were applied to the demographic variables, 
DALYs, and CEA results using Microsoft Excel software.  
Results  
During 2003–2010, a total of 536,846 operations were performed in 79 countries (Fig. 1) on 
364,467 patients. The geographic locations of the procedures are detailed in Table 2. The ratio 
between numbers of cleft lip/palate patients operated on in 2010 and the expected number of 
new cases during that year is shown in Fig. 2. The high and low points of each bar correspond to 
the lower and upper extremes of incidence assumed. SmileTrain therefore performed that year 
approximately 36% of the yearly rate of new cleft surgeries needed in LMICs. In only five of the 
countries (four in Asia and Djibouti in Africa) was the number of surgeries performed equal to or 
larger than the mean yearly incidence of cleft lip/palate. The rare values over 100% simply reflect 
SmileTrain actually starting to address the unoperated cleft backlog.  
 
Fig. 1: World map shows countries with SmileTrain presence during the study 
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Fig. 2: Range of percentage of expected new cases of cleft lip/palate operated on during 2010 by 
SmileTrain, by region. 
 
Upper limit: 1:1,500 incidence; lower limit: 1:300 incidence; arrowhead marker: 1:700 incidence; SEA: 
Southeast Asia 
Table 2: Numbers of cleft procedures by year and region 
 
Africa Americas Eastern 
Europe 
Middle 
East 
SEA* West 
Pacific 
Grand Total 
2003 91 687 139 35 10630 13349 24931 
2004 156 717 122 732 12256 13137 27120 
2005 378 883 143 456 17732 16701 36293 
2006 775 979 155 1497 27640 20388 51434 
2007 3201 4536 245 1706 37680 27279 74647 
2008 5272 6583 166 4629 48775 38445 103870 
2009 6859 6431 904 5622 48317 35861 103994 
2010 9973 7386 2163 8385 52237 34413 114557 
Grand 
Total 
26705 28202 4037 23062 255267 199573 536846 
* SEA = south-east Asia 
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The sex of the patients was predominantly male, with 38.3% females (range 36.7 % in the western 
Pacific region–40.9 % in Africa). Patients with cleft lips with or without cleft palate were 36 % 
female, and those with isolated cleft palates were 48 % female.  
The mean age at primary surgery was 6.2 years, with the highest age (9.8 years) in Africa, and the 
lowest (2.2 years) in eastern Europe (p<0.001). The fluctuations in mean age in each region over 
time are depicted in Fig. 3. Similarly, most individual countries revealed no significant change in 
mean age over the 8-year period. The only notable exception was China, where the mean age 
decreased from 5.1 to 4.1 years.  
Fig. 3: Mean age at primary surgery, by year and region 
 
SEA: Southeast Asia  
The size of the global backlog in cleft surgeries was estimated using various cleft incidences of 
902,581, 2,106,021, and 421,204 patients (mean 1,143,269 patients). The distribution of this 
backlog by region for each incidence is illustrated in Fig. 4.  
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Fig. 4: Size of global backlog in cleft procedures, by region 
 
 
Table 3 shows the distribution of types of surgeries by region and year. Significantly, Africa has a 
great preponderance of cleft lip over cleft palate repairs compared to other regions (p = 0.021).  
The sensitivity analysis permutations selected yielded 2.1, 4.7, and 2.3 million DALYs averted 
through the surgeries over the 8-year period, with an average value of 2.9 million. The range of 
burden of disease values generated by each method is depicted in Fig. 5. The largest component 
of the burden of disease (86 %) was averted in Southeast Asia and the western Pacific region. 
Similar methods used to derive averted DALYs per procedure yielded 3.8, 9.0, and 4.7 DALYs 
(mean 5.8 DALYs). This mean value was lowest in Africa (3.7 DALYs) and highest in eastern Europe 
(6.7 DALYs).  
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Table 3: Distribution of surgical procedures by region, in % 
 
Africa Americas Eastern 
Europe 
Middle 
East 
SEA West Pacific 
Unilateral CL 71.3 29.5 28.9 40.8 46.5 37.1 
Bilateral CL 12.2 8.3 7.7 8.2 8.2 6.6 
CP 10.9 34.8 47.8 38.8 31.6 43.2 
Revision CL 3.9 21.0 12.5 10.5 10.0 11.0 
Fistula 
closure 
1.7 6.3 3.2 1.7 3.7 2.1 
CL = cleft lip; CP = cleft palate; SEA = South-East Asia 
Fig. 5: Averted cleft disability-adjusted life years (DALYs), by region.  
  
Estimate A: YLL(0,0) * global average disability weights (DWs) * risk of permanent disability * effectiveness of 
treatment. Estimate B: YLL(0,0) * DCP1 DWs without/with surgery. Estimate C: YLL(3,1) * DCP1 DWs without/with 
surgery 
The total delayed averted burden of cleft disease due to advanced age at surgery by region is 
shown in Fig. 6. The total burden over 8 years was estimated by two methods at 190,910 and 
456,625 DALYs, respectively (average 323,768 DALYs). The distributions of the delayed averted 
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burden by year and sex were similar to those of the averted DALYs. Figure 7 demonstrates that 
the mean delayed averted burden per patient, regardless of the method used, correlated directly 
with the age at surgery, being highest in Africa and lowest in eastern Europe.  
 
Fig. 6: Delayed averted total DALYs derived using two methods, by region.  
 
Method A: using average global DWs. Method B: using DWs with/without treatment  
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Fig. 7: Delayed averted burden of cleft disease per patient derived using two methods, by region.  
 
Method A: using average global DWs. Method B: using DWs with/without treatment 
The total cost estimated for the procedures performed was US$195,948,790. The sensitivity 
analysis carried out for averted DALYs per procedure was then used to calculate the mean cost 
per DALY, resulting in values of $100, $44, and $81, respectively. The cost per DALY by region is 
charted in Fig. 8, which shows the cost to be highest in Africa.  
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Fig. 8: Range of dollars per DALY derived using three methods, by region 
 
The same methods used in Fig. 5 were used here. 
Discussion  
Using the GBD framework, initial estimates suggested that 14 million DALYs, or about 9 % of 
surgical DALYs and 1 % of all DALYs, are due to congenital conditions [6]. Subsequent work 
estimated averted DALYs through individual hospitals and surgical missions [11–13]. Although 
less useful for health systems planning than population-based data, this approach documented 
the impact of specific interventions and generated simple cost-effectiveness analyses. Though 
not population-based, the current study is truly global: In 2010, SmileTrain treated between 13 
and 66 % of all new cleft cases in its 79 countries of activity.  
Table 2 shows that SmileTrain-funded surgical procedures have steadily increased in all regions. 
The vast majority (84.7 %) were done in Southeast Asia and the western Pacific. These regions 
are densely populated, and the infrastructure and human resources allow scaling up of programs. 
As SmileTrain primarily funds procedures by local surgeons, countries with a critical mass of 
surgeons can increase significantly their surgical output with external funding. Consequently, Fig. 
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2 shows that Asian countries had the highest ratio of repaired versus estimated new cleft 
lip/palate cases (73.8 %), regardless of the calculation method. In contrast, fewer than 20 % of 
new cases in Africa were repaired in 2010, despite a huge backlog. This is likely multifactorial: 
limited availability of surgeons and adequate facilities, poor communication and access to 
information and care in remote areas, and administrative challenges.  
The sex split in procedures favors males (62 %). This is consistent with the literature for cleft lip 
with or without palate (60–67 %) but is higher than expected for isolated cleft palate, where the 
expected male ratio is only 33 % [18]. In some areas, this suggests that sex bias may affect 
families’ decision to seek care for children with less visible deformities (cleft palate).  
The average age at surgery for any congenital condition ideally repaired soon after birth can be 
used as a surrogate marker of ‘‘surgical backlog’’ (the number of unoperated children/adults in 
a population who are older than the ideal age for that procedure). Predictably, African patients 
were the oldest at surgery (mean 9.8 years) and European patients the youngest. In fact, many 
cleft lip repairs in Africa and other LMICs were performed on senior citizens.  
The size of the global backlog in cleft surgeries was estimated by three different methods to be 
between 421,000 and 2.1 million—a tremendous challenge for any cleft intervention. The 
backlog distribution mirrors not only population trends but also effective coverage for the 
condition. Figure 4 shows that Africa and SEA have the most severe problem. Addressing the 
backlog is complicated by the increasing surgical challenge and worsening functional results of 
cleft palate repairs in patients with increasing age [2].  
The natural expectation is that at any given site the age distribution will steadily decrease over 
time as the backlog is addressed. Although this may indeed be happening in some individual 
institutions [19], it was not observed at any country or regional level except China. With more 
than 26,000 primary cleft surgeries performed in 2010, China is probably one of the few countries 
were SmileTrain and other organizations are at least beginning to address the global cleft 
backlog.  
In contrast to other regions, age distribution in Africa actually increased from 2.0 to 10.7 years 
(Fig. 3). This is likely because early in each program procedures were performed at national 
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centers of expertise, where the mean age of patients was already quite low [20]. The program 
then expanded to remote areas, with much older patients. Another factor for the age plateau is 
the continuous opening of new programs in each country, generating a mixed picture nationally 
and regionally.  
The balance between cleft lip and palate procedures in Asia, the Americas, and eastern Europe is 
similar, resembling incidence statistics for the condition [19]. For several likely reasons, Africa 
has a significantly lower rate of cleft palate repairs, as reported previously [2, 21–23]. First, cleft 
palate, unlike isolated cleft lip, can be fatal in infants, thus creating a ‘‘hidden mortality’’ [24], 
resulting in fewer cleft palate operations. In addition, patients are more likely to access care for 
a visible, disfiguring condition (cleft lip) than for a hidden, functional one (cleft palate). In fact, 
Wilson and Hodges [24], as well as others, have suggested performing the palate surgery with or 
even before the lip surgery, thereby increasing the chance of patients returning for the second 
surgery [2, 21]. Finally, surgery for cleft palate is more challenging than for cleft lip, requiring 
better facilities and postoperative care. As SmileTrain disbursement rates are identical regardless 
of procedure, the incentive to repair palates is diminished [19].  
Bickler et al. [4] have suggested that burden of surgical disease can be divided into met, unmet, 
and unmeetable need. Our study focused on the met need (avertable DALYs), generally the only 
component estimable without population-based data. DALY calculations confirmed the large 
burden of disease averted through SmileTrain funding. Whereas the DALY values correlated 
closely with numbers of procedures, the mean DALY values per procedure were lowest in Africa. 
This was because of the older patients (fewer averted years left to live with disability) and lower 
life expectancy in the region. Overall, most DALYs were averted in Southeast Asia and the western 
Pacific, consistent with the literature [6]. In 2010, an estimated 308,476–638,030 DALYs were 
averted in those two regions, corresponding to 4.4–9.1 % of the 7 million DALYs estimated by the 
Bellagio Working Group for all congenital surgical conditions in those regions [25].  
Our data also allowed estimation of the delayed averted burden caused by the YLD before 
surgery. This previously unidentified factor is part of the unmet need, although its irrecoverable 
nature makes it behave more like an unmeetable need. Not only is past suffering not recoverable, 
but in the case of many pediatric surgical conditions delay in care may be associated with more 
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difficult procedures and higher likelihood of complications. A 20-year-old patent with unoperated 
cleft palate will not only have needlessly suffered for 19 years from the sequelae of her condition, 
but her surgery will be more challenging than in a 1-yearold, and her speech deficits likely 
irreversible.  
This study provides the first minimum estimate of the delayed averted burden of disease and 
highlights its magnitude. The general lack of decrease in mean delayed averted DALYs in all 
regions (and actual increase in Africa) is explained by the significantly less than 100 % of new cleft 
cases repaired each year by SmileTrain. Singh estimated the cleft backlog in India at 
approximately 1 million cases, which would take 100 years to clear if 15,000 surgeries were 
performed yearly above the cleft incidence [26]. Our estimates of backlog were more 
conservative (e.g., between 233,000 and 544,000 in India), but the magnitude remains 
significant. Other cleft charities also operate in most countries but with limited additional impact 
on the overall backlog.  
Cost-effectiveness analysis has been a natural companion to GBD work. Several recent 
publications explored the cost-effectiveness of short-term surgical missions [11–13]. In cleft 
work, Magee et al. [17] assessed the cost-effectiveness of eight Operation Smile missions, costing 
primary cleft surgeries at $796 (using standard life tables) or at $34 after extending disability 
beyond the age of 5 years. They included only direct costs incurred by the mission, with no 
mention of institutional or patient costs. Corlew [16] compared two methods of estimating the 
economic impact of cleft repairs (gross national income per capita and value of a statistical life), 
documenting favorable cost-effectiveness.  
Cost-effectiveness analysis in this study relied on a simple, preset reimbursement rate for all cleft 
procedures, rather than actual costs incurred. Figure 8 highlights the significantly higher cost per 
DALY in Africa compared to other world regions. This is likely due to the artificial ‘‘leveling of the 
playing field’’ through similar SmileTrain reimbursements globally combined with the lower 
number of averted DALYs per patient in Africa. Moreover, health care costs in Africa are often 
surprisingly high compared to those in other LMICs—evidenced by 50,000 Kenyans opting for 
surgical tourism to India, for instance [27].  
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Estimates of $72–$134 per DALY compare favorably with other interventions in LMICs [8, 11]. 
Even for the poorest countries, $100 represents only a fraction of the gross domestic product 
(GDP) per capita when, according to the World Health Organization, ‘‘interventions costing less 
than 3 9 the GDP per capita for each DALY averted represent good value for money’’ [28]. Our 
data thus support the cost-effectiveness of specialized surgery in children and greater resource 
allocation toward pediatric surgical care in LMICs [4, 6].  
Limitations  
There are several limitations to the current study. Smile- Train’s involvement in any given country 
is nonrandom, being governed by a variety of logistical ad hoc reasons. Our sample, although 
large, is not fully representative of LMICs (only 79 of 171 LMICs are represented). Also, within 
each country additional cleft work is often performed by other providers.  
Second, DWs for procedures not included in the GBD project [8] and values for risk of permanent 
damage and probability of successful surgery are, in the absence of available literature data, 
entirely the author’s educated estimates. The current paucity of DW data in the surgical GBD 
literature reflects the challenge of empirically deriving valid weights [29] and the limited interest 
in covering the spectrum of individual condition weights. As such, it behooves our surgical 
community to contribute to the literature and validate DW values for the conditions of interest 
to us.  
Another limitation in our backlog calculations is the ideal age of surgery for each condition. 
Standards for timing of surgery exist in developed countries but continuously change and evolve: 
cleft lip surgery is usually performed at 3 months of age. In recent years, it is often accompanied 
by soft palate closure, with delayed hard palate closure by 12–15 months. These standards may 
need to be modified in LMICs. We used more traditional repair guidelines, setting the ideal repair 
time for cleft lip at 6 months and for cleft palate at 1 year.  
Finally, in the CEA we opted for the reimbursement value for each surgery as an appropriate 
surrogate of cost. Although the actual costs may be (in the author’s experience) anywhere 
between 50 and 100 %of the reimbursement rate, their value is less important because the 
ultimate cost of the surgery among all providers (hospital, surgeon, anesthetist, cleft charity) is 
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the reimbursement value. It must be noted, however, that this value primarily covers variable 
(operating), rather than fixed (capital depreciation), costs [13].  
Conclusions  
Despite a remarkable number of surgeries performed and the yearly increase by one cleft charity, 
the unmet and delayed averted global burden of cleft disease remains significant in all regions. 
Large geographic disparities reflect varied challenges regarding access to surgery. Cleft surgeries 
are cost-effective interventions to reduce GBD. Collaboration between cleft surgery providers is 
necessary to advocate for resources and allocate them most appropriately. Scaling up care for 
cleft patients must focus on more difficult-to-reach areas globally by building infrastructure and 
training local expertise.  
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Abstract 
Background 
This study attempts to quantify the burden of disease averted through the global surgical work 
of a large cleft charity, and estimate the economic impact of this effort over a ten-year period. 
Methods 
Anonymized data of all primary cleft lip and cleft palate (CLP) procedures in the Smile Train 
database were analyzed and disability-adjusted life years (DALYs) calculated using country-
specific life expectancy tables, established disability weights (DWs), and estimated success of 
surgery and residual disability probabilities; multiple age weighting and discounting 
permutations were included. Averted DALYs were calculated and gross national income (GNI) 
per capita was then multiplied by averted DALYs to estimate economic gains. 
Results 
548,147 primary cleft procedures were performed in 83 countries between 2001-2011. 547,769 
records contained complete data available for the study; 58% were cleft lip and 42% cleft 
palate.  Averted DALYs ranged between 1.46M  and 4.95M. The mean economic impact ranged 
between USD 5510 and 50,634 per person. This corresponded to a global economic impact of 
between USD 3.0B  and 27.7B USD, depending on the DALY and GNI values used. The estimated 
cost of providing these procedures based on an average reimbursement rate was USD 197M 
(0.7-6.6% of the estimated impact).  
Conclusions 
The immense economic gain realized through procedures focused on a small proportion of the 
surgical burden of disease highlights the importance and cost-effectiveness of surgical 
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treatment globally. This methodology can be applied to evaluate interventions for other 
conditions, and for evidence-based health care resource allocation. 
Introduction 
Several metrics have been used in the measurement of health interventions, including life 
expectancy, mortality rates, Disability-Adjusted Life Years (DALYs), Quality-Adjusted Life Years 
(QALYs), and others [1,2,3]. However, in order to compare the societal impact of health care to 
other sectors, a common measurement tool is needed. Economic assessment is such a cross-
sector “universal currency”, its main drawback being the difficulty of measuring economic 
benefit.  
This study uses a framework derived from previous work [4,5,6,7,8,9,10,11] to examine the 
economic value of the programs of a non-governmental organization.  Smile Train (ST) supports 
the surgical care of patients with cleft lip and palate (CLP) in low- and middle-income countries 
(LMICs). ST identifies and trains surgical teams in each country and contracts to provide 
operative care for a pre-determined fee per case [12]. This model is akin to the specialty 
surgical hospital platform described by Shrime et al [13], but uses LMIC surgeons exclusively. 
Given that CLP impacts the social, physical, and economic lives of affected individuals, this study 
estimates the economic impact of the ST work, providing a framework for examining the value 
of health interventions for cross-sector comparison. 
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Methods 
The approach was to estimate the economic productivity of treated individuals, then derive the 
counterfactual of their economic productivity had they not been beneficiaries of the programs. 
The database of all procedures performed in ST programs between 2001 and 2011 was utilized. 
Only primary (first-time) CLP repair procedures were included. Country-specific life expectancy 
(LE) values were used, rather than a universal value as used by the Global Burden of Disease 
(GBD) study [14].  
The standard DALY formula was used for burden of disease (BoD): DALYs = YLL (Years of Life 
Lost) + YLD (Years Lived with Disability). The YLL factor was omitted in light of the small 
mortality of cleft lip and palate.  
The counterfactual BoD in DALYs potentially incurred by each patient without the surgical 
intervention (which includes the non-avertable as well as the avertable DALYs [15]), was 
estimated thus: 
BoDwithout intervention = (DWuntreated * ageoperation ) + (DWuntreated * LEage at treatment) 
 where DWuntreated = disability weight for CLP untreated (both DWuntreated and DWtreated from the 
GBD study [16] and LEage at treatment = life expectancy at the age the operation occurred, from the 
Standard West Level 26 Life Table [17]).   
DALYs actually incurred by each patient , or the BoDwith intervention, were then estimated in two 
ways. The first used the GBD study method for calculating DALYs :  
BoDwith intervention = (DWuntreated * ageoperation) + (DWtreated * LEage at operation)   
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DALYs incurred with the intervention were also estimated by the method published by McCord 
et al Error! Bookmark not defined.[11] and widely followed in the surgical literature [18,19,20,21]. This 
method multiplies the ideal impact of surgical intervention by the Risk of Permanent Disability 
without surgery (RPD) and the Estimate of Residual Disability (ERD) after the operation. The 
latter factor aims to account for the residual effects of the deformity, the possibility of post-
operative complications, and the possible need for further procedures. In CLP the RPD is 1.0, 
since disability is expected in the absence of surgery in 100% of cases, while the resolution of 
disability (1-ERD) was estimated to be between 75 – 94% for cleft lip and between 25-74% for 
cleft palate. For the purpose of this study the two factors were combined into a single 
“Effectiveness Factor” (EF) of 0.8 for cleft lip and 0.5 for cleft palate, similar to the previously 
used “Probability of Successful Treatment” (PST) for CLP [10]. This Effectiveness Factor 
postulates that the operation, on average, resulted in resolution of 80% of the residual 
disability for cleft lip and 50% for cleft palate patients. This EF was hence used in place of the 
DWtreated: 
BoDwith intervention = (DWuntreated*Ageoperation ) + (DWuntreated * (1-EF) * LEAge at operation)     
 The difference between DALYs without and with surgical intervention represents the effect of 
the intervention on the health status of the patient and, globally, on alleviating BoD. Figure 1 
shows the calculation markers in a schematic fashion.  
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Figure 1: Diagram of age milestones and calculations used for estimating averted DALYs 
 
 
 
DALYs were calculated with and without age weighting as was done in the original GBD study 
[22], and with and without 3% future discounting. 
These averted DALY values were then multiplied by the GNI per capita for each country [23] to 
give the economic value added to the national economy over the lifetime of each patient. Using 
both the Atlas and Purchasing Power Parity (PPP) methods, two economic totals for each 
country were derived for each DALY calculation. The methodologies used in this study for 
calculating DALYs and the economic gain are shown diagrammatically in Figure 2.  
DALYs if no treatment (counterfactual): 
Birth           Ageoperation                            LE 
  |______________________________|______________________________________________________________________________| 
   DWuntreated*Ageoperation+                DWuntreated*LEAge at operation                       
 
 
DALYs with treatment using GBD methodology: 
Birth           Ageoperation                        LE 
  |______________________________|______________________________________________________________________________| 
  DWuntreated*Ageoperation+                  DWtreated*LEAge at operation                        
   
 
 
DALYs with treatment using Effectiveness Factor: 
Birth           Ageoperation                        LE 
  |______________________________|______________________________________________________________________________| 
  DWuntreated*Ageoperation+       DWuntreated*Effectiveness Factor*LEAge at operation           
 
Averted DALYs = DALYs if no treatment – DALYs with treatment 
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Figure 2: Diagram of sensitivity analysis methodologies used in calculating the economic value of 
interventions 
 
 
Individual totals were summed to give an estimate of economic value added for the entire 
program. This was reported by year and for the entire period of the study. 
A cost-effectiveness analysis (CEA) was performed as previously reported for Smile Train [10]. 
As actual costs at the hundreds of individual sites vary widely and were not available, the set 
contributions per procedure paid by the organization were used as a proxy. 
Data analysis and simple descriptive statistics were performed in Microsoft Excel®.  
186
 
 
 
Results 
Tables 1 and 2 show the results in very accessible format.  Between 2001-2011, 548,147 
primary operations to repair CLP were performed in 83 countries. Figure 3 shows the cases 
available for study and the patient characteristics.   
Figure 3: Cases available for study and Patient characteristics 
548,147 cases in database 
 
378 cases from Palestinian Territories excluded 2° to Life Table data not available 
 
547,769 cases for burden of disease analysis  
4396 cases from Myanmar and Somalia 2° to no World Bank economic data for these years 
 
543,373 cases for economic study 
 
No PPP data for Argentina, and Atlas data only through 2006, so Argentina cases after 2006 used 2006 
GNI/cap data; Argentina cases excluded from PPP analysis. 
Djibouti data only available through 2005, so Djibouti cases after 2005 used 2005 GNI/cap data 
 
543,373 cases for study: 
38% female   62% male 
 
58% cleft lip   42% cleft palate 
average age 5.56  average age 6.80 
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Table 1: Averted Burden of Disease in DALYs per patient and total 
 
 
 Sum of averted DALYs using Eff factor 
 0,0 3,0 3,1 
Cleft Palate 1,749,252 759,125 921,451 
Cleft Lip 1,607,513 704,900 834,406 
Total 3,356,765 1,464,025 1,755,857 
 Sum of averted DALYs using GBD DW treated vs. untreated 
Cleft Palate 3,271,329 1,419,662 1,723,233 
Cleft Lip 1,681,327 737,268 872,721 
Total 4,952,656 2,156,930 2,595,954 
 Average of averted DALYs per pt using Eff factor 
Cleft Palate 7.61 3.30 4.01 
Cleft Lip 5.06 2.22 2.63 
Total 6.13 2.67 3.21 
 Average of averted DALYs per pt using GBD DW treated vs. untreated 
Cleft Palate 14.22 6.17 7.49 
Cleft Lip 5.29 2.32 2.75 
Total 9.04 3.94 4.74 
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Table 2: Economic Gain per patient and total by method of calculation 
 
 
 
 
Total averted DALYs achieved by method of calculation and year are shown in Figure 4. Table 1 
details the DALYs averted by procedure and by the various calculation methods. Using the GBD 
DW method, about one-third of the averted BoD was due to cleft lip repairs and two-thirds to 
cleft palate repairs; using the effectiveness factor method this was slightly greater than half, 
both reflecting the greater disability associated with cleft palate.  
Atlas 0,0 PPP 0,0 Atlas 3,0 PPP 3,0 Atlas 3,1 PPP 3,1
CP 32,216 82,405 13,693 35,303 16,478 42,629
CL 10,362 27,639 4,391 11,843 5,102 13,847
Total 19,538 50,634 8,297 21,693 9,878 25,932
Atlas 0,0 PPP 0,0 Atlas 3,0 PPP 3,0 Atlas 3,1 PPP 3,1
CP 17,227 44,064 7,322 18,877 8,811 22,795
CL 9,907 26,426 4,198 11,323 4,878 13,239
Total 12,981 33,832 5,510 14,495 6,529 17,251
Sum of 0,0 Altas 
economic gain
Sum of 0,0 PPP 
econmic gain
Sum of 3,0 Atlas 
econ gain
Sum of 3,0 PPP 
econ gain
Sum of 3,1 Atlas 
econ gain
Sum of 3,1 PPP 
econ gain
CP 7,409,516,181 18,952,646,713 3,149,314,664 8,119,377,845 3,789,848,882 9,804,409,158
CL 3,292,831,886 8,782,991,330 1,395,432,488 3,763,409,139 1,621,160,945 4,400,167,793
Total 10,702,348,067 27,735,638,043 4,544,747,152 11,882,786,984 5,411,009,827 14,204,576,950
Sum of 0,0 EF 
Atlas econ gain
Sum of 0,0 EF 
PPP econ gain
Sum of 3,0 EF 
Atlas econ gain
Sum of 3,0 EF 
PPP econ gain
Sum of 3,1 EF 
Atlas econ gain
Sum of 3,1 EF 
PPP econ gain
CP 3,962,032,958 10,134,401,368 1,684,008,536 4,341,611,764 2,026,516,416 5,242,635,452
CL 3,148,268,535 8,397,396,589 1,334,169,598 3,598,186,299 1,549,988,025 4,206,989,694
Total 7,110,301,493 18,531,797,956 3,018,178,134 7,939,798,063 3,576,504,442 9,449,625,147
Average economic gain per pt using DW untreated vs. treated (USD)
Average economic gain using Effectiveness Factor (USD)
Sum of economic gain using DW untreated vs. treated (USD)
Sum of economic gain using Effectiveness Factor (USD)
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Figure 4: Averted BoD through cleft lip and palate surgery by method and year 
          
 
 
 
Values derived for the economic gain from repair of cleft lip and palate using the Atlas 
methodology for GNI ranged between 3.0  billion and 10.7 billion USD and between 7.9 billion 
and 27.7 billion USD using PPP. Using the effectiveness factor, for each person undergoing cleft 
lip repair, the average economic gain, calculated without age weighting or discounting, was 
9,907  USD using the Atlas method and 26,426  USD using PPP. For cleft palate, these gains 
were 17,227  USD by Atlas and 44,064  using PPP. Using the GBD method of calculating DALYs, 
these figures were 10,362 USD Atlas and 27,639 USD PPP for cleft lip and 32,216 USD Atlas and  
82,405 USD PPP for cleft palate.  These data are detailed in Table 2. Figure 5 depicts the ranges 
of economic impact by method per year.  
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Figure 5: Economic impact by year and calculation method without age weighting or discounting. 
 
 
The overall cost for the interventions studied was estimated at 197 million USD, which 
represents between 0.7 and 6.6% of the estimated economic gain, depending on the valuation 
method used. In terms of cost-effectiveness, this represents between $40 - 135 / DALY. 
Discussion 
This study is an effort to quantify the value of a global surgical program in economic terms. 
Besides providing economic data on the impact of surgical repair of CLP, the methodology lends 
itself to similar calculations in other specialties and programs. 
The current study builds on several preceding reports of economic modeling of interventions 
[4,6,8,9,24]. Methodologically, measuring the economic benefit of a health intervention 
requires four data points: definition of the health problem, definition of the intervention and its 
probability of success, quantitative estimates of the change due to the intervention, and a 
method of converting the health effect into economic terms. [5] All of these require significant 
assumptions and are subject to multiple methodological approaches to address the 
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assumptions. These lead to wide confidence intervals, but barring extensive, expensive, and 
lengthy direct studies of individual economic productivity, such assumptions are necessary.  
While the anatomic clefts are the core problems comprising the defects studied, there are 
secondary issues: hearing problems, increased rates of infection, difficulties eating and 
corresponding malnutrition, and orthodontic problems.  These are addressed through the DWs 
from the GBD study and the “effectiveness factor” (EF) method.  
In regard to the interventions, the mean age of the patients was quite advanced, reflecting a 
significant backlog [10] and delayed access to surgical care in LMICs. The preponderance of cleft 
lip repairs does not reflect the expected relative incidence of CLP, thus pointing towards a 
possible tendency to repair cleft lips but not palates. This has been observed in low-resource 
settings [10] and may even reflect a hidden mortality of cleft palate infants [25]. Finally, the 
gender distribution is skewed with a preponderance of males, a potential reflection on gender 
inequity issues in many low-resource settings.  
The DALY data reflect the large BoD which is avertable through surgical intervention even in a 
narrow specialty.  The 1-5 million DALYs averted over 10 years is viewed in the context of an 
estimated 25 million DALYs for overall surgical BoD in Africa [26], and the mean averted DALYs 
per patient is similar to those estimated for hydrocephalus and inguinal hernia [6,27]. 
The economic value of improved health resulting from the surgical interventions was 
determined using GNI per capita, based on the premise that each individual theoretically 
contributed an equal share. A first assumption was that CLP affects equally all sectors of society 
regardless of socioeconomic stratum, a reasonable assumption based on current epidemiologic 
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knowledge.  A second assumption was that DALYs account for all the social, psychological, and 
secondary losses associated with CLP. Alternative econometric methodologies such as labor 
productivity, willingness to pay, value of a statistical life, or direct income studies may be the 
focus of future studies. 
The GNI data indicate a very substantial economic impact, in keeping with other reports on 
surgery in limited resource settings. Using a similar methodology, Alkire et al estimated the 
economic impact of treating CLP in Sub-Saharan Africa (SSA) to USD 252 - 441 million, while 
Warf et al projected the economic impact of surgically treating hydrocephalus in SSA to around 
1 billion USD [6].  
Cost-effectiveness analysis (CEA) is significantly limited in this context by the assumptions 
necessary in the modeling, but is a natural extension of studies of economic impact. A frequent 
metric of CEA is the $/DALY. The current estimate of $40-135/DALY compares favorably with a 
previous report from Smile Train of $70-134/DALY for CLP repairs [10] and with other CLP CEA 
studies ranging between USD 29 – 285/DALY [4,28,29]. 
Limitations 
There are several limitations to the current study, some of which have been alluded to above. 
First, the sample is not random – the locale of the interventions, both nationally and regionally, 
reflects strategic and logistic choices within one large non-governmental organization. Absent 
data for some countries compounds this effect, though it affects a very small proportion of the 
entire dataset.  
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DALY calculations rely on DWs which are notoriously difficult to estimate accurately [30] and on 
subjective effectiveness factors. In the face of multiple competing strategies such as age 
weighting and future discounting, the authors’ only recourse was to offer ranges rather than 
precise values. One specific additional limitation of our study was the assumption that mortality 
from CLP is negligible, which in some low-resource settings may not be true [25]. Higashi et al. 
found that in addition to a small mortality attributable to the cleft deformity, there also was a 
higher all-cause mortality in unrepaired than repaired clefts throughout life. [31] Any mortality 
associated with cleft deformities would serve to increase our estimates of economic benefit to 
repair.  The uncertainty is also exacerbated by the econometric estimates, which include two 
alternative methodologies (Atlas and PPP) yielding disparate results.  
This study does not purport to evaluate complications, quality of care, externalities, or any 
other measures of the specific procedures performed. It also does not specifically account for 
the costs of the procedures; our cost-effectiveness analysis relied on the average 
reimbursement rates paid by the organization for each intervention.  
There are other reasons for believing that our economic estimates, while impressively high, are 
still underestimates. It is well-recognized that school attendance, cognitive development, and 
social development during childhood have significant effects on adult productivity [32], and this 
is not included in the DALY estimates. The Smile Train work also includes a number of 
secondary procedures which increase the economic impact of this surgical program.  
Conclusions 
The current study documents the tremendous economic value of a scaled surgical program. 
Whether the actual contribution to the global economy is closer to 3 billion or 30 billion USD, it 
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highlights the significant economic and public health value of vertical surgical interventions like 
CLP repair in low-resource settings. For a donor cost under 200 million USD, a 15- to 150-fold 
increase was added to the economies of the 83 beneficiary countries. Moreover, the clinical 
effect of these surgical interventions is a permanent one, not requiring ongoing therapy or 
expense to maintain or renew the gain. Congenital anomalies such as CLP are the ultimate 
“poverty trap” as described by Banerjee and Duflo [33], as without resolution of these issues 
there is little opportunity for the individual who otherwise has the same potential as any other 
person to break out of her/his economic state. 
While the current study is limited to a small area of surgical care, similar studies can be 
undertaken in other specialties. Such studies would add to the growing body of evidence 
supporting the value and cost-effectiveness of surgical care as a primary health intervention 
globally. This should inform advocacy efforts for resource allocation in the funding of health 
care globally.  
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Chapter 11 
General Discussion 
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This section will overview the entire work presented in chapters 1 through 9 and summarize it, 
highlighting the key findings and identifying the key limitations and gaps left. Finally, it will point 
to the areas of further research generated by the current work, and the most potentially 
rewarding directions for expanding this work.  
Major findings 
Part I 
In a global health measurement context dominated by a wealth of DALY-based data painstakingly 
generated each year by the Institute for Health Measurement Evaluation (IHME)(6), the current 
work started, in chapters 1 and 2, by asking some uncomfortable questions. Yes, the DALY has 
proven itself a useful metric in such global-sized estimates of BoD, enabling country comparisons 
and, in particular, identification of detailed trends over time for the health ailments of our 
society. But when it comes to the surgeon who joins a surgical mission and wants, at the end of 
her stay, to know the real impact she has made, does this measurement system work?  
The answer is generally guarded. The same DALYs which seemed to perform well in expressing 
the global BoD from malaria or hypertension seem much more difficult to apply to pediatric 
surgery. There are several obvious reasons for this: first, in an attempt to cover the entire 
spectrum of human disease, we are lacking disability weights (DWs) for many important surgical 
conditions. Secondly, even the published DW values available often appear to lack face and 
construct validity, and rarely include both pre-operative and post-operative (residual) values (31). 
Moreover, a multitude of uncertainties limit the value and credibility of the actual DALY values, 
with debates still raging around the validity of age weighing and future discounting, use of 
universal or local life expectancies, and the best way to estimate DW values cross-culturally (32). 
And ultimately, DALY values were designed to measure global burden of disease rather than 
impact of treatment, thus averted DALY values in isolation have little meaning. 
If the current DALY framework does not serve the surgical community well, what alternatives do 
we have? While chapter 1 focused on the weaknesses and limitations in the traditional use of 
DALYs, chapter 2 offered several practice-based alternatives. These could be divided into 
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evolutionary (step-wise) and revolutionary (disruptive) approaches. The evolutionary strategies 
retain the DALY as choice metric for BoD, but tweak it for improved use in surgical work. Here 
the traditional division of BoD into avertable, averted, and non-avertable (11) stands out, 
together with the novel addition by this author of the fourth category: the delayed (or prevalent) 
averted burden suffered through delayed access to care. Alternative methods of DW estimation 
before and after surgical intervention are also included here. 
More disruptive alternatives offered include the concepts of “need” rather than burden, again 
divided into unmet, met, unmeetable, and delayed (or prevalent) need. Other ways to quantify 
BoD include surgical backlog (for non-fatal disease) and effective coverage, as well as economic 
approaches to evaluating surgical care provision, such as cost-effectiveness analysis and long-
term economic impact.  
The conclusion of part I is that the framework for surgical BoD measurement is not currently 
adequate in providing reliable, defendable and convincing data needed in surgical subspecialties. 
The field is however young and opportunities for different or revised metrics exist. 
Part II 
The second part of this thesis explored some venues for addressing the concerns expressed in 
part I, and identifying better ways to quantify surgical need and surgical impact.   
As this entire work is within the subspecialty of pediatric surgery, the first task was to generate a 
solid set of DW values within that specialty. This presented the challenge of selecting in a small-
scale DW derivation experiment a solid methodology, comparable to the large-scale GBD studies 
produced by the IHME. The challenge however became a unique opportunity: to compare and 
select the most appropriate valuation method(s) for DW estimation, and to compare the resulting 
DWs across cultures. 
These objectives were accomplished in chapter 3 by selecting, based on existing literature, two 
psychometric and two econometric valuation methods used in other similar DW estimation 
projects, and comparing the DW values thus obtained for a set of 15 congenital surgical health 
states. Reassuringly, the four methods yielded strikingly similar results for each health state, thus 
supporting the validity of using any one of these methods in future DW estimates. Moreover, the 
202
 
 
values obtained in an LMIC setting (Kenya) were quite similar to those obtained in an HIC setting 
(Canada), supporting the cross-cultural usability of the results. In fact the only geographic 
discrepancies noted were in the health states related to fertility (ranked more important in low-
resource settings) and cosmetic appearance (ranked less important). For the few health states 
for which previous DW values had been published by the GBD group, the newly derived values 
showed high levels of agreement with existing values. This initial study thus demonstrated that 
valid DW values can be readily generated in surgical specialties. 
An alternative method of estimating DW values had been introduced two decades ago by Murray 
(4) and subsequently widely used in surgical BoD studies (16–18). It grades each surgical 
condition on a functional scale in terms of specific limitations in ability (of recreation, education, 
procreation, and occupation). While less precise than direct estimation, this method expands the 
DALY metric calculations to any disease condition or health state, and thus formed the basis for 
the studies presented in chapters 4 and 5. Moreover, the method lends itself to quantifying 
overall BoD, as would be encountered in a population. Thus in a field dominated by institutional 
studies, chapter 4 explored a population-based surgical BoD due to congenital conditions. This 
novel experiment combined a random household survey design with a photographic portfolio of 
common visible congenital conditions, contrasting results presented both as prevalence values 
and as DALYs, thus highlighting the qualitatively different information generated through the 
DALY metric.  
Expanding the basic GBD concepts to surgical interventions introduced the concept of “met 
need” measured in averted DALYs, which requires reliable residual disability values following 
surgical intervention. This task was tackled in chapter 5, which sought to measure the impact of 
pediatric surgical work in a defined population: a large self-enclosed refugee camp in northern 
Kenya. Here as in subsequent studies, the residual post-operative surgical disability was 
estimated using McCord and Chowdry’s method of modulating post-intervention DALYs by the 
risk of permanent disability and the probability of successful treatment (16). This generated a 
first-time quantification of the actual impact of targeted surgical interventions in children, both 
overall and per patient. The study went however beyond standard DALYs. In this classic setting 
of delayed access to care (most children had virtually no access to surgical care before entering 
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the camp) the study quantified for the first time the “burden of waiting” for surgical care, in 
delayed averted DALYs. It also expressed the surgical burden and activity within the population 
in non-DALY terms, revealing a very poor effective coverage (under 15%) in the camps. Finally, 
the study used basic cost-effectiveness analysis (CEA) to document the high cost-effectiveness of 
the range of pediatric surgical procedures performed in the camp: between $40 - $90/DALY, 
which is vastly superior to the WHO standard typically applied (33).  
Once the new methodology had been successfully applied to individual populations, the stage 
was set for comparative institutional studies, aimed at revealing the differences in surgical BoD 
alleviation between high- and low-and-middle income countries. Chapter 6 was specifically 
designed to use the newly derived DW values from chapter 3 in the native settings where these 
values had been generated. This permitted a unique comparison of impact in averting surgical 
BoD between two pediatric surgical units in countries literally at the opposite ends of the Human 
Development Index (34). While the individual types of surgical procedures predominant in each 
institution reflected various socio-economic factors, the study highlighted the higher averted 
DALYs (met need) both overall and per procedure in the low-resource setting.  
While the comparison of met DALYs between the two economically disparate sites highlighted 
broad variations in practice and surgical need, contrasting delayed (prevalent) averted DALYs can 
provide a unique window into access to care at each site. This was the aim of chapter 7, which 
measured for the first time in the literature the “burden of waiting” in DALYs. The study identified 
precisely the types of procedures or specialties for which this burden of waiting is greatest, at 
both sites. And while the delayed averted burden was predictably much higher in the low-
resource setting, the estimation of a BoD secondary to delayed access to care in the high-
resource setting offers a novel way to empirically support patient waitlist discussions in the 
surgical specialties.   
The next step (proceeding in fact in parallel with the previous ones) was to use the entire 
spectrum of BoD measurement and impact valuation methods developed in order to describe 
and audit the large-scale ongoing work of global surgical providers. SmileTrain, world’s largest 
cleft charity, provided a fitting dataset for such an exploration. Do the millions of dollars donated 
yearly “to ensure that every child born with a cleft—anywhere in the world—has the opportunity 
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to live a full and productive life” (35) translate into a commensurate impact on burden of cleft 
disease, is cost-effective, and truly benefits economically the communities in which it is 
implemented? This was the subject of chapters 8 and 9, two studies based on a 600,000 patient 
global database provided by the SmileTrain organization. In chapter 8 the surgical need met 
through the charity was first calculated for each global region, highlighting the major global 
impact that a surgical charity can have. This “happy story” message however was dampened by 
the estimates of delayed averted burden, effective coverage, and backlog in cleft care. Delayed 
access to cleft surgery resulted in up to half a million delayed DALYs (prevalent or “lost” DALYs of 
children having suffered from the disease before their condition was treated). As for the numbers 
of children operated yearly in each region, though it was impressive (SmileTrain has now 
provided over one million cleft surgeries globally (35)), it is still smaller than the number of new 
cases of cleft lip and palate (the “incident need”) born yearly within some regions. Thus as the 
surgical work impacts this incident need, the prevalent need (or backlog) continues to grow. One 
of the most sobering findings of the study was, in fact, its first-time estimation of backlog in cleft 
surgeries – a staggering million cases globally, with over 300,000 children waiting for surgery in 
both Africa and South-East Asia alone. On the economic side, however, the news was better: 
repairing cleft lips and palates could be done at the very affordable price of USD 70-130 / DALY, 
well in keeping with other surgical procedures in LMICs, and less expensive, for instance, than 
treating a person with HIV/AIDS (23). 
Finally, chapter 9 explored further the economic benefits of the same surgical charity. It 
estimated an economic impact between USD 5,500 – 50,000 per person, translating into an 
immense USD 3 to 28 billion globally over a 10-year period of time. Most notably, these gains 
were realized very efficiently against costs averaging between 1 – 7% of the gains. The Lancet 
Commission on Global Surgery stated that addressing surgical needs can increase the GNP of 
individual nations by up to 2-3% (25), and this last chapter points in the same direction.  
Overall, from Part II it can be concluded that the theoretical framework as introduced in Part I 
could be applied to providing a variety of global health care indicators applicable and meaningful 
to surgical specialties.  
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Limitations 
As any work in a new field, the current project suffers from two main types of limitations: 
limitations in scope (“acts of omission”), and threats to validity and reliability (“acts of 
commission”). We will start with the latter, which must be duly recognized before any significant 
conclusions are drawn. 
Regarding threats to validity and reliability and sources of uncertainty, all BoD work is fraught 
with significant limitations, introduced at each step in the calculations. Many of these limitations 
are in fact discussed in detail in chapter 1, which offers a critique of the DALY methodology. As 
described there, all the DALY studies in this thesis suffer from assumptions and value choices 
centering on three issues: universal vs. regional life expectancy, use of age weighing and future 
discounting, and the very concept of disability weights. This set of limitations was addressed in 
all relevant chapters by providing sensitivity analyses and presented ranges rather than distinct 
values, highlighting the degree of uncertainty propagated across the project. The concept of 
disability weight itself, central to the current project, has been met with multiple critiques and 
rebuttals for decades (36,37). Fundamentally, it undertakes the philosophically challenging and 
questionable task of assigning value to suffering, and opens itself to questions of context, culture, 
and myriads of socio-economic factors. Moreover, DWs are not necessarily stable over time, and 
may vary significantly even within one health state with its infinite potential levels of severity. 
Like the DALYs themselves, arguably the greatest weakness of DWs is at the more fundamental 
level of semantics: are respondents grading the clinical handicap associated with a given health 
state (the “disabling impairment”), or the pain and social stigma of the condition (the actual 
“disability” (38)), or both? 
Having acknowledged from the onset these methodological limitations, the empirical studies of 
part II (chapters 3-9) still built on these assumptions, and in fact added some new ones. The 
central methodological study deriving new DWs (chapter 3) noted that each valuation method 
used for DW derivation comes with its own value choices, and the decision as to how to combine 
the DWs derived by each method into one unitary value introduced further uncertainty.  
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Applying the DALY framework to populations (as in chapters 4 and 5) added significant limitations 
in sampling methods, survey validity, and non-random choice of procedures undertaken based 
on availability of skills. Estimating met need, and thus residual disability, is by itself a very 
approximate process based on expert opinion, rather than actual observation, of complication 
rates. Moreover, such complication rates with their ensuing residual impairments vary widely 
between high- and low-resource settings, and even between providers and sites in similar 
settings. Also, calculating exact averted DALYs for health states requiring more than one surgical 
intervention (as in the case of staged procedures) is both difficult and inexact. Finally however, it 
must be borne in mind that the DALY framework was in the first place designed for estimating 
overall burden of disease, not the impact of intervention. 
The novel concept of delayed averted BoD relies on measurement of the delay itself, which is 
imprecise as the ideal timing for surgical intervention for any congenital condition often varies 
with expert opinion and with local facilities such as anesthetic support. Furthermore, it is difficult 
to assess delays in care predicated by associated anomalies, predilection for combined multi-
system interventions to minimize anesthetic use, and patient / caregiver preference.  
In this work surgical backlog has been estimated in a novel way using the mean age of the patients 
operated, with the implication that choice of intervention among patients with the same 
condition is independent of age. This assumption is generally, but not universally, correct. One 
example of such an exception are surgical interventions in children with cleft palate, where many 
surgeons do not offer palate closure above a set age (typically 10 years) in light of limited chance 
of speech recovery in older children.  
Effective coverage is generally a simple and “fool-proof” concept, but it clearly varies widely 
geographically - and thus any attempts to generalize the data obtained must be viewed with 
caution. Moreover, in the case of the SmileTrain work, the prevailing assumption was that all 
cleft interventions in the countries where SmileTrain worked where funded and provided by that 
organization. This assumption is inaccurate, as other cleft providers contribute a small but 
variable minority of the surgical procedures.   
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Finally, cost-effectiveness analyses and economic valuations arguably introduce some of the 
greatest levels of uncertainty. Here uncertainties in DALYs are compounded by the challenges of 
estimating direct and indirect costs of care, and in the studies of the cleft surgeries these costs 
were, of necessity, replaced by artificial reimbursement rates. As for the economic valuations, 
there are multiple options available for estimating such data across countries, and the chosen 
option of simple multiplication of averted DALYs by the GNI is naturally crude. 
The other major set of limitations in the current work pertains to “errors of commission” – gaps 
that have not been covered or were incompletely addressed. There are several examples of such 
gaps in the project. For instance, the disability weights were estimated using four deliberately 
chosen valuation methods, with many other, potentially equally appropriate, methods being 
omitted. Also, cleft BoD estimates omit deaths from the disease and focus only on disability. 
While deaths from cleft disease are indeed rare, they are definitely not nil (39).  
Cost-effectiveness analyses in our studies were very simplistically undertaken, using SmileTrain 
per-case reimbursements as a surrogate of actual direct and indirect costs. This is clearly 
inaccurate, as costs are often lower (though occasionally higher) than the agency’s 
reimbursements, depending on hospital type and national costs of care. The omitted presence 
of other cleft surgery providers in each country of SmileTrain activity did not affect the averted 
DALYs, CEA, or economic impact, but accurate backlog and effective coverage data would require 
including the elusive total number of cleft surgeries performed in each region.  
Directions for future research 
A good research study should raise more questions than it has answered – and our work is 
certainly no exception. The process of improving and applying the BoD framework to a surgical 
specialty is complex, and the current project is only a beginning. The inquiry started with the 
critique of the existing methods and then suggested some new ones - but ultimately no good, all-
round, metric for burden of surgical disease burden has been found. While backlog and effective 
coverage are useful adjuncts, they clearly don’t appear to be replacing the DALYs. The quest for 
an ideal metric continues. 
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The methodology used for estimating DWs in pediatric surgery has generated useful and valid 
results. The method would however benefit from validation in other specialties, using either the 
same four valuation methods or any of the single individual ones shown to yield similar results. 
This strategy offers a simple and efficient way of generating specialty-specific DWs for use in 
quantifying the burden of surgical disease in any specialty area.  The cultural aspect of DWs is 
also not settled – and duplicating the study in other socio-economic settings would likely prove 
very useful. 
When estimating residual disability after surgical interventions, we have used very granular 
extrapolated criteria for success and complications. A key study would be needed to validate this 
technique by comparing it to the “gold-standard” – actual long-term follow-up of patients post-
operatively.  
The population study included in the project was quite limited in extent and validity, and it invites 
further similar population studies with larger household sample sizes and wider sampling of other 
sets of diseases. Such an expanded study may be combined with a standardized country-wide 
tool, such as the SOSAS tool (40).  
The comparative study of two pediatric surgical centers was significantly affected by the 
uniqueness of each institution chosen, significantly limiting generalizability. Replicating such 
studies in other centers and with other predominant pathologies is necessary.  
One of the novel approaches in BoD studies introduced by this work is the hitherto 
underdeveloped concept of surgical backlog, which is simple and very easily applicable. The age 
cohort method is attractive but will require empirical validation though studies where this 
method can be compared to direct population-based estimates of backlog.  
Within the existing DALY framework as applied to surgical care, the emerging concept of delayed 
or prevalent averted burden is also novel, requiring further exploration and application to other 
specialties. This concept could also be expanded in high-resource settings where it provides first-
hand empirical evidence of morbidity (rather than mortality) in surgical wait list systems designed 
to prioritize surgical services.  
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Beyond the extended application and validation of the key findings of this work, the research 
agenda in global pediatric surgery remains extensive. The existing work published through the 
Lancet Commission on Global Surgery offers a good, if challenging, point of departure. Much of 
the data generated to support the main statements and recommendations of the Commission 
will need to be contextualized and applied to children’s surgery. Following are some suggested 
research deliverables needed to achieve this goal, both from the LCoGS and outside it: 
 Identify number of children globally who don’t have prompt access to surgical care; 
 Estimate number of additional surgical interventions globally needed to provide adequate 
surgical care to children; 
 Estimate numbers of surgical and anesthesia providers required to adequately staff the 
needed surgical interventions; 
 Develop reliable markers of quality of pediatric surgical care and easy-to-use indices of 
care; 
 Identify “bellwether procedures” for children’s surgery, as markers of hospitals able to 
provide essential pediatric surgical services; 
 Estimate percentages of pediatric population, regionally and globally, at risk of 
catastrophic and impoverishing out-of-pocket expenditures for surgical care;  
 Identify major barriers to surgical care of children and reasons for delayed access. 
“The fields are ripe with the harvest, but the workers are few” (Luke 10:2). As the global academic 
community affirms its commitment to equitable health care for the world’s children, the research 
agenda ahead is growing, presenting global health researchers with ample opportunities for 
significant and meaningful projects. 
Conclusions 
The current thesis focused on the burden of disease encountered and addressed in pediatric 
surgery. It started by identifying the weaknesses in the current GBD system and the gaps that 
needed to be filled. It then proceeded in identifying a variety of existing and newly developed 
measures, both incremental and disruptive, which would render the GBD framework better 
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suited for measuring the impact of surgical endeavors. These measures were then uniquely 
applied and tested in a variety of clinical settings in low- and high-income countries, and their 
specific benefits identified. Many other areas of investigation however remained unanswered 
and will require further studies.  
Despite some significant limitations, the work has demonstrated the process of applying the GBD 
framework to pediatric surgery, and constitutes therefore a model for similar BoD projects in 
other surgical specialties. Through studies such as the current one and those which will follow, 
global health care workers will be increasingly empowered with scientific data for concerted 
advocacy and fund allocation decisions in limited-resource areas.  
And then hopefully, the surgeon returning from the medical mission will have a clear idea of the 
impact that she has had. 
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Introduction 
Global surgery is a relatively new surgical discipline. Its focus is not just on international surgery, 
but on equity of resources and advocacy - establishing it therefore not only as a professional and 
academic discipline, but extending its sphere of action into social activism and health care policy. 
One primary focus of global surgery is the study of the global burden of surgical disease, which is 
measured in disability-adjusted life-years (DALYs). The DALY is a “health gap” measure, a 
summary measure of health incorporating both mortality and morbidity data. Its basic formula 
is: 
DALY = YLL + YLD = N * LE + I * LE * DW, 
where YLL = years of life lost, YLD = years lived with disability, N= number of deaths, LE = life 
expectancy at onset of disease, I = number of incident cases in the population over period of 
time, and DW = disability weight. 
Within surgery, the burden of disease has been divided into met burden (averted DALYs), unmet 
burden (avertable DALYs), and unmeetable burden. Furthermore, estimates of residual DALYs due 
to disability (morbidity) following surgical intervention have allowed researchers to calculate the 
actual impact of surgical interventions for various conditions, as well as the cost-effectiveness of 
surgery, expressed in $/DALY. 
There is however no data available in the literature on the met and unmet burden of pediatric 
surgical disease, or its cost-effectiveness. Part of the reason for this was the absence of disability 
weights for even common pediatric surgical conditions, which are needed to calculate DALYs. 
 The aim of this work was to first develop a burden of disease framework for pediatric surgery, 
then estimate the burden of pediatric surgical disease by generating disability weights for 
pediatric surgical conditions. These DWs were then applied in various settings both in high-
income countries (HICs) and especially low-and middle-income countries (LMICs), and used to 
measure the impact and cost-effectiveness of pediatric surgery. 
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Discussion 
The thesis includes 2 major parts. Part I reviews and critiques the current theoretical framework 
for surgical burden of disease measurement, offering several alternative metrics usable in 
pediatric surgery. Part 1 includes chapters 2 and 3, which discuss various metrics of burden of 
disease from their perspective of suitability to surgical disease, and propose refined or alternative 
metrics for use in global surgical care. Part II builds up on the aforementioned theoretical 
framework through several empirical studies which explore its implications and applications. This 
includes generating DWs for pediatric surgery, then building the evidence for the burden of 
surgical disease in children and the cost-effectiveness of its treatment. 
Chapter 4 focuses on estimating DWs for common pediatric surgical conditions. It details the 
methodology used to derive these DWs and the results obtained in two widely divergent health 
care settings (HIC and LMIC). 
Using the DWs generated in chapter 3, the magnitude of the pediatric surgical burden of disease 
in various African settings is surveyed and estimated in chapter 5 (using population-based data) 
and chapter 6 (using institutional data). DALY-based estimates were complemented in these two 
chapters by measures of effective surgical coverage and surgical backlog, and data on the cost-
effectiveness of interventions. 
Moving from estimating total burden of disease to estimating averted burden (or "met need") 
through surgical intervention, chapter 7 expands the work started in chapter 3 by using the 
newly-derived DW values to measure averted burden of disease in the two (LMIC and HIC) 
pediatric surgical settings where the weights had been derived. 
The previously undescribed concept of delayed averted burden "lost" through various delays in 
accessing surgical care is examined in chapter 8 by comparing the results between an LMIC and 
HIC setting. This study shows the applicability of the delayed averted burden not only for 
estimating the impact of delayed access to care in LMICs, but also for surgical wait list burden in 
high-income countries. Chapter 9 applies the same concept in the context of one disabling 
condition (cleft lip and/or palate), as chapter 5 also applied it to one isolated population world's 
largest refugee camp). 
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The empirical valuation of surgical interventions on children in LMICs was then undertaken using 
the $/DALY metric in two settings: the global work of a large surgical charity (chapter 9) and the 
work of another, smaller, charity in a defined population (chapter 6). Finally, chapter 10 uses the 
same large data set of chapter 9 to estimate the global economic impact of one large surgical 
charity. 
Conclusion 
The work described basically applies, for the first time, the burden of disease framework to the 
specialty of pediatric surgery. It seeks first to define and improve this framework, generates 
critical factors in the burden of disease calculations, then applies them in a variety of settings to 
produce an essential corpus of data necessary for all future endeavors in the field of global 
pediatric surgery. 
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Introductie 
Global surgery (letterlijk: mondiale chirurgie)  is een relatief jonge chirurgische discipline. De 
focus ligt niet alleen op de mondiale chirurgie, maar ook op het promoten van een rechtvaardige 
en toegankelijke gezondheidszorg wereldwijd. Global surgery laat zich kenmerken als een 
professie en academische discipline, maar draagt ook bij aan het op de politieke agenda zetten 
van verbetering van de gezondheidszorg en ontwikkeling met betrekking tot internationale 
gezondheidszorg. 
Het meten van ziektelast of „Burden of Disease“ is een kernactiv iteit van Global Surgery.  Dit 
wordt uitgedrukt in DALYs (disability adjusted life-years). De DALYs is een maat voor de totale 
hoeveelheid gezondheid die verloren gaat in een bevolking door ziekte, opgebouwd uit twee 
componenten: het verlies aan levensjaren en en verlies in kwaliteit van leven in jaren geleefd met 
ziekte. In formule:  
DALY = YLL + YLD = N * LE  + I * LE * DW 
waarbij YLL = verloren levensjaren, YLD = jaren geleefd met ziekte, N = aantal sterfgevallen,  
LE = levensverwachting bij optreden van de ziekte, I = aantal incident gevallen in de bevolking,  
DW = wegingsfactor voor ziekte.  
Binnen de chirurgie, wordt onderscheid gemaakt naar ziektelast die wordt voorkomen door de 
chrirugie (averted DALYs), en ziektelast die niet is voorkomen (unmet burden), en ziektelast die 
niet kan worden voorkomen (unmeetable burden).  Verder worden er ramingen gemaakt van de 
rest-morbiditeit na een operatie om onderzoekers te helpen de werkelijkle impact van 
chirurgische ingrepen voor verschillende condities te berekenen, evenals de kosten-effectiviteit 
uitgedrukt in $ / DALY. 
Er zijn echter geen gegevens beschikbaar in de literatuur over de voorkomen en onvervulde 
ziektelast van pediatrische chirurgie ziekte, of over de kosten-effectiviteit ervan. Een van de 
redenen hiervoor was de afwezigheid van wegingsfactoren voor de ernst van veel voorkomende 
aandoeningen in dit vakgebied die nodig zijn voor de berekening van DALYs.  
Het eerste doel van dit proefschrift was een conceptueel kader te ontwikkelen voor ziektelast 
van aandoeningen in de pediatrische chirurgie, en vervolgens om de ziektelast meetbaar te 
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maken door wegingsfactoren voor de betreffende aandoeningen te ontwikkelen. Die 
wegingsfactoren zijn vervolgens gebruikt om de effecten en kosteneffectiviteit van pediatrische 
chirurgie te meten, in landen met hoge inkomens (HIC) maar vooral lage-en midden-inkomens 
landen (LMICs).  
Discussie 
Het proefschrift bestaat uit 2 delen. Deel I beschrijft en bekritiseerd het huidige theoretisch kader 
voor het meten van ziektelast van chirurgische aandoeningen, en presenteert alternatieve maten 
die geschikt zijn voor gebruik in pediatrische chirurgie. Deel 1 bevat de hoofdstukken 2 en 3, 
waarin de bruikbaarheid van traditionele ziektelast maten wordt besproken voor aandoeningen 
in de chirurgie, en voorstellen worden gedaan voor verfijning of alternatieve maten.  
Deel II bouwt voort op de eerder genoemde theoretisch kader met empirische studies die de 
implicaties en toepassingen verkennen. In dit deel worden de wegingsfactoren vastgesteld voor 
aandoeningen binnen de pediatrishce chirurgie, om vervolgens gegevens te verzamelen over de 
ziektelast die kinderen met deze aandoening ervarer en de kosteneffectiviteiy van de 
behandeling van deze aandoeningen.  
Hoofdstuk 4 richt zich op het schatten van wegingsfacotern voor veel voorkomende pediatrische 
chirurgische aandoeningen. Het beschrijft hoe de wegingsfactoren zijn vastgesteld en hoe de 
resultaten van pediatrische chirurgie verschillen tussen landen met een hoog inkomen en landen 
met lage of midden inkomens.  
Gebruik makend van de wegingsfactoren voor ziekten uit hoofdstuk 3, is berekend hoeveel 
ziektelast aandoeningen in het gebied van de pediatrische chirurgie genereren in verschillende 
Afrikaanse landen op basis van populatie gegevens (hoofdstuk 5) en institutionele data 
(hoofdstuk 6). De ziektelast metingen vanuit het DALY kader zijn in die berekeningen aangevuld 
met informatie omtrent chirurgische dekking en chirurgische achterstand, en gegevens over de 
kosten-effectiviteit van interventies.  
Aanvullend hierop beschrijft hoofdstuk 7 hoeveel ziektelast in lage- en midden inkomens landen 
en in hoge inkomens landen wordt voorkomen met pediatrische chirurgie.  
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Hoofdstuk 8 vergelijkt voor lage- en midden inkomens en voor hoge inkomens landen de 
consequenties van vertragingen in de toegang tot chirurgische zorg, waardoor een deel van de 
te voorkomen of afgewende ziektelast (averted burden) niet gerealiseerd wordt. Deze studie laat 
zien dat delayed averted burden een toepasbaar concept is voor het inschatten van de gevolgen 
van de vertraagde toegang tot zorg in lage en midden inkomens landen, maar ook voor de 
gevolgen van wachtlijsten voor chirurgie in landen met hoge inkomens. Hoofdstuk 9 past delayed 
averted burden toe in een specifieke setting, namelijk bij de behandeling van schisis (hazenlip en 
/ of gespleten gehemelte)  in een geïsoleerde populatie ( 's werelds grootste vluchtelingenkamp). 
Ten slotte is er een economische evaluatie uitgevoerd van chirurgische ingrepen bij kinderen in 
lage en midden inkomenslanden, voor twee instellingen:  een instelling die mondiaal actief is 
(hoofdstuk 9) en een andere, kleinere instelling die haar activiteiten tot een specifieke populatie 
heeft beperkt (hoofdstuk 6). Hoofdstuk 10 berekent tot slot de wereldwijde economische impact 
van een grote, mondiaal actieve liefdadigheidsinstelling voor chirurgie, gebruik makend van de 
gegevens uit hoofdstuk 8.  
Conclusie 
Dit proefschrift past voor het eerst het ziektelast concept toe in de pediatrische chirurgie. 
Kritische factoren voor verfijning en uitbreiding van het ziektelast kader voor dit veld zijn eerst 
gedefinieerd, en daarna toegepast om in meerdere contexten gegevens te genereren die richting 
geven aan toekomstige inspanningen op het gebied van de pediatrische chirurgie.  
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